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SUMMARY
1 The yeast Rhodotorula graminis strain KGX 39 can grow on D(—)- or L(+)-mandelate as 
a sole source of carbon and energy. The first step in the dissimilation of mandelate 
involves stereospecific oxidation to phenylglyoxylate, and this is then degraded via 
benzaldehyde to benzoate. Preliminary evidence had indicated the presence of a 
dye-linked L(+)-mandelate dehydrogenase and an NAD+-dependent D(—)-mandelate 
dehydrogenase in this organism. This thesis is concerned with the purification and 
characterization of the NAD+-dependent D(—)-mandelate dehydrogenase.
2 A reliable and reproducible method for the purification of D(—)-mandelate 
dehydrogenase was developed, and the procedure involved chromatography on 
DEAE-Sephacel, Phenyl Sepharose and Matrex Gel Orange A. The procedure yielded 
1-2 mg of protein from 40-50 g wet wt. of cells. The enzyme was homogeneous as judged 
by denaturing and non-denaturing polyacrylamide-gel electrophoresis and could be 
stored for several months at -20°C with negligible loss of activity.
3 D(—)-Mandelate dehydrogenase is a dimer as judged by comparison of the subunit 
Mr (38 000) and native Mf (77 200) values estimated by SDS-PAGE and gel filtration 
respectively.
4 The amino acid composition indicated the presence of only one cysteine residue per 
subunit. The approximate number of residues per subunit calculated from the amino acid 
composition and subunit Mf was 354.
5 The first 57 residues from the amino terminus were sequenced. No significant 
homologies were apparent when the sequence was compared with an archived database 
containing the sequences of over 10 000 proteins. However, the amino terminal did 
contain a run of 9 residues which could usefully be converted into an oligonucleotide 
•probe" for cloning the D(—)-mandelate dehydrogenase gene.
6 The absorption spectrum showed no evidence that the enzyme was associated with or 
contained bound flavin, haem or cytochrome as prosthetic group.
7 D(—)-Mandelate dehydrogenase catalyses the reversible interconversion of 
D(—)-mandeiate and phenylglyoxylate. The assay procedures developed to measure 
D(—)-mandelate dehydrogenase involved monitoring the reduction of NAD+ 
(forward/oxidation reaction) and the oxidation of NADH (reverse/reduction reaction) at 
340 nm. The enzyme produced approximately equimolar amounts of phenylglyoxylate 
and NADH, indicating that the enzyme catalyses a reaction with a stoicheiometry of 1 mole 
of D(—)-mandelate oxidised per mole of NAD+ reduced. The equilibrium constant, K ' , 
for the oxidation of D(—)-mandelate was calculated to be 1.59 x 10‘11 M and thus 
reduction of phenylglyoxylate is thermodynamically favoured.
x i x
8 The optimum pH for the oxidation of D(—)-mandelate was 9.5 and the optimum for the 
reduction of phenylglyoxylate was 5.85. The pi value of the enzyme was 5.9.
9 D(—)-Mandelate dehydrogenase is an NAD(H)-dependent enzyme and transferred the 
pro-R hydrogen from the C4 position of the dihydronicotinamide ring of NADH to 
phenylglyoxylate. The enzyme was unable to couple the oxidation of D(—)-mandelate to 
the reduction of NADP+ or the reduction of phenylglyoxylate to the oxidation of NADPH. It 
was also unable to use DCIP or DCIP plus PMS as artificial electron acceptors.
10 D(—)-Mandelate dehydrogenase was not active with L(+)-mandeiate as substrate 
although it was a competitive inhibitor of the enzyme. A number of ring-substituted 
mandelates and ring-containing mandelate analogues were substrates. The enzyme was 
not active with a range of aliphatic 2-hydroxy and 2-oxocarboxylic acids as substrates 
although they could inhibit enzymic activity.
11 D(—) -Mandelate dehydrogenase was not inhibited by a range of possible metabolic 
inhibitors including benzaldehyde, benzoate, succinate, glucose, ADP/Mg2+, ATP/Mg2+ 
or acetyl-CoA, although the oxidation reaction was inhibited by high concentrations of 
phenylglyoxylate.
12 D(—-)-Mandelate dehydrogenase was neither activated nor inhibited by a range of 
salts and metal ions, neither was it inhibited by the metal chelating agents EDTA, 
diethyldithiocarbamic acid, bathophenanthroline disulphonic acid, dihydroxybenzene 
disulphonic acid, pyrazole, 8-hydroxyquiniione or 2 ,2-dipyridyl.
13 D(—)-Mandelate dehydrogenase was inhibited by A/-ethylmaleimide but not by the 
thiol reagents 4-(chloromercuri)benzoate, iodoacetate, iodoacetamide or 
5,5'-dithiobis(2-nitrobenzoic acid).
14 The Km values for D(—)-mandelate and NAD+ at pH 9.5 were 319 {jM and 71 fiM 
respectively, and the maximum velocity was 123 pmol min'1 (mg protein)'1. The apparent 
Km and V values of D(—-)-mandelate, NAD+, phenylglyoxylate and NADH at pH 5.85, 
pH 7.0, pH 8.0 and pH 9.5 were determined. At all values of pH tested the apparent Km 
values for phenylglyoxylate and NADH were significantly lower than for D(—)-mandeiate 
and NAD+, and the apparent maximum velocities were significantly greater in the reverse 
(reduction) reaction than in the forward (oxidation) reaction.
15 Methods were developed for the synthesis and purification of the affinity label 
D(—)-2-(bromoacetyI)mandelic acid. Mass spectrometry, 1H-NMR spectroscopy, circular 
dichroism and elemental analysis were used to confirm the synthesis of the compound.
XX
16 D(—)-2-(Bromoacetyl)mandelate irreversibly inactivated D(—)-mandelate  
dehydrogenase. The inactivation obeyed rate saturation kinetics and the substrate, 
D(—)-mandeiate, protected the enzyme from inactivation. The enzyme was inactivated 
with a stoicheiometry of 1.27 moles of label bound per mole of enzyme subunit.
1 7  D (  — ) - M a n d e l a t e  d e h y d r o g e n a s e  i n a c t i v a t e d  w i t h  
D(—)-2-(bromo[14C]acetyl)mandelate was digested with trypsin to produce peptides for 
purification and sequencing. Substrate protection experiments indicated that 2 tryptic 
peptides were specifically labelled by the inhibitor. Both of these (TP 1 and TP 2) were 
purified, although only TP 1 could be purified to homogeneity. A further, 
non-radiolabelled, tryptic peptide (TP 3) was purified for sequencing. All 3 tryptic peptides 
were sequenced and although no significant homology was evident upon comparison 
with a database of archived sequences, TP 1 had similar sequence to regions at the 
carboxy termini of Pseudomonas putida mandelate racemase and L(+)-mandelate 
dehydrogenase.
18 Several mandelate-utilising yeasts were isolated from natural environments by 
selective enrichment. The ability of these yeasts, and other yeasts from culture 
collections, to grow on D,L-mande!ate as a sole source of carbon and energy was tested. 
Extracts of those yeasts capable of growth on D,L-mandeIate were assayed for mandelate 
dehydrogenase activity.
19 Antisera were raised in rabbits against the R. graminis D(—-)-mandelate 
dehydrogenase. Anti-ft graminis D(—)-mandelate dehydrogenase sera cross-reacted 
with their homologous antigen and with 3 other yeast NAD+-dependent mandelate 
d e h yd ro g en a s es , but not with the  m an d e la te  d e h yd ro g en a s es  of 
Acinetobacter caicoaceticus, Lactobacillus curvatus or the D(—)-2-hydroxyisocaproate 
dehydrogenase of Streptococcus faecalis. Anti-A caicoaceticus D(—)-mandelate 
dehydrogenase serum cross-reacted with its homologous antigen but not with any of the 
other mandelate dehydrogenases tested.
20 The final chapter discusses the possible evolutionary origin of the R. graminis 
D(—)-mandelate dehydrogenase and the relationships between it and other mandelate 
dehydrogenases and NAD+-dependent dehydrogenases. The possible use of this 
enzyme as a diagnostic test for urinary 4-hydroxy-3-methoxymandelate is also discussed. 
The chapter concludes with possible future lines of research.
CHAPTER 1 
INTRODUCTION
1.1 The comparative enzymology of prokaryotes and eukaryotes
1.1.1 Introduction
On the whole, zoologists and botanists have used morphological criteria to classify the 
animal and plant kingdoms, although such criteria are of limited use in classifying 
microorganisms such as bacteria and yeasts. Therefore, microbiologists have turned to 
physiological and metabolic differences amongst microorganisms to distinguish them. 
However, since the advent of biochemical techniques which have allowed determination 
of gene sequences and the properties of their respective gene products, it has been 
possible to look for relationships amongst organisms at the molecular level, indeed, it was 
sequence analysis of bacterial 16S ribosomal RNA (rRNA) and the analogous 18S rRNA of 
eukaryotes that led to the important discovery that methanogenic bacteria were a group of 
organisms as distinct from eubacteria and eukaryotes, as eubacteria and eukaryotes were 
from each other (Woese & Fox, 1977). Later studies revealed that halophilic bacteria, 
sulphur-dependent and thermoacidophilic bacteria were also members of the 
archaebacteria, and that many of their biochemical properties are exclusive to this group 
(Fewson, 1986).
it is well established that prokaryotes (archaebacteria and eubacteria) and 
eukaryotes form two distinct groups of organisms which differ with respect to their cellular 
organisation. For example, eukaryotes uncouple transcription and translation by means 
of a nuclear envelope, they possess rough endoplasmic reticulum, Golgi cisternae, 
microtubules, microfilaments, lysosomes and other "microbodies*, larger ribosomal 
subunits, and have linear rather than circular chromosomes (Cavalier-Smith, 1981). 
However, both groups have a common requirement to carry out the essential metabolic 
processes, and we can therefore pose the question as to whether these two distinct forms 
of life have evolved similar or dissimilar metabolic pathways. The fossil record is of little 
use in helping to answer this question, although extant genetic sequences may be 
regarded as fossils" in that they represent the successful descendants of their ancestors. 
We are able to determine these gene sequences, compare them and so determine 
whether they are likely to have evolved from a common ancestor. The sequences of many 
thousands of genes and proteins are now known, as are the tertiary structures of over 400 
proteins (Eisenberg & Hill, 1989; Thornton & Gardner, 1989). Numerous studies have 
compared groups of related proteins and it is widely accepted that significant sequence 
homology between two proteins is indicative of evolutionary relatedness. Furthermore, 
detailed structural studies of particular groups such as the cytochromes, globins and 
serine proteases have revealed that the tertiary structure is related to the primary structure 
of the polypeptide and, moreover, that the difference between homologous proteins is 
directly related to the extent of the sequence divergence (Chothia & Lesk, 1986).
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1.1.2 Central metabolic pathways
There are numerous examples of enzymes from centra! metabolic pathways which have 
been purified and characterized from both prokaryotes and eukaryotes, and this offers the 
opportunity to compare them and to ask the question: How similar are they ?
The most extensively characterized central metabolic pathway is the glycolytic 
pathway, with more known about the detailed structures of the enzymes involved than 
about any other comparable group (Fothergill-Gilmore, 1986). Sequence data are 
available for virtually all of the enzymes and in three cases, phosphofructokinase, 
triosephosphate isomerase and glyceraldehyde-3-phosphate dehydrogenase, the 
sequences of the enzymes from prokaryotes and eukaryotes have been determined. 
Unfortunately, crystallographic studies have concentrated mainly on eukaryotic enzymes, 
although the three dimensional structures of phosphofructokinase and 
glyceraldehyde-3-phosphate dehydrogenase from Bacillus stearothermophilus are known 
(Biesecker etal., 1977; Artavansis-Tsakonas & Harris, 1980; Kolb etal., 1980; Walker et a/., 
1980; Evans et al., 1981; Leslie & Wonacott, 1984).
The third enzyme of the glycolytic pathway, phosphofructokinase, is an allosteric 
enzyme that catalyses the irreversible transfer of a phosphoryl group from ATP to 
fructose 6-phosphate. It is subject to feedback control and is believed to play an 
important role in regulating flux through the pathway. The enzymes from E  coli and 
B. stearothermophilus are tetramers with subunit Mf values of approximately 33 000, and 
although the enzymes from mammals are also tetramers they have considerably larger 
subunit Mt values of about 85 000 (Fothergill-Gilmore, 1986). Furthermore, the enzymes 
differ with respect to their mode of allosteric regulation. Whilst the bacterial enzymes are 
activated by ADP and GDP, and inhibited by phosphoenolpyruvate, the regulation of the 
mammalian enzymes is more complex as they are activated by AMP, ADP and cyclic AMP 
and inhibited by ATP and citrate (Fersht, 1985). On the basis of these comparisons the 
two enzymes would seem to be sufficiently different that the possibility of common 
ancestry is unlikely. However, evidence for a common evolutionary origin for the two 
groups has come from comparison of the amino acid sequences of the enzymes from 
B. stearothermophilus and rabbit muscle. Although the rabbit enzyme is approximately 
twice the size of the B. stearothermophilus enzyme, the bacterial enzyme is homologous 
to both the amino and carboxy terminal halves of the rabbit enzyme, suggesting that the 
mammalian enzyme has evolved by duplication and fusion of a gene to yield another 
homologous gene with twice its original size (Figure 1.1; Poorman et al., 1984; 
Fothergill-Gilmore, 1986). Interestingly, the amino terminal half of the rabbit enzyme is 
more like the bacterial enzyme (44% homology) than is the carboxy terminal half 
(34% homology), and it is therefore likely that the amino terminal half has been 
constrained during its evolution to a greater extent than the carboxy terminal half. 
Presumably the amino terminal half has evolved more slowly in order to retain the catalytic
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properties of the enzyme, whereas the carboxy terminal half has evolved more rapidly and 
has thus acquired the additional allosteric properties characteristic of mammalian 
phosphofructokinases (Fothergill-Gilmore, 1986).
Other eubacterial and eukaryotic glycolytic enzymes for which a common 
evolutionary origin has been indicated by sequence comparisons are triosephosphate 
isomerase and glyceraldehyde-3-phosphate dehydrogenase. The triosephosphate 
isomerases from B. stearothermophilus and rabbit muscle are 40% homologous, although 
the rabbit enzyme is more closely related to other eukaryotic triosephosphate isomerases 
e.g. the enzymes of Saccharomyces cerevisiae, coelocanth and chicken are 51%, 84% 
and 87% homologous respectively (Fothergill-Gilmore, 1986). Similarly, the 
glyceraldehyde-3-phosphate dehydrogenases from B. stearothermophilus and 
Thermus aquaticus are 53% and 49% homologous respectively to the enzyme from pig 
muscle although, as above, the pig enzyme is more closely related to other eukaryotic 
glyceraldehyde-3-phosphate dehydrogenases e.g. the enzymes of S. cerevisiae, chicken 
and human (Jones & Harris, 1972; Fothergill-Gilmore, 1986).
T h e  am ino  ac id  s e q u e n c e  of th e  B. s t e a r o t h e r m o p h i l u s  
giyceraldehyde-3-phosphate dehydrogenase is also homologous with that of the lobster 
enzyme, with 51% of the residues identical in both sequences (Figure 1.2). Moreover, the 
crystal structures of the two enzymes have been determined and the overall structure of 
the B. stearothermophilus holo-enzyme (Figure 1.3) is very similar to that of the lobster 
enzyme (Buehner etal., 1974; Biesecker etal., 1977). In each case the subunits consist of 
two domains, the first domain containing most of the residues involved in binding NAD+, 
and the second domain containing the residues involved in catalysis. Comparison of the 
secondary and tertiary structural features of the bacterial and lobster NAD+-binding 
domains shows them to be very similar, although the catalytic domains differ. 
In particular, the interactions of the /3-sheet regions, /3g with /36 and £7 with /38, in the 
bacterial catalytic domain gives rise to a modified hydrogen bonding pattern which, in 
turn, results in an additional salt bridge between aspartate-293 and arginine-194 
(Biesecker et al., 1977). Even though the catalytic domains differ in structure, the 
sequence homology shown in Figure 1.2 extends throughout the length of the two 
proteins and presumably both enzymes had a common evolutionary origin but have 
undergone divergence to meet the specific requirements of each organism. For example, 
the B. stearothermophilus enzyme is notably more thermostable than the lobster enzyme 
and presumably the additional intra-subunit interactions such as the salt bridge between 
aspartate-293 and arginine-194 account for this phenomenon (Amelunxen, 1967; 
Amelunxen etal., 1970; Biesecker et al., 1977).
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Figure 1.1 Comparison of the sequences of phosphofructokinase from rabbit muscle
and B. stearothermophilus
The rabbit sequence is shown in two halves, with the bacterial sequence between them. 
The residue numbering is based on the bacterial sequence. Valine-353 in the amino 
terminal half of the rabbit enzyme is peptide-bonded to alanine-5 in the carboxy terminal 
half. Serine-348 is the site of phosphorylation. The region enclosed in parentheses 
(residues 81-106 of the carboxy terminal half) is of uncertain sequence. Reproduced from 
Poorman et al. (1984).
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Figure 1.2 Alignment of the amino acid sequences of glyceraldehyde-3-phosphate 
dehydrogenase from B. stearothermophilus and lobster
The B. stearothermophilus sequence (upper) and lobster sequence (lower) are aligned to 
maximise homologies and regions of non-identity are boxed. Deletions are introduced at 
residues 35 and 189 and insertions at 122A and 138A of the bacterial enzyme. 
Information is taken from Davidson et al. (1967) and Biesecker et al. (1977). Reproduced 
from Biesecker et al. (1977).
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Figure 1.3 The subunit structure of holo-glyceraldehyde-3-phosphate  
dehydrogenase from B. stearothermophilus
Arrows represent /3-strands, and cylinders are a-helices. A skeletal model of NAD+ is 
superimposed, and the two hatched circles indicate the positions of inorganic phosphate 
(upper circle) and the 3-phospho group of the triose (lower circle). The secondary 
structure closely resembles that of lobster glyceraldehyde-3-phosphate dehydrogenase 
except where there are insertions or deletions in external loop regions between segments 
of secondary structure. Information is taken from Biesecker et al. (1977). Reproduced 
from Fothergill-Gilmore (1986).
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Although such examples clearly demonstrate common evolutionary ancestry for 
these enzymes in eubacteria and eukaryotes, not all glycolytic enzymes show such 
homology. Probably the best documented case is for fructosebisphosphate aldolase, the 
enzyme that catalyses the reversible aldol cleavage of fructose 1,6-bisphosphate to 
glyceraldehyde 3-phosphate and dihydroxyacetone phosphate. The enzymes of 
vertebrates, insects and higher plants are members of Class I aldolases. They are 
tetrameric, with the enzymes from mammals having subunit M{ values of 40 000 although 
the enzymes from plants are somewhat smaller and have subunit Mr values of 
28 000 - 30 000 (Horecker et al., 1972). During catalysis they form a Schiff-base 
intermediate between the carbonyl group of dihydroxyacetone phosphate and the 
e-amino group of an active site lysine residue, and are inactivated by reduction with 
NaBH4 in the presence of the substrate. In contrast, the Class II enzymes of bacteria and 
fungi are smaller than the Class I enzymes e.g. fructose 1,6-bisphosphate aldolase from 
S. cerevisiae is a dimer of identical 40 000 subunits (Harris et al., 1969). They also differ 
markedly with respect to the reaction mechanism employed during catalysis. Unlike the 
Class I enzymes, they do not form a covalent enzyme-substrate intermediate but are 
dependent upon a divalent metal ion (usually Zn2+) for activity (Horecker et al., 1972). 
Therefore , it seems likely that whilst some of the glycolytic enzymes in eubacteria and 
eukaryotes share a common evolutionary origin, others do not, and presumably they have 
evolved in an independent manner.
Another enzyme of central metabolism which has been the focus of intense 
biochemical investigation is citrate synthase. This "housekeeping" enzyme of the TCA 
cycle catalyses the condensation of acetyl-CoA and oxaloacetate to form citrate, and its 
regulation may contribute to the overall control of the cycle. It is found in virtually all 
living organisms and has been characterized from a wide variety of sources including 
archaebacteria, Gram negative and Gram positive eubacteria, fungi, plants and animals 
(Weitzman & Danson, 1976). Comparison of a range of citrate synthases shows that they 
fall into two groups with very distinct properties; one group containing the enzymes of 
Gram positive eubacteria and eukaryotes, with the other containing the enzymes of the 
Gram negative eubacteria (Table 1.1). The two groups differ with respect to their native Mf 
and subunit number, although subunit Mr values are similar. They also differ with respect 
to inhibition by physiological concentrations of NADH and ATP, and their substrate 
dependence of activity i.e. allosteric versus non-allosteric modulation. On the basis of 
these comparisons it would seem that the two groups of enzyme evolved from quite 
different origins. However, comparison of the sequences of the citrate synthases from 
E. coli, S. cerevisiae and pig heart (Figure 1.4) show them to be conserved, and although 
there is less homology between the E  coli enzyme and either of the eukaryotic proteins, 
the homology is approximately 30% and is therefore significant.
The differences in physiological properties between the two groups have been 
shown to be related to the quaternary structure of the enzymes. Although wild-type E  coli 
normally express a citrate synthase characteristic of the Gram negative eubacteria, a
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revertant mutant strain has been isolated which expresses an enzyme characteristic of the 
Gram positive eubacteria and eukaryotes (Table 1.2). The mutation(s) lead to a switch in 
phenotype, resulting in the concomitant loss of the enzyme’s W am eric nature and 
regulatory sensitivity, and this is consistent with the view that the allosteric regulation of 
the wild-type E. coli citrate synthase by NADH and 2-oxoglutarate is dependent upon the 
quaternary structure (Danson et al., 1979). The sequence homologies amongst the three 
enzymes strongly indicate common ancestry for eubacterial and eukaryotic citrate 
synthases, whereas the divergence of sequence between the E. coli enzyme and the two 
eukaryotic proteins reflects the different properties of the two groups. In particular, the 
ability of the E. coli enzyme to associate into tetramers and to be regulated allosterically 
is presumably due, in part, to the amino acid residues at the subunit interfaces i.e. the 
dimeric enzymes of the Gram positive eubacteria and eukaryotes as well as the mutant 
E. coli citrate synthase have different subunit interactions and therefore cannot form 
tetramers.
Homology amongst other eubacterial and eukaryotic TCA cycle enzymes has also 
been revealed by sequencing studies. Fumarase, which catalyses the reversible 
hydration of fumarate and L-malate, has been characterized from several sources and 
there appears to be two distinct classes of the enzyme. Class I contains the FUMA and 
FUMB enzymes of E. coli and the immunologically related fumarase of Euglena gracilis. 
These are characteristically thermolabile dimers with subunit Mx values of about 60 000 
(Shibata et al., 1985; Woods et al., 1988). Both FUMA and the E. gracilis enzyme function 
in the TCA cycle under aerobic conditions, whereas FUMB is expressed under anaerobic 
conditions and functions to provide fumarate as an electron acceptor. Class II contains 
the FUMC enzyme of E. coli and the fumarases of Bacillus subtilis, S. cerevisiae, birds and 
mammals, and these are characteristically thermostable tetramers with Mr values of 
48 000 - 50 000 (Beeckmans & Kanarek, 1977, 1982; Kobayashi et al., 1981; 
Woods et al., 1988). Like the fumarases of E  coli (FUMA) and E. gracilis, the Class II 
enzymes all seem to function in the TCA cycle. Whilst sequence comparison shows there 
is no obvious homology between the two classes of fumarase, there is striking homology 
amongst the enzymes of class II, with the E  coli FUMC enzyme showing 63% homology 
with the B. subtilis enzyme, 56% with the S. cerevisiae enzyme and 59% with the fumarase 
of human liver mitochondria (Miles & Guest, 1985; Woods et al., 1986, 1988; 
Wu & Tzagoloff, 1987; Kinsella & Doonan, 1986).
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Table 1.1 Properties of citrate synthases
Reproduced from Weitzman & Danson (1976).
Gram positive eubacteria/eukaryotes Gram negative eubacteria 
Native Mf 90 000 -100 000 240 000 - 280 000
Subunit Mx 50 000 - 60 000 50 000 - 60 000
Subunit number 2 6
NADH sensitivity — +
ATP sensitivity +  —
Substrate dependence Hyperbolic Sigmoidal
Table 1.2 Comparison of wild-type E. coli, mutant E. coli and pig heart 
citrate synthase
Reproduced from Danson etal. (1979).
Pig heart 
100 000 
Hyperbolic 
7 
10
14
0
a Determined at an oxaloacetate concentration of 2 xKm
b Determined at an acetyl-CoA concentration of 0.5 x Km
Property Wild-type E. coli Mutant E. coli
Native Mx 230 000 100 000
Substrate dependence Sigmoidal Hyperbolic
Km for acetyl-CoA ( j jM )  400 11
Km for oxaloacetate (pM) 55 10
Inhibition by
1 mM-2-oxoglutaratea (%) 75 10
Inhibition by
0.1 mM-NADHb (%) 90 0
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Figure 1.4 Alignment of the amino acid sequences of citrate synthase from £. coli 
(ECS), S. cerevisiae (YCS), and pig heart (PCS)
The sequences are aligned to maximise homologies and regions of homology are boxed. 
Information is taken from Bloxham etal. (1982), Ner et al. (1983), Bhayana & Duckworth 
(1984) and Suissa et al. (1984). Reproduced from Suissa et al. (1984).
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Another central metabolic pathway which has been characterized in both 
prokaryotes and eukaryotes is the shikimate pathway, the biosynthetic route by which 
plants and microorganisms synthesize the aromatic amino acids and related compounds 
(Figure 1.5). Although all organisms so far studied use the shikimate pathway to convert 
erythrose 4-phosphate and phosphoenoipyruvate to the common precursor chorismate, 
there are remarkable differences amongst species in the organisation of the enzymes that 
catalyse the central five reactions of the pathway (Reactions 2-6 of Figure 1.5). In several 
prokaryotes including Aerobacter aerogenes, Bacillus subtilis, Escherichia coli, 
Pseudomonas aeruginosa, Salmonella typhimurium and Streptomyces coelicolor the 
enzymes are separable and, moreover, in E. coli, B. subtilis and S. typhimurium the 
structural genes which encode these enzymes are widely scattered about the genome 
(Berlyn & Giles, 1969; Henner & Hoch, 1980; Bachmann, 1983; Sanderson & Roth, 1983). 
However, in algae, mosses and higher plants such as Chlamydomonas reinhardii, 
Physcomitrella patens, Nicotlana tabacum and Pisum sativum three of the enzymes are 
separable but two, 3-dehydroquinase and shikimate dehydrogenase, occur as a 
bifunctional polypeptide (Berlyn et al., 1970; Polley, 1978; Mousedale et al., 1987). 
In fungi, the organisation is even more complex, as all five enzyme activities are found on 
a single polypeptide. The presence of this arom pentafunctional enzyme has been 
demonstrated in various phycomycetes, ascomycetes and basidiomycetes e.g. Rhizopus 
stolonifer, Phycomyces nitans, Saccharomyces cerevisiae, Aspergillus nidulans, 
Neurospora crassa, Coprinus lagopus and Ustilago maydis (Giles etal., 1967; Ahmed & 
Giles, 1969; Lumsden & Coggins, 1977; Larimer et al., 1983). Furthermore, genetic 
studies have revealed that the arom complexes of S. cerevisiae and A. nidulans are the 
products of single genes, indicating that these multifunctional enzymes are not formed by 
post-translational aggregation of five separate gene products (Charles et al., 1986; 
Duncan ef al., 1987).
Although there is a marked diversity in the organisation of the five central 
enzymes of the shikimate pathway, comparison of the sequence of the S. cerevisiae arom 
pentafunctional enzyme with the five corresponding monofunctional enzymes of E. coli 
has revealed regions which are conserved in both the yeast and bacterial proteins 
(Figure 1.6) although, perhaps not surprisingly, there is a higher degree of sequence 
identity between the S. cerevisiae and A  nidulans arom polypeptides. Sequence analysis 
has also shown linker regions between the functional domains of the pentafunctional 
enzymes, and presumably it is these that give the S. cerevisiae arom polypeptide a slightly 
greater Mr value (174 555) than the combined values of the five E  coli enzymes 
(159 698) (Duncan et al., 1987). The sequence homologies between these prokaryotic 
and eukaryotic enzymes strongly indicate a common evolutionary origin for the shikimate 
pathway. Furthermore, the pentafunctional enzymes of fungi and presumably the 
bifunctional enzymes found in plants, are likely to have evolved by the fusion of ancestral 
E  co//-like genes (Hawkins, 1987) although, as pointed out by Hardie & Coggins (1986),
Page 12
the possibility that the multifunctional enzymes are more ancient and that the 
monofunctionai bacterial enzymes arose from them by the mutational insertion of stop and 
start codons, cannot be ruled out.
The ability to determine gene sequences and the properties of their respective 
gene products has enabled detailed comparisons of a variety of central metabolic 
enzymes. The sequence homologies between prokaryotic and eukaryotic enzymes of the 
glycolytic pathway, the TCA cycle and the shikimate pathway indicate common ancestry 
in the two groups of organisms, and presumably they were established early in cellular life 
before the prokaryotes and eukaryotes diverged. The homologies also indicate that the 
basic catalytic structures of the enzymes have been conserved during evolution. Indeed, 
many of the glycolytic enzymes seem to be evolving at a rate of only 4-6 accepted point 
mutations per 100 million years and aldolase (A isoenzyme) is the least rapidly changing, 
at 2.4 accepted point mutations over the same time scale (Fothergill-Gilmore, 1986). 
As the enzymes of central metabolic pathways catalyse reactions fundamental to the 
maintenance of life, it is perhaps not too surprising that they have evolved slowly. 
Selection pressures have presumably constrained the rapid evolution of these enzymes, 
for although mutation may well improve catalytic efficiency, rapid evolution also carries 
with it the increased risk of producing a reduction in efficiency or at worst, a non-functional 
protein.
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Figure 1.5 Reactions of the early common pathway of aromatic amino acid 
biosynthesis
Enzymes; a, 3-deoxy-D-arab/no-heptulosonic acid 7-phosphate synthase; 
b, 3-dehydroquinate synthase; c, 3-dehydroquinase; d, shikimate dehydrogenase; 
e, shikimate kinase; f, 5-enoylpyruvylshikimate-3-phosphate synthase; g, chorismate 
synthase. Modified from Duncan etal. (1987).
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Figure 1.6 Amino acid homologies between the S. cerevisiae arom pentafunctional 
enzyme and the corresponding monofunctional E. coli enzymes 
Enzymes; aroB, dehydroquinate synthase; aroA, 5-enoylpyruvylshikimate-3-phosphate 
synthase; aroL, shikimate kinase; aroD, 3-dehydroquinase; aroE, shikimate 
dehydrogenase. Numbers above and below the sequences indicate amino acid positions 
in the S. cerevisiae enzyme and in the individual E. coli enzymes, respectively.
Information is taken from Duncan et al. (1984, 1986), Millar & Coggins (1986),
Millar et al. (1986), Duncan et al. 
Reproduced from Duncan ef a/. (1987).
(1987) and Anton & Coggins (1988).
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1.1.3 Peripheral metabolic pathways
Peripheral metabolic pathways enable microorganisms to metabolise a diverse range of 
organic compounds, and those involved in the degradation of aromatic compounds 
channel them to relatively few key intermediates such as catechol and protocatechuate. 
These, in turn, are degraded via the ortho and mefa-ring cleavage pathways to yield 
compounds that enter the central amphibolic pathways. As aromatic compounds of 
natural and pollutant origin are widespread in the environment, those organisms able to 
utilise them gain a distinct ecological advantage over those which cannot.
Although the study of prokaryotic and eukaryotic central metabolic pathways has 
revealed some fascinating evolutionary relationships, the fact that the proteins are highly 
conserved indicates they are of ancient origin and, therefore, not best suited for 
investigating more recent evolutionary events. More likely candidates in this respect are 
the peripheral metabolic pathways. Unlike the central metabolic pathways, peripheral 
pathways would appear to be subject to less evolutionary constraint. Microorganisms that 
possess them are often nutritionally versatile, and so if mutation leads to the loss of a 
particular enzymic activity and, as a consequence, to the loss of the whole pathway the 
organism may still be able to grow on other carbon sources. Indeed, it is unlikely that 
microorganisms in natural environments grow on single substrates, in contrast to typical 
laboratory experiments. This ability to survive deleterious mutations in peripheral 
pathways differs from that in central pathways e.g. if one of the shikimate pathway 
enzymes became inactive the organism would presumably die or at least become multiply 
auxotrophic. Furthermore, peripheral metabolic pathways are inducible and may operate 
only when a particular substrate becomes available. As many of the compounds 
degraded via peripheral pathways are uncommon and may be only occasionally present 
in the environment, the genes encoding peripheral enzymic pathways may lie dormant for 
substantial lengths of time, and therefore accrue mutations without expression of the 
mutant protein. Microbial peripheral pathways may also evolve more rapidly as the 
chance of genetic change by transformation and/or plasmid mediated transfer are 
greater. Indeed, many of the enzymes of peripheral pathways are plasmid-encoded 
(e.g. Williams, 1981; Chalmers et al., 1990a), and even in organisms in which they are 
chromosomally-encoded, mechanisms of transformation and of non-conjugal DNA 
transfer have been demonstrated (e.g. Ahlquist et al., 1980; Vakeria et al., 1985). 
Despite this, most experiments aimed at unravelling evolutionary relationships amongst 
enzymes have concentrated on the central pathways, with relatively little known about the 
evolution of peripheral metabolic pathways.
However, one peripheral pathway which has been characterized in prokaryotes 
and eukaryotes is the quinate pathway. Several bacteria and fungi including 
Acinetobacter calcoaceticus, Pseudomonas aureofaciens, Pseudomonas putida, 
Aspergillus nidulans, Fusarium oxysporum, Neurospora crassa and Penicilllum spinulosum 
can grow on quinate as a sole source of carbon and energy (Giles et al., 1967; Cain etal., 
1968; Ahmed & Giles, 1969; Hawkins etal., 1982; Van Kleef & Duine, 1988), and it is a
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particularly important degradative pathway since quinate is widely distributed in plants in 
both the free state and as a constituent of chlorogenic acid (Pridham, 1965). The 
inducible quinate pathway is relatively short and consists of only three catalytic steps 
which convert quinate to the key intermediate protocatechuate. It has been the focus of 
intense study not only because of its role in recycling plant-derived quinate in the 
environment, but also because one of the catalytic steps; conversion of 3-dehydroquinate 
to 3-dehydroshikimate, is a reaction shared with the shikimate pathway (Figure 1.7).
The first enzyme of the pathway, quinate dehydrogenase, is an NAD+-dependent 
enzyme in Aerobacter aerogenes, P. aeruginosa and N. crassa, whereas in 
A. calcoaceticus and P. putida the enzymes are dye-linked and dependent upon 
pyrrolo-quinilone quinone (PQQ) for activity (Mitsuhashi & Davis, 1954; Ahmed & Giles, 
1969; Tresguerres et al., 1970; Ingledew & Tai, 1972; Van Kleef & Duine, 1988). These 
observations demonstrate that there are two classes of quinate dehydrogenase in both 
prokaryotes and eukaryotes, and presumably they have evolved from independent 
origins. Interestingly, P. aureofaciens, unlike most microorganisms, contains both 
NAD+-dependent and PQQ-dependent quinate dehydrogenases, although the 
physiological significance of this is as yet unknown (Van Kleef & Duine, 1988).
Even more fascinating evolutionary relationships have been revealed by 
comparison of the A. nidulans and N. crassa quinate dehydrogenases with the shikimate 
dehydrogenase domain of the A  nidulans arom polypeptide, and the product of the 
N. crassa QA-1S repressor gene. Although the proteins have quite different physiological 
functions i.e. the quinate dehydrogenases catalyse the oxidation of quinate and shikimate 
to 3-dehydroquinate and 3-dehydroshikimate respectively, shikimate dehydrogenase 
catalyses the reduction of dehydroshikimate to shikimate and the repressor protein 
regulates the expression of the quinate pathway enzymes, they nevertheless have 
conserved sequence (Figure 1.8; Hawkins et al., 1988). The sequence homologies 
strongly suggest common evolutionary ancestry for these proteins and, moreover, it is 
likely that the catabolic quinate dehydrogenases have evolved from the anabolic 
shikimate dehydrogenase, and that the ability of the repressor protein to bind quinate may 
have evolved by acquisition of the quinate binding function from quinate dehydrogenase. 
If these suppositions are correct, it implies an economy in the evolution of peripheral 
metabolic pathways, in that organisms use pre-existing genetic information for the 
production of novel phenotypic traits.
The second enzyme of the pathway, 3-dehydroquinase, has been extensively 
studied in A  nidulans and N. crassa. The enzymes of both organisms are induced by 
quinate and are heat-stable, multimeric proteins (probably dodecamers) consisting of 
subunits with Mf values of 16 000 - 18 000. Furthermore, both enzymes show significant 
sequence identity with each other and antibodies raised against the N. crassa enzyme 
cross-react with the enzyme from A  nidulans (Hawkins et al., 1982; Giles et al., 1985; 
Da Silva et al., 1986). By contrast, the A  nidulans and N. crassa biosynthetic
3-dehydroquinases are constitutively expressed, and although they form part of the arom
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pentafunctional polypeptide, the 3-dehydroquinase domain has similar size, sequence 
and catalytic properties to the corresponding monofunctional E  coli enzyme (Chaudhuri 
etal., 1986; Charles etal., 1986; Duncan etal., 1986, 1987). These observations clearly 
demonstrate the presence of two classes of 3-dehydroquinase in microorganisms; Class I 
enzymes which function in aromatic amino acid biosynthesis and Class II enzymes which 
function in the degradation of quinate (White et al., 1990). Moreover, this division is 
supported by the lack of sequence homology between the biosynthetic and catabolic 
enzymes of A  nidulans (Charles et al., 1985). Although this dichotomy would seem to be 
well defined, the constitutively expressed biosynthetic 3-dehydroquinase of 
Streptomyces coelicolor, unlike all other biosynthetic 3-dehydroquinases so far 
characterized, is a large multimeric protein, is notably heat-stable and its amino terminus 
has significant sequence homology with the catabolic enzymes of A  nidulans and 
N. crassa (Figure 1.9; White et al., 1990). The presence of a class II ■catabolic" type 
enzyme in the shikimate pathway of S. coelicolor raises some interesting questions as to 
the physiology and evolutionary origin of the enzyme. Although S. coelicolor cannot grow 
on quinate as a sole source of carbon and energy, and quinate dehydrogenase activity 
has not been detected in this organism, might it be able to co-metabolise quinate in the 
presence of other utilisable carbon substrates ? If this is the case, the single enzyme may 
serve a biosynthetic as well as a degradative function. Furthermore, what is the 
evolutionary relationship between this enzyme and the catabolic enzymes of A  nidulans 
and N. crassa and has there, at some time, been genetic transfer between the 
streptomycetes and filamentous fungi ?
Although few peripheral metabolic pathways have been characterized in as much 
detail as the quinate pathway, this example clearly shows how the study of these 
pathways in prokaryotes and eukaryotes can reveal evolutionary relationships which 
might not otherwise be revealed from examination of the more highly conserved central 
metabolic pathways. Moreover, if we are able to understand the processes which underlie 
the molecular evolution of these pathways, it would presumably aid the rational design 
and construction of new genes and proteins by recombinant DNA technology. Indeed, in 
this context many peripheral metabolic pathways are of major ecological importance as 
they function to re-cycle organic matter in the biosphere and, with the increasing problem 
of environmental pollution, attempts are being made to manipulate these pathways in 
order to increase the degradative capacity of microorganisms (Ramos &Timmis, 1987).
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Figure 1.7 Reactions of the quinate and shikimate pathways illustrating the common 
enzymic conversion of 3-dehydroquinate to 3-dehydroshiklmate
Enzymes; a, bi-specific quinate/shikimate dehydrogenase; b, 3-dehydroquinase; 
c, dehydroshikimate dehydratase; d, dehydroquinate synthase; e, 3-dehydroquinase; 
f, shikimate dehydrogenase.
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Figure 1.8 Homologies between A  nidulans quinate dehydrogenase, the shikimate 
dehydrogenase domain of the A  nidulans arom polypeptide, and the N. crassa quinate 
dehydrogenase and QA- 1S repressor protein
The sequences are 1, N. crassa quinate dehydrogenase; 2, A. nidulans quinate 
dehydrogenase; 3, the shikimate dehydrogenase domain of the A. nidulans arom 
pentafunctional polypeptide; 4, the carboxy terminal sequence of the N. crassa QA-1S 
gene product. Gaps have been inserted into the sequence to maximise the homology 
which is indicated by boxing identical or closely related residues. Information is taken 
from Charles et al. (1986), Huiet & Giles (1986) and Hawkins et al. (1988). Reproduced 
from Hawkins et al. (1988).
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S A. nidulans
Figure 1.9 Alignment of the amino terminal sequence of the S. coelicolor
3-dehydroquinase with the sequence of the quinate-inducible 3-dehydroquinases 
from A. nidulans and N. crassa
Identical amino acid residues are boxed, and asterisks indicate residues that could not be 
identified unambiguously. Reproduced from White et al. (1990).
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1.2 Microbial metabolism of mandelate
1.2.1 Mandelate in the environment
Mandelic acid (2-hydroxy-2-phenylacetic acid) is a naturally occurring aromatic 2-hydroxy 
acid which exists in two enantiomeric forms (Figure 1.10). The pKa of its carboxyl group is 
3.37, and so under most physiological conditions it occurs as the mandelate anion 
(Fewson, 1988b). Although there are few reports of free mandelate in nature, mandelate 
and a variety of related compounds continually enter the environment from several 
sources. For example, mandelate and phenylglyoxylate are excreted in animal urine, with 
the normal human urinary mandelate concentration being 1-15/iM although it may rise to 
elevated levels in pathological conditions such as phenylketonuria (Luthe et al., 1983). 
Similarly, 3,4-dihydroxymandelate and 4-hydroxy-3-methoxymandelate, which are 
breakdown products of adrenalin and noradrenalin, are excreted in animal urine as is 
4-hydroxymandelate which is a breakdown product of the neurotransmitter octopamine 
(Armstrong et al., 1957; Axelrod & Saavedra, 1977). Urinary mandelate is also found after 
exposure to styrene (Chakrabarti, 1979), administration of ethylbenzene or acetophenone 
(Sullivan et al., 1976) and after application of a solution of mandelic acid which is used as 
a bladder irrigation fluid to prevent urinary tract infection during urethral catheterization 
(Van Putten, 1979). Mandelic acid is also a component of certain drugs such as
3.3.5-trimethylcyclohexanyl mandelate, a vasoactive substance (Middleton et al., 1983) 
and methenamine mandelate, a urinary antiseptic (Greenwood & Slack, 1981). 
In addition, D(—)-mande!ic acid is used as a chiral synthon for the production of various 
semisynthetic penicillins, cephalosporins and antiobesity agents (Yamazaki & Maeda, 
1986 and references therein; Vasic-Racki etal., 1989) and, presumably, ingestion of such 
drugs leads to the excretion of mandelate and related compounds into the environment.
Mandelate and various mandelate analogues are also produced by algae, fungi 
and higher plants (Fewson, 1988b). The fungus Aspergillus niger produces 
4-hydroxymandelate when grown on phenylalanine or phenylacetate (Kishore etal., 1974, 
1976), the parasitic bracket fungus Polyporus hispidus produces 4-hydroxymandeiate 
from phenylalanine and tyrosine (Perrin & Towers, 1973) and there is evidence to suggest 
that the related fungus Polyporus tumulosus produces 4-hydroxymandelate,
2.5-dihydroxymandelate and 3,4-dihydroxymandelate from shikimate (Crowden, 1967). 
Plants are also known to produce mandelate analogues such as 3-carboxymandelate and
3-carboxy-4-hydroxymandelate, which are precursors in the biosynthesis of 
(3-carboxyphenyl)glycine and (3-carboxy-4-hydroxyphenyl)glycine respectively 
(Larsen & Wieczorkowska, 1975). Other plants synthesize glycosides of mandelonitrile 
e.g. (R)-prunasin and (S)-sambunigrin are the /3-glucosides of D- and L-mandelonitrile 
respectively, and other glycosides such as (R)-holocalin, (S)-zierin, amygdalin, vicianin 
and lucumin contain either mandelonitrile or hydroxymandelonitrile moeities (Conn, 1981).
In addition to plants, some animals such as the polydesmoid millipede 
Harpaphe haydeniana synthesize and store a drop of D-mandelonitrile which it converts to 
benzaldehyde and HCN as a repellent (Duffey & Towers, 1978). However, as pointed out
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by Fewson (1988b) neither the synthesis nor breakdown of mandelonitrile in plants or 
animals directly involves mandelate itself, although the possibility exists that liberation of 
these compounds into the soil might give rise to mandelate after hydrolytic reactions).
Although there seem to have been no attempts to quantify the amount of 
mandelate in nature, these examples demonstrate how mandelate and various mandelate 
analogues of natural and man-made origin may enter the environment and therefore serve 
as growth substrates for microorganisms. In some habitats mandelate and related 
compounds may indeed be rare, but in others they may be a permanent feature e.g. in 
stockyards where deposition of animal faeces and urine may provide continual supplies of
3,4-dihydroxymandelate and 4-hydroxy-3-methoxymandelate. Indeed, it was for this very 
reason that Sze and Dagley (1987) chose a soil sample from a cattle yard to selectively 
enrich an organism capable of growing on D,L-4-hydroxy-3-methoxymandelate as a sole 
source of carbon and energy, and it was presumably because of this that they were 
successful in isolating a strain of Acinetobacter Iwoffi with the desired phenotype.
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D(—)-Mandelic acid L(+)-Mandelic acid
Figure 1.10 Enantiomers of mandelic acid
1.2.2 Bacterial metabolism of mandelate
Numerous bacteria including Acinetobacter calcoaceticus, Arthrobacter spp., Azotobacter 
beijerinckii, Bacillus sphaericus, Nocardia spp., Pseudomonas aeruginosa, Pseudomonas 
convexa, Pseudomonas fluorescens, Pseudomonas multivorans, Pseudomonas putida and 
Rhizobium leguminosarum are capable of growing on D(—)-, L(+)- or D,L-mandelate as 
the sole source of carbon and energy (Stanier et al., 1966; Stevenson, 1967; Baumann 
et al., 1968; Rosenberg, 1971; Bhat & Vaidyanathan, 1976a; Fewson, 1988b; 
Chen et al., 1989). Although mandelate metabolism has been established in a diverse 
range of bacteria, it is only for A  calcoaceticus and P. putida, that the enzymes and 
regulatory processes involved have been studied in detail.
The first step in the catabolism of mandelate by A  calcoaceticus involves 
oxidation to phenylglyoxylate by a pair of stereospecific mandelate dehydrogenases 
which are integral membrane proteins requiring flavin as prosthetic group 
(Figure 1.11 b,c; Allison et al., 1985a,b; Hoey etal., 1987). Some strains, e.g. wild-type 
strain NCIB 8250, have an L(+)-mandelate dehydrogenase and can grow only on 
L(+)-mandelate (Kennedy & Fewson, 1968b), whereas other strains, e.g. wild-type strain 
EBF 65/65, have a D(—)-mandelate dehydrogenase and can grow only on 
D(—)-mandelate (Hills & Fewson, 1983a). However, both wild-type strains can give rise to 
mutants that have a second dehydrogenase, specific for the other enantiomer, that is 
co-ordinately regulated along with the pre-existing enzyme (Hills & Fewson, 1983a,b). 
Furthermore, the properties of an original D(—)-mande!ate dehydrogenase (from a mutant 
strain derived from strain EBF 65/65) and an evolved D(—)-mandelate dehydrogenase 
(from a mutant strain derived from strain NCIB 8250) are indistinguishable from each other 
and antiserum raised against the evolved enzyme cross-reacts identically with the evolved 
and original enzymes (Fewson etal., 1988).
The phenylglyoxylate produced from the oxidation of mandelate is then converted 
to benzaldehyde by a thiamin pyrophosphate-dependent phenylglyoxylate decarboxylase 
(Figure 1.11 d; Barrowman & Fewson, 1985), after which the benzaldehyde is oxidised to 
benzoate by benzaldehyde dehydrogenase I, one of a pair of NAD+-dependent 
benzaldehyde dehydrogenases found in this bacterium (Figure 1.11 e; Macintosh & 
Fewson, 1988a; Chalmers & Fewson, 1989a). Two isofunctional benzaldehyde 
dehydrogenases occur as the mandelate and benzyl alcohol pathways converge at the 
point of benzaldehyde, and different induction mechanisms have evolved to induce 
specifically the enzymes of the two pathways. During growth on mandelate, mandelate 
dehydrogenase, phenylglyoxylate decarboxylase and benzaldehyde dehydrogenase I are 
induced by phenylglyoxylate, whereas during growth on benzyl alcohol, benzyl alcohol 
dehydrogenase and benzaldehyde dehydrogenase II are induced by benzaldehyde or 
benzyl alcohol (Livingstone et al., 1972). The benzoate formed by oxidation of 
benzaldehyde is then converted to catechol, via 3,5-cyclohexadiene-1,2-dio!-1-carboxylate 
(Figure 1.11 f,g), which is then fed into the catechol branch of the /3-ketoadipate pathway, 
ultimately yielding the amphibolic intermediates succinate and acetyl-CoA.
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Enzymes; a, mandelate racemase; b,b*, L(+)-m andelate dehydrogenase; 
c, D(—)-mandelate dehydrogenase; d,d*, phenylglyoxylate decarboxylase; 
e.e* .  be nz a l de hy de  dehydrogenase;  f, benzoa t e  1 , 2 - oxygenase ;  
g, 3,5-cyclohexadiene-1,2-diol-1-carboxylate dehydrogenase; h, L(+)-mandelate 
4-hydroxylase; i, L(+)-4-hydroxymandelate oxidase; j, 4-hydroxybenzoate 3-hydroxylase. 
Adapted from Fewson (1988b).
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P. putida differs from A  calcoaceticus in that its ability to grow on D(—)-mandelate 
is not endowed by the possession of a stereospecific D(—)-mande!ate dehydrogenases, 
but by the presence of mandelate racemase and L(+)-mandelate dehydrogenase. 
Mandelate racemase, the most highly characterized of all the mandelate pathway 
enzymes, is a soluble, metal-dependent enzyme that catalyses the non-redox 
racemization of D(—)- and L(+)-mandelate (Figure 1.11 a; Hegeman etal., 1970; Kenyon 
& Hegeman, 1970; Fee et al., 1974a). L(+)-Mandelate is then converted to benzoate by 
the successive actions of a flavin-dependent L(+)-mandelate dehydrogenase, a thiamin 
pyrophosphate-dependent phenylglyoxylate decarboxylase, and two benzaldehyde 
dehydrogenases one of which is specific for NAD+ and the other for NADP+ 
(Figure 1.11 b,d,e; Hegeman, 1966a,b,c; Hegeman, 1970; Tsou etal., 1990). Then, in a 
manner analogous to A  calcoaceticus, the benzoate formed is converted to catechol 
which enters the /3-ketoadipate pathway to yield succinate and acetyl-CoA 
(Figure 1.11 f,g). However, although most strains of P. putida degrade mandelate by this 
route, a single strain has been reported which grows on both enantiomers using 
mandelate racemase and D(—)-mandelate dehydrogenase rather than L(+)-mandelate 
dehydrogenase (Kenyon & Hegeman, 1979), whereas other strains possess a 
D(—-)-mandelate dehydrogenase in the absence of the racemase and can therefore grow 
only on D(—)-mandelate (Hegeman et al., 1970). P. aeruginosa can also grow on 
L(+)-mandelate, which is oxidised by an L(+)-mande!ate dehydrogenase with the rest of 
the pathway the same as that found in P. putida (Rosenberg, 1971).
A further difference is seen in the metabolic pathway used by P. convexa. This 
bacterium, which is probably a strain of P. putida (Hegeman etal., 1970), has a mandelate 
racemase and can therefore grow on both enantiomers, but instead of oxidising 
L(+)-mandelate to phenylglyoxylate it hydroxylates the aromatic ring with an NADPH, 
tetrahydropteridine, Fe2+ and 0 2-dependent L(+)-mande!ate 4-hydroxylase to form 
4-hydroxymandelate (Figure 1.11 h; Bhat & Vaidyanathan, 1976b). The 
4-hydroxymandelate is then oxidatively decarboxylated to 4-hydroxybenzaIdehyde by a 
membrane bound, FAD, Mn2+ and 0 2-dependent L(+)-4-hydroxymandelate oxidase 
(Figure 1.11 i; Bhat & Vaidyanathan, 1976c). Then, after oxidation of 
4-hydroxybenzaldehyde to 4-hydroxybenzoate, the 4-hydroxybenzoate is further 
hydroxylated at position 3 of the aromatic ring to form protocatechuate which enters the 
protocatechuate branch of the /3-ketoadipate pathway (Figure 1.11 e*,j; Bhat & 
Vaidyanathan, 1976a). Therefore, P. convexa differs from all other strains of 
Pseudomonas and Acinetobacter, in that it hydroxylates L(+)-mandelate rather than 
dehydrogenating it, converts 4-hydroxymandelate to 4-hydroxybenzaldehyde without the 
intermediate synthesis of 4-hydroxyphenylglyoxylate and uses the protocatechuate 
branch of the /3-ketoadipate pathway, rather than the catechol branch.
Many of the enzymes of the mandelate pathway show substrate ambiguity and will 
readily catalyse their respective reaction with a number of ring-substituted analogues. For 
example, A  calcoaceticus will to grow on 2-hydroxymandelate, 4-hydroxymandelate,
3,4-dihydroxymandelate and 4-hydroxy-3-methoxymandelate, degrading them to either 
catechol or protocatechuate (Figure 1.12; Kennedy & Fewson, 1968b) and, likewise, 
P. putida grows on 4-hydroxymandelate (Gunter, 1953). However, some ring-substituted 
mandelates e.g. 4-chloromandelate and 4-bromomandelate do not support growth of 
either bacterium as they are metabolised only to the level of the corresponding 
halo-benzoate (Hegeman, 1966a; Kennedy & Fewson, 1968b). However, as pointed out 
by Fewson (1988b), partial metabolism may nevertheless be important in nature where 
mixed populations of microorganisms may totally degrade compounds which are beyond 
the scope of any one individual microorganism.
The mandelate pathway also acts as a metabolic 100061" by allowing growth on a 
variety of aromatic substrates which can be metabolised to any one of the pathway 
intermediates. For example, P. putida can convert ethylmandelate, mandelamide, 
methylmandelate, phenyl 1,2-ethanediol and phenylglyoxal to mandelate 
(Hegeman, 1966a), L-phenylglycine to phenylglyoxylate (Van den Tweel etal., 1986) and 
those strains which contain the TOL plasmid can convert toluene to benzaldehyde via 
benzyl alcohol (Worsey & Williams, 1975) (Figure 1.13) Therefore, if an organism 
possessing the mandelate pathway, evolves a new enzymic activity which converts a 
previously non-metabolisable compound to an intermediate of the mandelate pathway it 
should be able to grow on an additional substrate.
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Figure 1.12 Metabolism of ring-substituted mandeiates by A  calcoaceticus
Information is taken from Kennedy & Fewson (1968b). Reproduced from Fewson (1988b).
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COOH
(3-ketoadipate pathway
Figure 1.13 A schematic representation of the mandelate pathway of P. putida as a 
"metabolic funnel" for the dissimilation of a range of compounds to benzoate and 
their channeling into the /3-ketoadipate pathway
Information is taken from Hegeman (1966a), Worsey & Williams (1975) & Van den Tweel 
etal. (1986). Adapted from Ramos &Timmis (1987).
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1.2.3 Fungal metabolism of mandelate
Several fungi including Aspergillus flavus, Byssochlamys fulva and Rhodotorula graminis 
can grow on D(—)-, L(+)- or D.L-mandeiate as the sole source of carbon and energy 
(lyayi & Dart, 1980; Dart & lyayi, 1981; Durham et ai., 1984), whereas other fungi 
e.g. Aspergillus niger and Neurospora crassa, which degrade both enantiomers in the 
presence of other carbon sources, may not necessarily be able to sustain growth on 
mandelate alone (Jamaluddin et a/., 1970; Ramakrishna Rao & Vaidyanathan, 1977). 
Metabolism of mandelate by fungi is less well understood than is bacterial mandelate 
metabolism and, moreover, there seem to have been no reports of any of the mandelate 
pathway enzymes having been purified to homogeneity from a fungal source, although 
some of the enzymes have been studied in crude extract or in partially purified form.
In all fungi so far examined, the first step in the dissimilation of mandelate is 
always oxidation to phenylglyoxylate catalysed by either D(—)- or L(+)-mandelate 
dehydrogenases. In A  niger strain UBC 814 there is a pair of stereospecific mandelate 
dehydrogenases; a soluble, dye-linked L(+)-mande!ate dehydrogenase which is 
stimulated by FAD and FMN, and a "particulate* D(—)-mandelate dehydrogenase which, 
unlike the L(+)-mandelate dehydrogenase, cannot reduce 2,6-dichloroindophenol and is 
not stimulated by either of the flavins (Figure 1.14 a,b; Jamaluddin etal., 1970). However, 
as the D(—)-mandelate dehydrogenase was assayed by estimating the amount of 
phenylglyoxylate formed, and the effect of nicotinamide nucleotides on its activity was not 
determined, it is unclear whether this enzyme is NAD(P)+-dependent. In a different strain 
of A  niger, there are D(—)- and L(+)-mande!ate dehydrogenases associated with both 
soluble and "particulate* fractions of the crude extract. The enzymes in both fractions 
were found to use NADP+ and, to a lesser extent, NAD+ as cofactors for the oxidation of 
D,L-4-hydroxymandelate, although the stereospecificities of the enzymes were not 
determined (Kishore et a/., 1976). There is also an NAD+-dependent mandelate 
dehydrogenase in B. fulva, although as with the A  niger enzymes, its stereospecificity was 
not demonstrated (lyayi & Dart, 1986). In the yeast R. graminis, there is a pair of 
stereospecific mandelate dehydrogenases; a membrane "associated", dye-linked 
L(+)-mandelate dehydrogenase and a soluble, NAD+-dependent D(—)-mandelate 
dehydrogenase (Figure 1.14 a,b; Durham, 1984). This was the first clearly reported case 
of an NAD+-dependent dehydrogenase being involved in the oxidation of mandelate and, 
as shown later in this thesis (Section 4.3.1), it catalyses the reversible interconversion of 
D(—)-mandelate and phenylglyoxylate. It is presumably a similar enzyme in the bracket 
fungus Polyporus tumulosus which converts 4-hydroxyphenylglyoxylate to
4-hydroxymandelate, although this observation was based upon radiolabelling studies 
rather than assay of the enzyme involved (Crowden, 1967).
Page 31
COOHI
H O - C -H
COOHI
H - C -O H
L (+ )-m a n d e lic  a c id  D ( -) -m a n d e lic  a c id
COOHI
C =  0
p h e n y lg ly o x y lic  a c id  
C
CHO!)
benzaldehyde
d
COOH5
benzoic  a c id
COOH
OH
A -hydroxybenzo ic  a c id
COOH
OH
OH
p ro to c a te c h u ic  a c id
r in g  c leavag e  
and
fu r th e r  m etabolism  
to
s u c c in a te  + acetylC oA
Figure 1.14 Metabolism of mandelate in A. niger, N. crassa and R  graminis
Enzymes; a, L(+)-mandelate dehydrogenase; b, D(—)-mandelate dehydrogenase; 
c, phenylglyoxylate decarboxylase; d, benzaldehyde dehydrogenase; e, benzoate
4-hydroxylase; f, 4-hydroxybenzoate 3-hydroxylase. Adapted from Fewson (1988b).
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The phenylglyoxylate produced from the oxidation of mandelate is then converted 
to benzaldehyde, and in A  niger, N. crassa and f t  graminis, as in bacteria, the enzyme is 
dependent upon thiamin pyrophosphate for activity (Figure 1.14 c; Jamaluddin et al., 
1970; Kishore et al., 1976; Ramakrishna Rao & Vaidyanathan, 1977; Durham, 1984). 
Benzaldehyde is then oxidised to benzoate by nicotinamide nucleotide-dependent 
benzaldehyde dehydrogenases, and in A  niger strain UBC 814 there are two isoenzymes, 
one of which is specific for NAD+ and the other for NADP+, whereas in R. graminis there is 
a single NAD+-dependent enzyme (Figure 1.14 d; Jamaluddin et al., 1970; Durham, 1984). 
R. graminis also grows on benzyl alcohol as a sole source of carbon and energy, and 
converts benzyl alcohol to benzaldehyde by means of an NAD+-dependent benzyl 
alcohol dehydrogenase (Middleton, 1988). However, it is not known whether the yeast 
has a second benzaldehyde dehydrogenase specifically associated with benzyl alcohol 
metabolism in addition to the NAD+-dependent enzyme induced during growth on 
mandelate.
The mandelate pathway of fungi then diverges from that found in bacteria, as the 
benzoate formed from the oxidation of benzaldehyde is converted to 4-hydroxybenzoate 
rather than to 3,5-cyc!ohexadiene-1,2-diol-1-carboxylate (Figure 1.14 e). In A  niger 
strain UBC 814 benzoate 4-hydroxylase is a soluble, tetrahydropteridine, NADPH and 
0 2-dependent enzyme, whereas in R. graminis it is membrane "associated", 
pteridine-independent and probably contains flavin as a cofactor (Reddy & Vaidyanathan, 
1975; McNamee & Durham, 1985). The final enzymic step prior to ring cleavage is further 
hydroxylation by 4-hydroxybenzoate-3-hydroxyIase to form protocatechuate, and in 
R. graminis the enzyme is soluble and NADPH-dependent (Figure 1.14 f, McNamee & 
Durham, 1985). Protocatechuate is then fed into the protocatechuate branch of the 
j8-ketoadipate pathway, ultimately yielding the amphibolic intermediates succinate and 
acetyl-CoA.
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1.2.4 The evolution of the mandelate pathway
Comparison of the mandelate pathways of A  calcoaceticus and P. putida with the 
pathway used by fungi (Figures 1.11 & 1.14) indicates that whilst they share some 
common steps i.e. dehydrogenation of mandelate, decarboxylation of phenylglyoxylate 
and dehydrogenation of benzaldehyde, they diverge at the level of benzoate resulting in 
the formation of catechol in bacteria and protocatechuate in fungi. Therefore, it seems 
likely that these pathways have evolved independently in prokaryotes and eukaryotes, 
and that the pre-existing genetic material in the two groups may have dictated the 
direction of mandelate catabolism by the evolving organisms. However, as little is known 
about the metabolism of mandelate in fungi, further studies are required before detailed 
comparisons can be made with the analogous bacterial pathways, in bacteria, however, 
the pathways for the degradation of mandelate have been characterized in more detail, 
and this offers the opportunity to investigate the possible mechanisms by which they have 
evolved. Although this section refers to the mandelate pathway, much of the discussion is 
equally applicable to the evolution of peripheral metabolic pathways in general.
The intriguing question is : How did the mandelate pathway evolve ? Horowitz 
(1945) proposed a mechanism of "retrograde evolution" to account for the early evolution 
of biosynthetic pathways and this idea could, in principle, be applied to catabolic 
pathways. He suggested that the substrate-binding site of an enzyme might serve as the 
product-binding site in a homologous enzyme, which after acquisition of a novel catalytic 
site by mutation, could mediate the preceding step in the evolving pathway. For example, 
let us assume that the ancestor of the modern day A  calcoaceticus strain NCIB 8250 
could grow on benzoate as a sole source of carbon and energy, but not on 
benzaldehyde, phenylglyoxylate or mandelate. By the mechanism proposed by Horowitz, 
duplication and mutation of the benzoate 1,2-oxygenase gene, so that the new gene 
product could bind benzaldehyde and dehydrogenate it to benzoate, would extend the 
pathway and enable the organism to grow on an additional carbon source. Subsequent 
duplication and mutation of the new benzaldehyde dehydrogenase gene could give rise 
to phenylglyoxylate decarboxylase, and so on to give mandelate dehydrogenase.
However, comparison of the enzymes that catalyse the successive steps of the 
mandelate pathway in A  calcoaceticus and P. putida show them to have markedly 
different properties e.g. mandelate racemase is soluble and metal-dependent, the 
mandelate dehydrogenases are flavin-dependent, integral membrane proteins, the 
phenylglyoxylate decarboxylases are thiamin pyrophosphate-dependent and the 
benzaldehyde dehydrogenases are nicotinamide nucleotide-dependent enzymes 
(See Section 1.2.2 and references therein). Furthermore, several of the successive steps 
involve radically different chemical mechanisms. Perhaps not surprisingly, the sequences 
of mandelate racemase, L(+)-mandelate dehydrogenase and phenylglyoxylate 
decarboxylase from P. putida do not appear to be homologous (Tsou et al., 1990). 
Therefore, it is difficult to imagine the mechanism proposed by Horowitz having given rise 
to the mandelate pathway, especially as major mutational restructuring of the gene
products would have been required at each step i.e. to alter the cofactor specificity, 
reaction mechanism and in one case to enable the enzyme to assume a completely 
different intracellular location. Similarly, retrograde evolution does not seem to have had a 
major role in the evolution of the glycolytic pathway as the structures and properties of the 
enzymes that catalyse consecutive reactions are, by and large, quite dissimilar 
(Fothergill-Gilmore, 1986). Nevertheless, it is unlikely that retrograde evolution has played 
no part at all in the evolution of metabolic pathways since there is extensive homology 
between the metB and metC genes which code for consecutive enzymes in the 
methionine biosynthetic pathway of E. coli (Parsot etal., 1987).
A more likely explanation to account for the evolution of the mandelate pathway, 
and in view of the fact that economy in biological systems is an obvious selective 
advantage, is that the enzymes of the pathway were recruited from other metabolic 
pathways. Indeed, the P. putida L(+)-mandelate dehydrogenase sequence is 
homologous to other 2-hydroxyacid dehydrogenases e.g. the amino terminal has 
sequence identity with spinach glycolate oxidase, as does its carboxy terminal with the 
carboxy termini of S. cerevisiae glycolate oxidase and cytochrome b2 lactate 
dehydrogenase (Guiard, 1985; Volokita & Somerville, 1987; Cederlund et al., 1988; 
Tsou et al., 1990). Similarly, phenylglyoxylate decarboxylase shows several regions of 
significant sequence homology with other thiamin pyrophosphate-dependent 
decarboxylases, namely E. coli pyruvate oxidase, the pyruvate decarboxylases from 
S. cerevisiae and Zymomonas mobilis and the acetolactate synthases from E. coli and 
S. cerevisiae (Squires et al., 1983; Grabau & Cronan, 1986; Kellerman et al., 1986; 
Conway et al., 1987; Tsou et al., 1990). The similarities between L(+)-mandelate 
dehydrogenase and other FMN-dependent 2-hydroxyacid dehydrogenases and between 
phenylglyoxylate decarboxylase and other thiamin pyrophosphate-dependent 
decarboxylases strongly favours the suggestion that both these enzymes have evolved by 
recruitment of enzymes from other metabolic pathways already established in P. putida 
(Tsou et al., 1990). Evidence to support this notion has come from the observation that 
the primary, secondary and tertiary structures of P. putida mandelate racemase and 
cic,cis-muconate lactonizing enzyme are homologous. Both enzymes form a/p barrels, 
characteristic of triosephosphate isomerase, and are superimposable on one another. 
Furthermore, the two enzymes have identical quaternary structures and several 
catalytically important residues in mandelate racemase are conserved in the lactonizing 
enzyme e.g. the three residues in the racemase active site which coordinate the Mg2+ ion 
(Tsou etal., 1990; G. A. Petsko, personal communication).
Although evidence is coming to light which indicates that the mandelate pathway 
has probably arisen by means of recruitment of enzymes from other metabolic pathways, 
concomitant with this acquisition must have been mechanisms which put them under 
appropriate regulatory control. Inability to express the newly evolved enzymes in the 
presence of the substrate would carry with it no selective advantage, and constitutive 
expression in the absence of the substrate would be wasteful. In P. putida the genes
Page 35
which encode mandelate racemase (mcf/A), L(+)-mandelate dehydrogenase (mdlB) and 
phenylglyoxylate decarboxylase (md/C) are arranged in an operon (md/CBA), whilst the 
genes encoding the NAD+ and NADP+-dependent benzaldehyde dehydrogenases 
(mdID and mdlB respectively) are clustered approximately 2 kilobases upstream. 
However, despite this spatial separation all 5 enzymes are co-ordinately induced by 
D(—-)-mandelate, L(+)-mandelate or phenylglyoxylate (Hegeman, 1966b,c; Tsou et al., 
1990). In contrast, the mandelate enzymes of A  calcoaceticus do not appear to be 
clustered in the same manner and, moreover, they are co-ordinately induced by 
phenylglyoxylate and not by either enantiomer of mandelate (Livingstone & Fewson, 1972; 
Vakeria et al., 1984, 1985). Therefore, even though the mandelate enzymes of 
A  calcoaceticus and P. putida have very similar properties, they are subject to quite 
different regulation which suggests that evolutionary constraints on catalytic function and 
regulation are presumably not the same (Fewson, 1988b).
In order to understand more fully the enzymology of mandelate metabolism and to 
address questions regarding the evolution of the pathway in fungi, R. graminis was 
chosen for further study. It seemed the most promising eukaryote to investigate, not only 
because it was a yeast and would therefore be easier to grow than filamentous fungi but 
also because of the high specific activities of the enzymes involved (Durham, 1984; 
Durham etal., 1984).
1.3 Rhodotorula graminis and the genus Rhodotorula
According to Fell et al. (1984), the genus Rhodotorula contains eight recognised species : 
Rhodotorula acheniorum, R. araucariae, R. aurantiaca, R. glutinis, R. graminis, R. iactosa, 
R. minuta and R. rubra, although other species have since been isolated and proposed as 
members e.g. R. grinbergsii (Ramirez & Gonzalez, 1984). Classification of the genus has 
been confused by the use of a large number of generic synonyms e.g. Chromotorula, 
Cryptococcus, Mycotorula, Torula and Torulopsis and an even larger number of species 
synonyms, although for the purpose of this thesis no attempt will be made to rename any 
species appearing in the literature which have names other than the eight recognised by 
Fell et al. (1984).
Cells are usually spheroidal, ovoidal or elongate with some strains producing 
pseudohyphae or true hyphae. As imperfect yeasts, they reproduce asexually by 
multilateral budding, and do not form ascospores or baliistospores, although some strains 
of R. glutinis represent opposite mating types of the perfect, basidiomycetous yeast 
Rhodosporidium toruloides (Banno, 1967). Members of the genus Rhodotorula form 
characteristic red or yellow carotenoid pigments, and many give mucous colonies due to 
capsule production, whilst others give pasty, dry and wrinkled colonies. They are all 
aerobic yeasts and are unable to ferment (Fell etal., 1984).
As a genus they are amongst the most widely distributed yeasts in both natural 
and man-made environments, and have been isolated from a diverse range of sources 
including soil, fresh and marine water, air, live and decaying plant tissue, insects, brine
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shrimp, fish, birds, beer, preserved food, oil drillings, animal tissues and faeces 
(Fell et al., 1984). Moreover, they are invariably found during examination of natural yeast 
populations e.g. R. glutinis, R. graminis, R. minuta, R. mucilaginosa, R. rubra and 
R. texensis have been isolated from polluted water and sewage (Cooke etal., 1960) and, 
in a separate study of the South Saskatchewan River, Rhodotorula species constituted 30 
out of the 129 yeasts isolated (Spencer et al., 1970). Probably the main reason for their 
wide-spread distribution is their nutritional diversity, with many strains being able to grow 
on a large number of carbon substrates. For example, R. graminis strain KGX 39 can 
grow on glucose, galactose, maltose, mannitol, ribitol, citrate and succinate as well as on 
aromatic compounds such as benzyl alcohol, mandelate, phenylalanine, protocatechuate 
and salicylate (Fell etal., 1984; Durham etal., 1984; Middleton, 1988). Indeed, species of 
Rhodotorula have often been isolated during studies of the utilisation of aromatic 
compounds by yeasts. Mills ef al. (1971) isolated yeasts from sewage and found that 
several strains of R. minuta, R. glutinis and R. rubra could grow on a variety of aromatic 
compounds including resorcinol, phloroglucinol, salicylate and gentisate, with one strain 
of R. glutinis also using phenol as a sole source of carbon and energy.
Studies on the utilisation of lignin, the second most abundant natural bio-polymer 
after cellulose, have also revealed that species of Rhodotorula are capable of utilising 
compounds associated with its degradation. Strains of R. macerans and R. mucilaginosa 
can grow on 4-hydroxybenzoate, ferulate and vanillate, with R. mucilaginosa also being 
able to use coumarate, all of which are breakdown products of beech, pine and spruce 
lignins (Cain et al., 1968; Cook & Cain, 1974). A strain of R. glutinis has also been found 
to grow on sinapate, a monomer of hard-wood lignin. However, although this yeast could 
degrade sinapate to syringate in the absence of glucose, further metabolism of syringate 
to 3-O-methylgallate, gallate and 2,6-dimethoxy-1,4-benzoquinone occurred only in the 
presence of glucose as a co-metabolite (Gupta et al., 1986). Co-metabolism of aromatic 
compounds is also a feature of other species of Rhodotorula; R. glutinis, R. mucilaginosa 
and R. m inuta  can co-m etabolise  the plant phenylpropanoid , rutin  
(Westlake & Spencer, 1966), and a species of the related genus Rhodosporidium 
co-metabolises 4-chloronitrobenzene to 4-chloro-2-hydroxyacetanilide and
4-chloroacetanilide (Corbett & Corbett, 1981). Other species of Rhodotorula, whilst 
unable to grow on certain aromatic compounds as the sole source of carbon and energy 
can, nevertheless, partially degrade them. For example, a strain of R. glutinis grew on 
phenol but not on monochloro or monobromophenols, although phenol-grown cells 
consumed oxygen in the presence of 2-, 3-, and 4-chlorophenoI, 4-bromophenol,
2,4-dichlorophenol and 2,4-dibromophenol, and converted 3- and 4-chlorophenol to
4-chlorocatechol (Walker, 1973). These examples highlight the nutritional diversity of the 
genus Rhodotorula and presumably they and other yeasts, particularly species of 
Candida, Cryptococcus, Debaromyces, Sporobolomyces and Trichosporon which also 
degrade a variety of aromatics (Cain etal., 1968; Mills etal., 1971; Gaal & Neujahr, 1979),
contribute to the overall microbial breakdown and recycling of these compounds in the 
environment. Moreover, this is significant since many natural and man-made aromatic 
compounds are recalcitrant and/or toxic (Fewson, 1981,1988a).
Species of Rhodotorula have also received particular attention as some of their 
enzymes have found use in biotransformation processes. The enzyme phenylalanine 
ammonia lyase from R. glutinis, f t  graminis and R. rubra catalyses the deamination of 
L-phenylalanine to trans-cinnamate and ammonia, allowing these organisms to grow on 
L-phenylalanine as a sole source of carbon, nitrogen and energy (Yamada et al., 1981; 
Orndorff et al., 1988). However, when the enzyme is incubated in the presence of high 
concentrations of trans-cinnamate and ammonia at elevated pH the reaction can be 
reversed and, as such, the enzyme from a species of Rhodotorula has been exploited in a 
commercial process for the production of L-phenylalanine (Hamilton et al., 1985). Other 
biotransformations in which Rhodotorula species have been employed include the 
synthesis of chiral cyclopentenones and the monitoring of asymmetric carbonyl reduction 
(Allenmark & Andersson, 1988; Okano etal., 1988).
Phenylalanine ammonia lyase has found potential use in the treatment of 
phenylketonuria. This inborn error of metabolism is usually treated by low dietary intake of 
phenylalanine, and studies with R. rubra grown on a hydrolysate of milk whey protein, but 
entrapped within a polypyrrole matrix, have enabled production of a low phenylalanine 
peptide mixture suitable as a phenylketonuria foodstuff (Watanabe et al., 1988). The 
enzyme from R. glutinis has also found a possible use in the direct treatment of the 
condition, as it can convert phenylalanine to trans-cinnamate within the alimentary tract 
and thereby reduce the blood phenylalanine levels of patients after ingestion of a normal, 
non-restrictive meal (Hoskins et al., 1980).
Finally, the lipid-soluble, carotenoid pigments from an undisclosed pink yeast, 
presumably a species of Rhodotorula, have been used to enhance the colour of farmed 
salmon. Unlike their counterparts in the wild, the meat of cultivated fish lacks the 
characteristic pinkness because of a deficiency of the pigment astaxanthin. However, 
feeding salmon with the yeast supplement has been successful in restoring the pink 
colour to the meat. Furthermore, studies have been undertaken to determine whether 
yeast derived pigment is an economically viable alternative to artificial colouring or pink 
crustacean waste which, at present, are used by salmon farmers to obtain the desired 
effect (Highfield, 1987; W. Hall, personal communication).
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1.4 Aims and scope of this thesis
Although several fungi can utilise mandelate as a growth substrate, none of the enzymes 
involved in the degradation of mandelate to benzoate seem to have been purified to 
homogeneity, although some of the enzymes have been studied in crude extract or in 
partially purified form. In contrast, all of the mandelate enzymes of the bacterium 
A. calcoaceticus; D(—)- and L(+)-mandelate dehydrogenase, phenylglyoxylate 
decarboxylase and benzaldehyde dehydrogenase I, have been purified and 
characterized. The principal aim of this project was therefore to purify and characterize 
the NAD+-dependent D(—)-mandelate dehydrogenase from the yeast f t  graminis in order 
to answer the questions : How similar are bacterial and fungal mandelate 
dehydrogenases, and what are the evolutionary relationships between them ?
The first objective was to design a purification procedure for the enzyme. 
Purification would in turn allow various physical, chemical and kinetic properties of the 
enzyme to be determined e.g. native and subunit , amino acid composition, amino 
terminal sequence and substrate and inhibitor specificities. Comparison could then be 
made between the f t  graminis D(—)-mandelate dehydrogenase and the mandelate 
dehydrogenases of A. calcoaceticus, as well as with other NAD+-dependent 
dehydrogenases. In addition, antisera raised against the yeast enzyme would enable an 
immunological comparison of the various mandelate dehydrogenases. A subsidiary aim 
of this project was to determine whether other yeasts were capable of growth on 
mandelate, and to isolate mandelate-utilising yeasts by selective enrichment from natural 
environments.
During the course of the present work, the aims were expanded to include 
experiments designed to identify amino acid residue(s) at the active site of 
D(—)-mandelate dehydrogenase which might be involved in catalysis. It was thought that 
the synthesis and purification of a bromoacetyl derivative of the substrate D(—)-mandelate 
would enable the active site to be probed for reactive and accessible nucleophilic groups. 
Furthermore, isolation of peptides derived from enzyme inactivated with a radiolabelled 
form of the inhibitor would allow purification and sequencing of peptide(s) corresponding 
to regions at or near the active site.
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CHAPTER 2 
MATERIALS AND METHODS
2.1 Materials
2.1.1 Chemicals
Chemicals were of the best quality commercially available and most of them were 
obtained from BDH Chemicals Ltd, Poole, Dorset, UK, except for those listed below.
Aldrich Chemical Company Ltd, Gillingham, Dorset, UK : anhydrous acetonitrile, 
anhydrous pyridine, bromoacetic acid, bromoacetylbromide, D,L-4-chloromandelic acid, 
D(—)-hexahydromandelic acid, isobutylchloroformate, thiopheneglyoxylic acid.
Amersham International, Little Chalfont, Bucks., UK : bromo[1-14C]acetic acid, 
glucose [1-3H],
Bethesda Research Laboratories, Gaithersburg, MD, USA: urea.
Boehringer Corporation, Lewes, Sussex, UK : DTT, NAD+ (free acid), NADP+ (disodium 
salt), NADH (disodium salt), NADPH (disodium salt), oxaloacetic acid, 2-oxoglutaric acid, 
Tris (base).
Fluka Chemicals Ltd, Glossop, Derbyshire, U K : D(—)-mandelic acid, L(+)-mande!ic acid, 
phenylglyoxylic acid.
Formachem (Research International) Ltd, Strathaven, Midlothian, UK: (NH4)2S 04.
FSA Laboratory Supplies, Loughborough, Leics., U K : acetic acid, acrylamide, ethanediol, 
formic acid, A/./V'-methylene-b/s-acrylamide, NaCI, orthophosphoric acid, SDS, sucrose. 
G.T. Gurr Ltd, London, UK: Pyronin Y.
James Burrough (F.A.D.) Ltd, Witham, Essex, UK: ethanol.
Koch Light Laboratories Ltd, Colnbrook, Bucks., UK : D,L-4-fluoromandelic acid, 
D,L-phenyllactic acid, phenylpyruvic acid, trichloroacetic acid.
May & Baker Ltd, Dagenham, Essex, UK: ethyl acetate, nitric acid, pyridine, toluene. 
Rathburn Chemicals, W alkerburn, Peebleshire, UK : dichlorom ethane, 
4-methylmorpholine, TFA.
Riedel de-Haen AG, Seelze, Hannover, FRG: NagCOg.
Scientific Marketing Association, London, UK: leupeptin.
Serva Feinbiochemica, Heidelberg, FRG; Brilliant Blue G-250.
Sigma Chemical Company, Poole, Dorset, UK : acetyl-CoA (lithium salt), ADP (disodium 
salt), ATP (disodium salt), bathophenanthroline disulphonic acid, benzamidine, Bicine, 
chloramphenicol, diethyldithiocarbamic acid, dihydroxybenzene disulphonic acid, 
2,2,-dipyridyl, 5,5'-dithiobis(2-nitrobenzoic) acid, Af-ethylmaleimide, fluorescamine, 
guanidine hydrochloride, D,L-2-hydroxycaproic acid, D,L-2-hydroxyisocaproic acid, 
D , L - 3 - h y d r o x y m a n d e l i c  a c i d ,  D , L - 4 - h y d r o x y m a n d e l i c  a c i d ,  
D,L-4-hydroxy-3-methoxymandelic acid, D,L-3-hydroxy-4-methoxymandelic acid, 
D,L-4-hydroxyphenyl!actic acid, D,L-2-hydroxyvaleric acid, D,L-2-hydroxyisovaleric acid, 
8-hydroxyquiniione, D(—)-lactic acid, iodoacetamide, D(+)-malic acid, Mes, Mops, Nitro 
Blue Tetrazolium, 2-oxovaleric acid, 2-oxoisovaleric acid, 2-oxoisocaproic acid,
2-oxooctanoic acid, 2-oxo-3-methylvaleric acid, pepstatin, PMSF, pyruvic acid, 
sodium azide, Tween 20 ,4-chloro 1-naphthol.
2.1.2 Chromatography media
Amicon Ltd, Stonehouse, Glos., UK: Dyematrex screening kit and Matrex Gel Orange A. 
Pharmacia Ltd, Milton Keynes, Bucks., UK : DEAE-Sephacel, Phenyl Sepharose, 
Sephadex G-50 and pre-packed FPLC Mono P (chromatofocussing) and Superose 6 
(gel filtration) columns.
Sigma Chemical Company, Poole, Dorset, UK: Blue Sepharose CL-6B.
2.1.3 Proteins and enzymes
BDH Chemicals Ltd, Poole, Dorset, UK : Saccharomyces cerevisiae alcohol 
dehydrogenase.
Boehringer Corporation, Lewes, Sussex, UK : pig heart lactate dehydrogenase, rabbit 
muscle pyruvate kinase, horse spleen ferritin and horse heart cytochrome c.
Fluka Chemicals Ltd, Glossop, Derbyshire, UK: S. cerevisiae alcohol dehydrogenase. 
Pharmacia Ltd, Milton Keynes, Bucks., UK : low Mf standards for SDS-PAGE, which 
included rabbit muscle phosphorylase b, bovine serum albumin, ovalbumin, bovine 
erythrocyte carbonic anhydrase, bovine milk a-lactalbumin and soya bean trypsin 
inhibitor.
Sigma Chemical Company, Poole, Dorset, UK : rabbit muscle aldolase, ovalbumin, 
Leuconostoc mesenteroides glucose-6-phosphate dehydrogenase and S. cerevisiae 
hexokinase.
Wilfred Smith Ltd, Edgeware, London, UK: bovine serum albumin (fraction V).
Worthington Biochemical Corporation, Freehold, NJ, USA: trypsin.
2.1.4 Miscellaneous materials
British Oxygen Corporation, Guildford, Surrey, UK: N2 , 0 2.
Difco Laboratories, Detroit, Ml, USA: Freund’s complete and incomplete adjuvants.
Fluka Chemicals Ltd, Glossop, Derbyshire, UK: Silica Gel 60.
Gibco, Paisley, Strathclyde, UK: heat-inactivated horse serum.
Macherey-Nagel, Duren, FRG: Polygram Sil G TLC plates.
Merck, Darmstadt, FRG: Kieselgel 60 F254 TLC plates.
Pharmacia Ltd, Milton Keynes, Bucks., UK: Polybuffer PB 74.
Schleicher & Schuell, Dassel, FRG: nitrocellulose.
Scottish Antibody Production Unit, Carluke, Lanarkshire, UK : normal donkey serum, 
normal rabbit serum, donkey anti-rabbit IgG peroxidase conjugate.
The Scientific instrument Centre, Eastleigh, Hants, UK: visking tubing.
Whatman International Ltd, Maidstone, Kent, UK: chromatography and filter papers.
2.2 General methods
2.2.1 pH measurements
The pH values of solutions were usually determined with an E.I.L model 7010 pH monitor 
(E.I.L Ltd, Cumbernauld, Strathclyde, UK) connected to a combined glass electrode 
(Probion Ltd, Glenrothes, Fife, UK). Small volumes, e.g. 1 ml assay mixtures, were 
measured with a Radiometer (Copenhagen, Denmark) type M26 pH monitor fitted with a 
GK 2302 micro pH electrode.
2.2.2 Conductivity measurements
The conductivities of solutions were determined with a Radiometer type CDM2e 
conductivity meter.
2.2.3 Glassware
Glassware was washed by immersion in a solution of Haemo-sol [Alfred Cox (Surgical) 
Ltd, Coulsdon, Surrey, UK] according to the manufacturer’s instructions, and then 
thoroughly rinsed with tap water and then distilled water. Glassware for chemical 
syntheses was baked overnight in an oven at 110°C. Glassware for protein chemistry was 
immersed in boiling 10% (v/v) nitric acid for 30 min, followed by thorough rinsing with 
distilled water.
2.2.4 Dialysis
Dialysis tubing was prepared by boiling for 10 min in 1% (w/v) EDTA and then rinsed and 
boiled 3 times in distilled water for 10 min. The tubing was stored in 20% (v/v) ethanol.
2.2.5 Protein estimation
Protein was estimated using the methods of Lowry et al. (1951) and Bradford (1976). 
Standard curves of A?5Q (Lowry) or A595 (Bradford) against protein concentration were 
constructed using BSA covering the range 10 to 100 pg ml'1. In both cases, unknown 
samples were made up to 1 ml with distilled water prior to the addition of reagents.
During enzyme purification, the A280 values of column effluents were measured 
with an LKB (Milton Keynes, Bucks., UK) Uvicord 2138 monitor. The AZQQ values of 
effluents from FPLC (Pharmacia) columns were measured with a Pharmacia UV-1 monitor.
2.2.6 Preparation of chromatography media
DEAE-Sephacel and Phenyl Sepharose were supplied pre-swollen and were poured 
directly into columns. Matrex Gel Orange A was washed with 5M-urea to remove unbound 
dye from the support matrix before use. Columns were equilibrated by washing with 
10 volumes of the appropriate buffer. DEAE-Sephacel and Matrex Gel Orange A were 
regenerated after use by washing with 1 M-NaCI, and Phenyl Sepharose was regenerated 
with 5M-urea. After the Orange A had been used several times it was fully regenerated by
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successive washes in 1 M-NaCI, 5 M-urea and 50% (v/v) chloroform in methanol. All 
columns were stored in 0.02% sodium azide, except the Superose 6 column which was 
stored in 20% (v/v) ethanol.
2.2.7 Lyophilizatlon
Samples for protein chemistry were frozen in appropriate vessels by placing them into 
methanol/dry ice. The tops were covered with Nescofilm (Nippon Shoji Kaisha Ltd, Osaka, 
Japan) punctured with a needle. Frozen samples were placed into a dessicator attached 
to a Flexi-dry lyophilizer (F.T.S. Systems Inc., Stone Ridge, NY, USA) and the dessicator 
evacuated with a Javac (Farnham, Surrey, UK) vacuum pump.
Yeast cultures were lyophilized in glass ampoules using an Edwards (Edwards 
High Vacuum Ltd, Crawley, Sussex, UK) Speedivac centrifugal freeze dryer according to 
the manufacturer’s instructions.
2.2.8 Scintillation counting and autoradiography
Radioactivity (14C and 3H) was measured using an LKB model 1209 Rackbeta liquid 
scintillation counter. Samples (maximum volume 500 p I) were added and thoroughly 
mixed with 5 ml or 10 ml of Ecoscint A (National Diagnostics, Manville, NJ, USA). 
Background radiation was measured by determining the counts from an equal volume of 
solvent not containing the radioactive sample.
TLC plates were autoradiographed by overlaying with Fuji RX-100 X-ray film. After 
exposure, the film was developed with a Kodak (Hemel Hempstead, Herts., UK) 
ME-3 X-OMAT processor according to the manufacturer’s instructions.
2.3 Microorganisms; maintenance, growth, harvesting and disruption
2.3.1 Source of microorganisms
Yeasts
Rhodotorula graminis strain KGX 39 was obtained from Dr D. R. Durham, Genex 
Corporation, Gaithersburg, MD 20877, USA, and was originally isolated from soil by 
enrichment culture using benzoate as the sole source of carbon (Durham etal., 1984).
Rhodotorula graminis (NCYC 502, 980 & 1401), Lloderomyces elongisporus 
(NCYC 928), Rhodotorula pilimanae (NCYC 759), Rhodotorula minuta (NCYC 931) and 
Candida tropicalis (NCYC 1503) were from the National Collection of Yeast Cultures, 
Norwich, Norfolk, UK
Pachysolen tannophilus (NCYC 614), Rhodotorula glutinis (NCYC 59), 
Rhodosporidium toruloides (NCYC 819), Candida utilis (NCYC 321), Candida nitratophila 
(NCYC 556), Hansenula anomala (NCYC 432) and Sporobolomyces roseus (NCYC 1609) 
were obtained from Dr C. R. Hipkin, School of Biological Sciences, University College of 
Swansea, Wales.
Candida pseudotropicalis (NCPF 3234) was obtained from Mr I. Watt, Department 
of Microbiology, University of Glasgow.
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Trigonopsis variabilis (CBS 1040), Torulopsis colliculosa (CBS 133), 
Hanseniaspora valbyensis (CBS 479), Debaromyces hansenii (CBS 767), Wingia robertsii 
(CBS 2934), Saccharomyces bayanus (CBS 380), Wickerhamia fluorescens (CBS 4565), 
Trichosporon cutaneum (CBS 2466) and Pichia membranaefaciens (CBS 107) were 
obtained from Ms E. Scott, Department of Medical Mycology, University of Glasgow.
Rhodotorula grinbergsii (IJFM 6000) was obtained from Professor C. Ramirez, 
Thailand Institute of Scientific and Technological Research, Bangkok 10900, Thailand.
Rhodotorula nothofagii (CCY 20-19-1) was obtained from Dr E. Slavikova, 
Czechoslovak Collection of Yeasts, Institute of Chemistry, Bratislava 842 38, 
Czechoslovakia.
Soil, compost, silage and animal faeces for enrichment of mandelate-utilising 
yeasts were collected with the help of Mr D. McKe!lar, Ms P. McKe!lar and Mr S. MacKenzie.
Bacteria
Acinetobacter calcoaceticus mutant strain C1219 [NCIB 11457, constitutive for 
D(—)-mandelate dehydrogenase, L(+)-mandelate dehydrogenase and phenylglyoxylate 
decarboxylase] was obtained from Professor C. A. Fewson, Department of Biochemistry, 
University of Glasgow.
Streptococcus faecalis (IFO 12964) was obtained from the Institute of 
Fermentation, Osaka, Japan.
A crude extract of Lactobacillus curvatus (DSM 20 019) was obtained from 
Dr W. Hummel, Institute for Enzyme Technology, University of Dusseldorf, FRG.
2.3.2 Maintenance of cultures
All yeasts except those obtained from the Department of Medical Mycology, University of 
Glasgow were maintained as lyophilized cultures in a filter-sterilized mixture of 3 parts of 
heat-inactivated horse serum to 1 part 30% (w/v) glucose. Those from the Department of 
Medical Mycology were supplied as actively growing cultures on Oxoid (Oxoid Ltd, 
Basingstoke, Hants, UK) Sabouraud-dextrose agar, and were used within a week of being 
received.
A  calcoaceticus mutant strain C1219 was maintained in 10ml of sterile complex 
medium (MMB broth, Allison etal., 1985a) and S. faecalis was maintained in 10ml of sterile 
Oxoid MRS broth (Man etal., 1960). Both bacteria were stored at 4°C.
2.3.3 Growth media 
Minimal media
(a) Mandelate salts medium : KH2P04 (2 g), (NHJ2S04  (1 g) and D,L-mandelic acid 
(0.75 g or 1.5 g) were dissolved in distilled water, the pH adjusted to 7.0 with NaOH and 
the volume made up to 1 I. The medium was then autoclaved and, after cooling, 20 ml of 
sterile 2% (w/v) MgS04.7H20  was added.
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(b) Yeast nitrogen base/mandelate medium : D.L-Mandelic acid (0.75 g or 1.5 g) and
6.7 g of Difco yeast nitrogen base (Difco Laboratories, Detroit, Mi, USA) were dissolved in 
distilled water, the pH adjusted to 6.0 with NaOH and the volume made up to 100 ml 
(x10 strength). The medium was filter-sterilized and 5 ml added to 45 ml of sterile distilled 
water giving a final concentration of 5 mM or 10 mM-D,L-mande!ate respectively. Solid 
medium was prepared by addition of 5 ml of the x10 strength liquid medium to 45 ml of 
molten Oxoid bacteriological agar N° 1 (15 g I*1).
Complex media
(a) MMB broth : Oxoid nutrient broth (26 g), D,L-mande!ic acid (1.5 g), L-glutamic 
acid.HCI (0.9 g), KH2P04 (2 g), (NH4)2S04 (1 g) and MgS04.7H20  (0.4 g) were dissolved 
in distilled water, the pH adjusted to 7.0 with NaOH and the volume made up to 1 I. When 
the medium was used for large scale growth of cells (10 I), polypropylene glycol) 2025 
(0.005%) was added as an antifoam.
(b) Oxoid MRS broth: Prepared according to the manufacturer’s instructions.
(c) Oxoid Sabouraud-dextrose broth and agar : Prepared according to the 
manufacturer’s instructions.
2.3.4 Sterilization
Growth media containing yeast nitrogen base were sterilized by filtration through Millipore 
(Watford, Herts., UK) 0.22 pm filters. All other growth media were sterilized by autoclaving 
at 109°C (5 p.s.i.) for 50 min (up to 500 ml) or 60 min (500 ml to 2 I). The 10 I fermenter 
and 20 I reservoir were autoclaved at 120°C (15 p.s.i.) for 75 min. Glass pipettes were 
sterilized by baking at 160°C for 105 min and plastic pipettes were sterilized with ethylene 
oxide (Anprolene) (H. W. Anderson Products Ltd, Clacton-on-Sea, Essex, UK).
The efficiency of sterilization was monitored using the appropriate Browne’s tube 
(A. Browne Ltd, Leicester, Leicestershire, UK), except for ethylene oxide sterilization where 
Anprolene exposure indicators were used.
2.3.5 Growth of microorganisms 
Growth of yeasts
(a) Growth of yeasts In minimal medium: Yeasts maintained as lyophilized cultures were 
rehydrated with sterile distilled water and subcultured onto Sabouraud-dextrose agar and 
grown at 23°C or 30°C for 2 to 5 days depending on the species. A loopful of culture was 
aseptically transferred to 50 ml of minimal medium (in a 250 ml conical flask) and shaken 
(200 r.p.m.) at 23°C or 30°C for 24 h, 48 h, 72 h or 96 h depending on the species.
(b) Growth of R. graminis KGX 39 In MMB broth : When large amounts of cells were 
required, R. graminis KGX 39 was grown in MMB broth in a 10 I fermenter fitted with a 
2 0 1 reservoir. The method used was essentially that described by Allison et al. (1985b) for 
the growth of A  calcoaceticus. An inoculum was prepared by aseptically transferring a 
loopful of culture from the solid medium to 200 ml of the complex medium (in a 1 I conical
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flask) and shaking (200 r.p.m.) at 30°C for 19 h. The entire culture was used to inoculate 
the fermenter (Braun Biostat V; F.T. Scientific Instruments, Tewkesbury, Glos., UK), which 
contained 10 I of the complex medium. The fermenter was operated at 30°C with an 
aeration rate of 4 I of sterile air min'1 and stirring at setting 2.5 (approx. 250 r.p.m.). 
After growth for 24 h, 9.5 I of culture were removed for harvesting and 9.5 I of fresh 
medium transferred from the reservoir. After a further 24 h growth, 9.5 I of culture were 
removed for harvesting and the remaining fresh medium transferred to the fermenter. The 
culture was grown for a final 24 h whereupon all the culture was removed and harvested.
Growth of bacteria
A. calcoaceticus strain C1219 was grown in MMB broth. Stock culture (0.1 ml) was 
aseptically transferred to 50 ml of MMB broth (in a 250 ml conical flask) and shaken 
(200 r.p.m.) at 30°C overnight. Then the entire culture was aseptically transferred to 
400 ml of fresh MMB broth (in a 2 I conical flask) and the culture shaken (200 r.p.m.) at 
30°C overnight. The cells were then harvested.
S. faecalis was grown in MRS broth. Stock culture (0.5 ml) was aseptically 
transferred to 50 ml of MRS broth (in a 250 ml conical flask) and shaken (200 r.p.m.) at 
30°C for 8 h. Then the entire culture was aseptically transferred to 400 ml of fresh MRS 
broth (in a 2 I conical flask) and shaken (200 r.p.m.) at 30°C overnight. The cells were 
then harvested.
2.3.6 Optical density measurements
The optical densities of cultures were determined by measuring the OD5g5, relative to the 
centrifuged medium, with a Pye-Unicam (Cambridge, Cambs., UK) SP30 
spectrophotometer. Samples were diluted with water so that the ODgg5 did not exceed 
0.4, and the medium was diluted by the same factor.
2.3.7 Harvesting ceils
All harvesting was carried out at 4°C. Cultures (up to 50 ml) were harvested by 
centrifugation at 12 000 g for 15 min in an M.S.E Highspeed 18 centrifuge (M.S.E. Ltd, 
London, UK), whereas larger volumes were harvested at 5 000 r.p.m. for 20 min in an 
M.S.E. Mistral 6L centrifuge. Pellets were resuspended in a volume of cold water equal to 
the original culture volume and recentrifuged. The pellets were combined, made to 50 ml 
with cold water and centrifuged at 12 000 g for 30 min in an M.S.E. Highspeed 18 
centrifuge. The supernatants were decanted and the pellets stored at -20°C.
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2.3.8 Cell disruption
Cell disruption was carried out at 0-4°C.
(a) Ultrasonic disruption of bacteria : Cell pellets were suspended in 3 volumes of the 
appropriate buffer and broken with a Lucas-Dawes (London, UK) ultrasonic probe, 
operated at 80 W for 5 x 30 s periods alternating with cooling periods of 30 s.
(b) French pressure cell disruption of yeasts : Cell pellets were suspended in 
3 volumes of the appropriate buffer and broken by 3 passages through a French pressure 
cell (FA-073 or FA-003 models; American Instrument Company, Silver Spring, MD, USA) at 
a pressure of 98 MPa.
2.3.9 Enrichment and selection of mandelate-utllislng yeasts
Samples for enrichment (approx. 1 g) were suspended in sterile distilled water (10 ml) and 
mixed. Suspensions (1 ml) were aseptically transferred to 50 ml of yeast nitrogen base 
containing 5 mM-D,L-mandelate and chloramphenicol (100 mg I*1) to inhibit bacterial 
growth. Flasks were shaken (200 r.p.m.) at 23°C until growth was observed. Samples 
from the first passage (1 ml) were transferred to 50 ml of fresh medium and incubated 
under the same conditions; a third passage was carried out where growth was marked. 
Appropriately diluted samples of all passages (in sterile distilled water) were plated onto 
yeast nitrogen base/mandelate/chloramphenicol agar plates and incubated at 23°C until 
growth developed. Representative colonies were selected and inoculated onto fresh 
selective media and Sabouraud-dextrose agar and grown at 23°C.
2.4 Enzyme assays
2.4.1 Equipment and definition of enzyme units
An LKB Ultrospec spectrophotometer was routinely used during enzyme purification and a 
Pye-Unicam SP8-100 spectrophotometer was used for enzyme characterization and 
kinetic experiments. Assays were carried out in 1 ml plastic cuvettes with a 1 cm light path 
at 27°C (300 K). Solutions were dispensed using Gilson (Gilson Medical Electronics, 
Villiers-le-Bell, France) Pipetman pipettes and Finn variable pipettes [Jencons (Scientific) 
Ltd, Leighton Buzzard, Beds., UK]. Volumes of less than 5 p\ were dispensed with a 
Hamilton (Hamilton Corporation, Reno, NV, USA) glass syringe. Assays were initiated by 
the addition of substrate and rates followed for 3 to 5 min. Blank assays were run 
containing all constituents except substrate, although in some cases a non-enzyme blank 
was also run.
One unit of enzyme activity is defined as 1 pmo\ of substrate converted min'1; 
specific activities are given as units (mg of protein)'1. The molar absorption coefficient of 
NADH at 340 nm is 6.3 x 103 M'1 cm’1 (Bergmeyer, 1985), and the molar absorption 
coefficient of DCIP at 600 nm (pH 7.5) is 21.54 x 103 M'1 cm'1 (Armstrong, 1964).
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2.4.2 Assay of NAD+-dependent D(—)-mandelate dehydrogenase
(a) For enzyme purification the oxidation of D(—)-mandelate was measured in an assay 
mixture containing:
660 p\ of 300 mM-glycine/NaOH buffer (pH 9.5) (200 mM assay concentration)
50 pi of 10 mM-NAD+ (500 pM assay concentration)
50 p I of 100 mM-D(—)-mandelate (pH 7.0) (5 mM assay concentration)
Enzyme
Distilled water to 1 ml 
The rate of NAD+ reduction was followed at 340 nm.
For enzyme characterization, assays were developed to measure the D(—)-mandelate 
dehydrogenase activity (oxidation/forward reaction) and the phenylglyoxylate reductase 
activity (reduction/reverse reaction).
(b) The oxidation of D(—)-mandelate was measured in a mixture containing :
800 p\ of 250 mM-Bicine/NaOH buffer (pH 9.5) (200 mM assay concentration)
50 p\ of 20 mM-NAD+ (1 mM assay concentration)
50 p\ of 100 mM-D(—)-mandelate (pH 7.0) (5 mM assay concentration)
Enzyme
Distilled water to 1 ml 
The rate of NAD+ reduction was followed at 340 nm.
(c) The reduction of phenylglyoxylate was measured in a mixture containing:
800 yul of 250 mM-potassium phosphate/NaOH buffer (pH 5.85)
(200 mM assay concentration)
50 p\ of 4 mM-NADH (200 pU  assay concentration)
50 p\ of freshly prepared 20 mM-phenylglyoxylate (pH 7.0)
(1 mM assay concentration)
Enzyme
Distilled water to 1 ml 
The rate of NADH oxidation was followed at 340 nm
2.4.3 Assay of yeast dye-linked L(+)-mande!ate dehydrogenase
The dye-linked L(+)-mandelate dehydrogenase activities of yeasts were assayed by 
measuring the reduction of DCIP at 600 nm essentially as described by Hegeman (1966a). 
The enzymes were assayed in a mixture containing :
800 p\ of 82.5 mM-potassium phosphate buffer (pH 7.0)
(66 mM assay concentration)
50 p\ of 1 mM-DCIP (50 pM assay concentration)
50 p\ of 160 mM-L(+)-mandelate (pH 7.0) (8 mM assay concentration)
Enzyme
Distilled water to 1 ml
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2.4.4 Assay of bacterial dye-linked mandelate dehydrogenase
The dye-linked D(—)- and L(+)-mandelate dehydrogenases of A  calcoaceticus were 
assayed as described by Hills and Fewson (1983a), except that the assay concentration 
of D(—)-mandelate used here was 4-fold greater. The reaction was followed by 
measuring the reduction of DCIP at 600 nm in the presence of BSA and PMS.
D(—)-Mandelate dehydrogenase was assayed in a mixture containing:
2 ml of 100 mM-potassium phosphate buffer (pH 7.5)
(66 mM assay concentration)
100 p\ of 2 mM-DCIP (67 pM assay concentration)
100 p\ of 10 mM-PMS (333 pM assay concentration)
200 p\ of 5% (w/v) BSA
100 p\ of 60 mM-D(—)-mandelate (pH 7.0) (2 mM assay concentration)
Enzyme
Distilled water to 3 ml
L(+)-Mandelate dehydrogenase was assayed exactly as for the D(—)-mandelate 
dehydrogenase, except that the assay contained 100 p\ of 15 mM-L(+)-mandelate 
(500 pM assay concentration) instead of D(—)-mandelate as substrate.
2.5 Standardisation of NADH and NAD+ concentrations
(a) The nm of NADH solutions were determined, and the molar absorption coefficient 
of 6.3 x 103 M‘1 cm*1 was used to convert absorbances to concentrations using the 
Beer-Lambert equation.
(b) The concentrations of NAD+ solutions were determined enzymically using an alcohol 
dehydrogenase assay, essentially as described by Boehringer Mannheim (1973). 
The reduction of NAD+ was followed at 340 nm, and the concentration of NADH at the 
end of the reaction was calculated as in 2.5 (a). Although the equilibrium of the reaction 
catalysed by alcohol dehydrogenase favours ethanol and NAD+, under the conditions 
used, conversion of NAD+ to NADH is virtually complete and the final A ^  is a measure of 
the initial amount of NAD+ added (Bergmeyer, 1985).
2.6 Standardisation of D(—)-mandelate and phenylglyoxylate
The concentrations of D(—)-mandelate and phenylglyoxylate in assay mixtures at 
equilibrium, were determined using a BIO-RAD (Hemel Hempstead, Herts., UK) 
C4 RP-304 reverse-phase HPLC column (250 mm x 4.6 mm) pre-equilibrated in 
0.1% TFA. Samples (20 pi) were injected, the compounds eluted at a flow rate of 
1 ml min'1 and detected at 210 nm. The peaks corresponding to D(—)-mandelic and 
phenylglyoxylic acids were identified after spiking samples with a known amount of pure 
compound. Peak areas were calculated by an on-line integrator and the amount of each 
aromatic acid was determined from a calibration curve constructed using known amounts 
of compound.
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2.7 Analysis of Initial enzyme velocities and determination of kinetic coefficients
The Km and V values of D(—)-mandelate dehydrogenase with respect to its substrates, 
were determined by the two-substrate method described by Engel (1981). The enzyme 
was assayed in the presence of several non-saturating concentrations of both substrates. 
The K value for each substrate, and the V value were determined when the concentrationm
of the other substrate had been extrapolated to infinity.
The apparent Km and V values were determined by measuring the initial velocities 
in the presence of several non-saturating concentrations of the first substrate, at a fixed 
high concentration of the second substrate. The fixed concentration of the second 
substrate was at least 6.5-fold more than its apparent Km , and in most cases was over 
10-fold. The kinetic data were analysed using the Direct Linear method (Eisenthal & 
Cornish-Bowden, 1974) using the Enzpack computer program (Williams, 1985). Although 
the values given in this thesis were from the Direct Linear method, the data were also 
analysed and compared with the values obtained using the linear plotting methods 
(Lineweaver-Burk, Hanes-Woolf and Eadie-Hofstee), again using the Enzpack computer 
program.
2.8 Standard deviation and linear regression analysis
Averages and standard deviations are given as the mean value ±  1 standard deviation 
about the mean, and the number of experiments used to obtain the mean and standard 
deviation are given in parentheses. Linear regression was done by the least mean 
squares method using the Apple Macintosh Cricket Graph computer program.
2.9 Enzyme purification
All steps were carried out at a temperature of 0-4°C.
2.9.1 Preparation of the crude extract
Approximately 40-50 g of thawed yeast cells were suspended in 3 volumes of buffer A 
[50 mM-Tris/HCI buffer (pH 8.0) containing 1 mM-DTT], mixed with a glass homogeniser, 
and broken by 3 passages through a French pressure cell at 98 MPa [Methods 2.3.8 (b)]. 
The homogenate was centrifuged at 12 000 g  for 30 min, the supernatant removed and 
further centrifuged at 64 000 g  for 2 h. The high speed supernatant was filtered through 
Whatman (Whatman International Ltd, Maidstone, Kent, UK) GF/A glass paper to remove 
insoluble lipids, and then dialysed overnight against 2 x 2 I of buffer A. The dialysed 
extract was used as the starting material for enzyme purification.
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2.9.2 Chromatography on DEAE-Sephacel
Extract (approx. 97 ml) was applied at 30 ml h*1 to a DEAE-Sephacel column 
(10.2 cm x 2.6 cm) pre-equilibrated in buffer A. Once loaded, the column was washed 
with buffer A at 50 ml h'1 until the A2QQ of the effluent decreased to approximately 0.06. 
Then, D(—)-mandelate dehydrogenase was eluted with a linear 0-150 mM-NaCI gradient 
in buffer A (total vol. =  600 ml) at a flow rate of 30 ml h"1. Fractions containing more than 
3% of the total activity loaded were pooled.
2.9.3 Chromatography on Phenyl Sepharose
The DEAE-Sephacel pool (approx. 82 ml) was applied at 30 ml h"1 to a Phenyl Sepharose 
column (10.0 cm x 2.6 cm) pre-equilibrated in buffer A. Once loaded, the column was 
washed at 40 ml h*1 with buffer A until the A28Q of the effluent returned to the baseline. 
The column was then washed with 130 ml of buffer A containing 25% (v/v) ethanediol, 
followed by buffer A containing 40% (v/v) ethanediol which eluted the enzyme. Fractions 
containing more than 3% of the total activity loaded were pooled.
2.9.4 Chromatography on DEAE-Sephacel
The Phenyl Sepharose pool (approx. 69 ml) was applied to a DEAE-Sephacel column 
(3.8 cm x 1.6 cm) pre-equilibrated in buffer A. Once loaded, the column was washed with 
buffer A until the A280 of the effluent returned to the baseline. The enzyme was then 
eluted with buffer A containing 100 mM-NaCI. The flow rate throughout was maintained at 
30 ml h'1. Active fractions were pooled (approx. 15 ml) and dialysed overnight against 
2 1 of buffer B [50 mM-potassium phosphate buffer (pH 7.5) containing 1 mM-DTT].
2.9.5 Chromatography on Matrex Gel Orange A
The dialysed pool was applied to a Matrex Gel Orange A column (15.5 cm x 2.6 cm) 
pre-equilibrated in buffer B. Once loaded, the pump was stopped for 30 min, and then the 
column washed with 200 ml of buffer B followed by 300 ml of buffer A. The flow rate was 
reversed and pure D(—)-mandelate dehydrogenase was eluted with buffer A containing 
0.5 mM-NADH. The flow rate throughout was maintained at 60 ml h'1. Active fractions 
were pooled (approx. 44 ml) and the enzyme concentrated either by vacuum dialysis or by 
dialysis against dry Aquacide 2 powder (Calbiochem Brand Biochemicals, La Jolla, 
CA, USA). The pool was further concentrated to 200 p\ using a Centricon-30 
microconcentrator (Amicon), and stored in buffer A containing 50% (v/v) glycerol at -20°C.
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2.10 Polyacrylamlde-gel electrophoresis
2.10.1 SDS-PAGE
SDS-PAGE was carried out according to the method of Laemmli (1970), using the 
following stock solutions:
Solution A : 3.0 M-Tris/HCI (pH 8.8) containing 0.23% TEMED
Solution B : 28% (w/v) acryiamide containing 0.735% tyAT-methylene-b/s-acrylamide 
(deionised with amberiite)
Solution C : 0.1 M-Tris/HCI (pH 6.8) containing 0.8% SDS and 0.25% TEMED 
Solution D : 20% (w/v) SDS
Solution E (reservoir buffer): 25 mM-Tris/192-mM glycine containing 0.5% SDS
(a) Resolving gel [12.5% (w/v) acryiamide]
Solution A (25 ml), solution B (89.3 ml), solution D (1 ml) and distilled water (81.2 ml) were 
mixed and thoroughly degassed. Ammonium persulphate (150 mg) dissolved in distilled 
water (1 ml) was added and the mixture swirled gently during a second degassing. The 
mixture was poured between glass plates, the top of the gel overlaid with a thin layer of 
n-propanol and the gel left to polymerize. After the gel had set, the n-propanol was 
poured off, and the top of the gel thoroughly washed with distilled water. The distilled 
water was removed and the top of the gel dried with blotting paper.
(b) Stacking gel [5.6% (w/v) acryiamide]
Solution B (17.5 ml), solution C (10 ml) and distilled water (54 ml) were mixed and 
thoroughly degassed. Ammonium persulphate (150 mg) dissolved in distilled water (1 ml) 
was added and the mixture swirled gently during a second degassing. The mixture was 
poured on top of the resolving gel, an 18-track Teflon comb inserted and the gel left to 
polymerize.
(c) Sample preparation and electrophoresis conditions
Samples were prepared using the following stock solutions:
Solution F : 500 mM-Tris/HC! (pH 8.8), containing 15% (w/v) SDS, 80% (w/v) sucrose and 
sufficient Pyronin Y to give an intense pink colour; the solution was heated and filtered 
through cotton wool prior to use.
Solution G : 2 M-DTT
Solution H (Mf marker solution) : 1 vial low Mf standards (Pharmacia), distilled water 
(400 /il) and solution F (100 /il); the solution was heated to 100°C for 10 min prior to use.
Typically, samples were prepared for electrophoresis by mixing distilled water 
(10 /il), solution F (5 pi), solution G (2.5 /l/I) and sample. Mf standards were prepared by 
mixing solution G (1 /il), solution H (10 //I) and distilled water (4.5 /il). Both samples and 
Mf standards were heated to 100°C for 2 min prior to loading. Gels were run at 100 mA 
until the dye front was approximately 2 mm from the bottom of the gel. Gels were cooled 
by continuously pumping an ice-slurry through a baffled chamber built into the apparatus.
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2.10.2 Non-denaturing PAGE
Non-denaturing PAGE was essentially the method of Laemmli (1970), except that SDS 
was omitted from all solutions. Gels were prepared from the following stock solutions: 
Solution A : 3.0 M-Tris/HCI (pH 8.8) containing 0.23% TEMED
Solution B : 28% (w/v) acryiamide containing 0.735% A/,A/'-methylene-h/s-acrylamide 
(deionised with amberiite)
Solution C : 100 mM-Tris/HCI (pH 6.8) containing 0.25% TEMED
Solution D (reservoir buffer) : 25 mM-Tris/192-mM glycine containing 0.01%
/3-mercaptoethanol
(a) Resolving gel [7.5% (w/v) acryiamide]
Solution A (25 ml), solution B (53.7 ml), distilled water (117.8 ml) were mixed and 
thoroughly degassed. Ammonium persulphate (150 mg) dissolved in distilled water (1 ml) 
was added and the mixture swirled gently during a second degassing. The resolving gel 
was cast as in Methods 2.10.1 (a).
(b) Stacking gel [5.6% (w/v) acryiamide]
Solution B (17.5 ml), solution C (10 ml) and distilled water (54 ml) were mixed and 
thoroughly degassed. Ammonium persulphate (150 mg) dissolved in distilled water (1 ml) 
was added and the mixture swirled gently during a second degassing. The stacking gel 
was cast as in Methods 2.10.1 (b).
(c) Sample preparation and electrophoresis conditions
Samples were mixed with glycerol (6 /il), 0.01% Bromophenol Blue (5 /il) and made up to 
60 /il with reservoir buffer. Gels were electrophoresed at 45 mA for 30 min prior to 
samples being loaded. Samples were electrophoresed at the same current until the dye 
front was approximately 2 mm from the bottom of the gel. Gels were cooled as in 
Methods 2.10.1 (c).
2.10.3 Staining of gels
(a) Protein staining
Protein was stained using the method of Lumsden and Coggins (1977). Gels were 
immersed in 0.1% Coomassie Brilliant Blue G-250 in 50% (v/v) methanol/10% (v/v) acetic 
acid for 45 min at 60°C. Destaining was carried out in 10% (v/v) methanol/10% (v/v) acetic 
acid at the same temperature.
(b) Activity staining
Gels were stained for D(—)-mandelate dehydrogenase activity essentially as described by 
Macintosh and Fewson (1988a), except that D(—)-mandelate was used as the substrate. 
Prior to staining, gels were soaked in 66.7 mM-sodium pyrophosphate buffer (pH 9.0) at 
4°C for 30 min with gentle swirling. Gels were stained for D(—)-mandelate 
dehydrogenase activity by immersing in 66.7 mM-sodium pyrophosphate buffer (pH 9.0) 
containing 1 mM-NAD+, 1 mM-D(—)-mandelate, 550 pM-PMS and 55 pM-Nitro Blue 
Tetrazolium in the dark for 10 min at 30°C.
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2.10.4 Gel scanning
Gels were scanned with an LKB 2202 Ultrascan laser densitometer. Gels were overlaid 
with Cling-film and the beginning of the resolving gel marked with a felt-tipped pen.
2.11 Immunological methods
2.11.1 Production of polyclonal antisera
Polyclonal antisera were raised in two New Zealand white rabbits by Dr I. D. Hamilton, 
Department of Biochemistry, University of Glasgow according to Home Office regulations. 
Pure D(—)-mandelate dehydrogenase (500 pg) was emulsified in 50% (v/v) Freund’s 
complete adjuvant and injected subcutaneously at several shaved sites along the back 
and hind quarters of the rabbits. After six weeks the rabbits were injected with 250 pg of 
pure enzyme emulsified in 50% (v/v) Freund’s incomplete adjuvant. Rabbits were bled 
from an ear vein two weeks later, and at two week intervals thereafter. The blood was left 
to clot at 4°C overnight, the serum decanted and fragments removed by centrifugation. 
Serum was stored at -20°C.
2.11.2 Immuno-Inhibition assay
Antisera raised against R. graminis KGX 39 D(—)-mandelate dehydrogenase 
(Methods 2.11.1) and antiserum previously raised against A  calcoaceticus C1123 
D(—)-mandelate dehydrogenase (Fewson et al., 1988) were used to probe several 
mandelate dehydrogenases in their native forms. Crude extract (100 pi) was mixed with 
antiserum (100 pi) and the mixture stood on ice for 1 h. Remaining enzymic activity in the 
supernatant was then assayed before and after centrifugation for 2 min in an Eppendorf 
(Poole, Dorset, UK) 3200 micro-centrifuge.
If loss of activity ensued, the cross reaction was quantified by immuno-titration. 
Serial dilutions of antisera [from undiluted antisera to 1:8192 in 50 mM-Tris/HCI (pH 8.0)] 
were prepared. Crude extracts containing mandelate dehydrogenase were appropriately 
diluted with 50 mM-Tris/HCI (pH 8.0) and samples (200 pi) were mixed with antisera 
(200 pi) at the various dilutions. The mixtures were stood on ice for 1 h and then the 
remaining mandelate dehydrogenase activity assayed as above. Control experiments 
were carried out using rabbit normal serum instead of immune serum.
2.11.3 Immuno-blotting (Western blotting)
Immuno-blotting was carried out essentially as described by Towbin etal. (1979).
(a) Electroblotting
Electroblotting was carried out in a solution of 190 mM-glycine/25 mM-Tris containing 
20% (v/v) methanol and 0.02% SDS, using a BIO-RAD Trans-Blot tank. 
SDS-polyacrylamide gels were prepared and run as in Methods 2.10.1. The proteins were 
transferred to nitrocellulose at 70 V (constant voltage) for 4 h.
(b) Development of blots
Blots were developed using the following buffers:
Buffer A : 20 mM-Tris/HCI (pH 7.2) containing 150 mM-NaCI
Buffer B : 20 mM-Tris/HCI (pH 7.2) containing 150 mM-NaCI and 0.5% Tween 20
Buffer C : 50 ml 10 mM-Tris/HCI buffer (pH 7.2) mixed immediately prior to use with 10 ml
methanol containing 30 mg 4-chloro 1-naphthol and 150 pi 4%(W/v) H20 2.
Blots were soaked overnight in buffer A containing 5% (v/v) normal donkey serum 
at 4°C, then rinsed twice with buffer A. They were then incubated in buffer B containing 
5% (v/v) normal donkey serum and 0.5% antiserum for 90 min at 23°C with gentle swirling. 
After washing for four 12 min periods in buffer B and five 12 min periods in buffer A the 
blots were incubated in buffer A containing 5% (v/v) normal donkey serum and 0.05% 
donkey anti-rabbit IgG conjugated to peroxidase, for 90 min at 23°C with gentle swirling. 
Blots were rinsed twice with 10 mM-Tris/HCI (pH 7.2) and then incubated (approx. 5 min) 
in freshly prepared buffer C for bands to develop. They were then washed with distilled 
water and stored dry between sheets of filter paper.
2.12 Synthesis, purification and analysis of D(—)-2-(bromoacetyl)mandelic acid
2.12.1 Synthesis of D(—)-2«(bromoacetyl)mandelIc acid
Two methods for the synthesis of D(—)-2-(bromoacetyi)mandelic acid were used. 
The method using bromoacetylbromide was essentially as described for the synthesis of
3-(bromoacetyl)chloramphenicol (Kleanthous ef a/., 1985), except that D(—)-mandeiic acid 
replaced chloramphenicol. As radiolabelled bromoacetylbromide was not commercially 
available, a method using bromo[1-14C]acetic acid was developed.
(a) Method 1 - Synthesis using bromoacetylbromide
D(—)-Mandelic acid (1 g, 6.5 mmol) was dried under vacuum over phosphorous 
pentoxide for 24 h at 30°C. It was then dissolved in anhydrous acetonitrile (10 mi) at 0°C 
and stirred under nitrogen. Bromoacetylbromide (578 pi, 6.5 mmol) was added, followed 
by dropwise addition of anhydrous pyridine (531 pi, 6.5 mmol) and the mixture stirred for 
30 min at 0°C. It was then stirred for a further 30 min at room temperature. Solvent was 
removed at 30°C by rotary evaporation under vacuum, and the oily residue remaining 
washed several times with acetonitrile. It was then redissolved in acetonitrile 
(approx. 2 ml) for purification. The reaction was monitored by TLC on silica gel plates, 
eluting with toluene/ethyl acetate/formic acid at 5:1:1 (v/v) and the products were 
visualised by their absorbance under ultra violet light.
(b) Method 2 - Synthesis using bromoacetic acid
D(—)-Mandelic acid (38 mg, 250 pmol) was dried under vacuum over phosphorous 
pentoxide for 24 h at 30°C. it was then dissolved in dichloromethane (50 ml) and cooled 
to -20°C in a dry ice/methanol bath. Bromo[1-14C]acetic acid (5 pmol at 56 pCi pmol*1) 
and bromoacetic acid (34 mg, 245 pmol) were dissolved in separate volumes of 
dichloromethane (2 ml and 10 ml respectively), then transferred to the reaction vessel and 
cooled to -20°C. 4-Methylmorpholine (27.8 pi, 250 pmol) was added, followed by
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isobutylchloroformate (32.8 pi, 250 pmol), and the mixture stirred for 2 min. Then, the 
D(—-)-mandelic acid dissolved in dichloromethane was added and the complete mixture 
stirred under nitrogen at -20°C for 4 h. It was finally left at -20°C overnight without 
further stirring. The reaction was monitored by TLC, the solvent removed and the 
products prepared for purification as in Methods 2.12.1 (a).
2.12.2 Purification of D(—)-2-(bromoacetyl)mandelIc acid
D(—)-2-(Bromoacetyl)mandelic acid was separated from pyridine and unreacted mandelic 
acid using pressurised •flash* chromatography as described by Still et al. (1978). 
A column (23.5 cm x 2.5 cm) of Silica Gel 60 was packed and equilibrated with toluene at 
a pressure of 35 kPa (5 p.s.i.) of nitrogen. The column was then washed with 300 ml of 
toluene/ethyl acetate 5:1 (v/v) containing 8.3% (v/v) formic acid. Sample was applied and 
washed into the top of the column under gravity, the column reservoir filled with solvent 
and the pressure re-applied. Fractions (5 ml) were collected manually and those 
containing D(—)-2-(bromoacetyl)mandelic acid identified by TLC as in Methods 2.12.1 (a).
When D(—)-2-(bromo[14C]acetyl)mande!ic acid was purified, column fractions 
were also counted as in Methods 2.2.8. Solvent from the pooled fractions was removed 
by rotary evaporation and the D(—)-2-(bromoacetyl)mandelic acid washed several times 
with acetonitrile. It was finally dried under vacuum, over solid NaOH for 48 h and then 
stored under nitrogen at 4°C.
2.12.3 Analysis of D(—)-2-(bromoacetyl)mandelic acid
(a) Nuclear magnetic resonance spectroscopy
The 1H-NMR spectrum of D(—)-2-(bromoacetyI)mandelic acid was obtained using a 
Bruker (Bruker Spectrospin Ltd, Coventry, West Midlands, UK) model WP 220 SY 
(200 MHz) NMR spectrometer, by Mr J. Gall, Department of Chemistry, University of 
Glasgow. The compound was dissolved in deuterochloroform and the resonances 
referenced to chloroform at 7.25 ppm and benzene [25% (v/v) in deuterochloroform] 
at 7.15 ppm.
(b) Mass spectrometry
The mass spectrum of D(—)-2-(bromoacetyl)mandelic acid was obtained using electron 
impact mass spectrometry with a Kratos MS-30 mass spectrometer by Dr T. Bugg and 
colleagues, Department of Organic Chemistry, University of Cambridge.
(c) Elemental analysis
The elemental composition of D(—-)-2-(bromoacetyI)mandelic acid was determined by 
Ms K. Wilson, Department of Chemistry, University of Glasgow. Carbon and hydrogen 
were analysed using a Carlo Erba (Carlo Erba Instruments, Crawley, Sussex, UK) Model 
1106 elemental analyser, whereas bromine was titrated with mercuric nitrate using 
bromobenzoic acid as a standard.
(d) Circular dlchroism
Circular dichroism was carried out by Ms S. Kelly using a JASCO J-600 
Spectropolarimeter at the Scottish CD Facility, School of Biological Sciences, University of 
Stirling. D(—)-2-(BromoacetyI)mande!ic acid (0.2 mg ml'1, 0.74 mM) and D(—)- and
L(+)-mandeiic acids (0.2 mg mi*1, 1.3 mM) dissolved in acetonitrile (HPLC grade), were 
scanned from 190-250 nm in a 0.02 cm pathlength cuvette.
2 . 1 3  Af f i n i t y  l ab e l l i ng  of  D ( — ) - ma n d e ! a t e  d e h y d r o g e n a s e  wi th  
D (—)-2-(bromoacety I) mandelate
2.13.1 Kinetics of inactivation
The kinet ics of inact ivat ion of D(— ) - ma nd e l a t e  d e h y d r o g e n a s e  by 
D(—)-2-(bromoacetyl)mandelate were determined in the absence and presence of the 
substrate, D(—)-mandelate. A stock solution (0.8 M) of the affinity label in acetonitrile was 
used to prepare the various dilutions used for inactivation.
(a) Inactivation In the absence of D(—)-mandelate
The inactivation mix (100 pi) contained D(—)-mandelate dehydrogenase (19 fig, 5 /iM), 
D(—)-2-(bromoacetyl)mandelate (1-4 mM) and acetonitrile (0.95 M). Immediately after 
addition of the label, the inactivation mix was vortexed and a sample (10 /il) removed and 
diluted into 990 /iI of 50 mM-Tris/HCI (pH 8.0). Samples (10-40 /il) were then assayed for 
residual phenylglyoxylate reductase activity as in Methods 2.4.2 (c). At 15 min intervals 
throughout the 2 h time course, samples (10 /il) were removed, diluted and assayed for 
residual enzymic activity. The activity of the sample taken immediately after addition of the 
label was taken as the 100% value. Control incubations containing enzyme, acetonitrile 
(0.95 M) but no inhibitor were carried out in parallel.
(b) Inactivation In the presence of D(—)-mandelate
The inactivation mix (100 /il) contained D(—)-mandelate dehydrogenase (19 fjg, 5 /iM), 
D(—)-2-(bromoacetyl)mandelate (1-8 mM), D(—)-mandelate (5 mM) and acetonitrile 
(0.95 M). The inactivation was carried out as in Methods 2.13.1 (a).
2.13.2 Stoichelometry of inactivation
A stock solution (63 mM) of D(—)-2-(bromo[14C]acetyl)mandelic acid in acetonitrile, with a 
specific activity of 1.12 nCi nmol'1 was used for this experiment and those given in 
Methods 2.13.3. The inactivation mix (1125 /il) contained D(—)-mandelate 
dehydrogenase (1.3 mg, 30.4 /iM), D(—)-2-(bromo[14C]acetyl)mandelate (1.4 mM) and 
acetonitrile (420 mM). Immediately after addition of the label, the inactivation mix was 
vortexed and a sample (5 /il) removed and diluted into 995 /il of 50 mM-Tris/HCI (pH 8.0). 
This was further diluted (250 /il into 750 /il of the same buffer) before samples (10 /il) were 
assayed for phenylglyoxylate reductase activity as in Methods 2.4.2 (c). At intervals 
throughout the 3 h inactivation, 5 /il were removed, diluted and appropriate samples 
(10-100 fji) assayed for residual activity. The activity of the sample taken immediately after
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addition of the label was taken as the 100% value. Covalent incorporation of label was 
monitored by a filter disc method and gel filtration; removing samples from the inactivation 
mix at the same time as those removed for assay of residual activity.
Filter disc method : Samples (50 /i I) were applied to 2.5 cm diameter circles of Whatman 
3MM filter paper and the protein precipitated by immersion in 5% (w/v) ice-cold 
trichloroacetic acid. Unbound counts were removed by washing the discs with fresh 
ice-cold trichloroacetic acid for 5 min, then with ice-cold ethanol: diethyl ether 1:1 (v/v) 
for 10 min and finally with diethyl ether at room temperature for 10 min before being left to 
dry. The filter discs were counted (Methods 2.2.8) and corrections made for quenching by 
the paper and the protein applied to it. The amount of protein applied to each disc was 
calculated from the initial protein concentration prior to addition of the affinity label.
Gel filtration : Samples (100 /il) were gel filtered through a column (30 cm x 1.5 cm) of 
Sephadex G-50 at a flow rate of 99 ml h'1. Fractions (3 ml) were collected, and the 
location and concentration of the protein determined by the Bradford method 
(Methods 2.2.5). The bound label was measured by counting samples (500 /il) of the 
fractions containing protein (Methods 2.2.8).
2.13.3 Identification and preparation of labelled peptides
In order to identify the labelled active site peptides, D(—)-mandelate dehydrogenase was 
inactivated by D(—)-2-(bromo[14C]acetyl)mandelate in the absence and presence of the 
substrate, D(—)-mandelate.
(a) Inactivation in the absence of D(—)-mandelate
The inactivation mix (371 /il) contained D(—)-mandelate dehydrogenase 
(500 (jg, 35.6 //M), D(—)-2-(bromo[14C]acetyl)mandelate (230 /iM) and acetonitrile 
(69 mM). Immediately after addition of the label the inactivation mix was vortexed and a 
sample (5 /il) removed, diluted and assayed for enzymic activity as in Methods 2.13.2. 
Residual enzymic activity was monitored throughout the 4 h inactivation.
(b) Inactivation In the presence of D(—)-mandelate
The inactivation mix (462 /il) contained D(—)-mandelate dehydrogenase 
(500 /;g, 28.6 /iM), D(—)-2-(bromo[14C]acetyl)mandelate (232 //M), D(—)-mandelate 
(100 mM) and acetonitrile (70 mM). The inactivation was carried out as in 
Methods 2.13.3 (a).
(c) Inactivation of D(—)-mandelate dehydrogenase for peptide purification
The inactivation mix (1.3 ml) contained D(—)-mandelate dehydrogenase (5 mg, 100 /iM), 
D(—)-2-(bromo[14C]acetyl)mandelate (2.4 mM) and acetonitrile (0.73 M). Samples (5 /il) 
were removed, diluted and the residual enzymic activity measured as in Methods 2.13.2.
(d) Preparation of Inactivated protein for trypsin digestion
Covalently labelled enzyme was separated from unbound label by gel filtration through a 
column (30 cm x 1.5 cm) of Sephadex G-50 at a flow rate of 99 ml h*1. Fractions (3 ml) 
were collected and the radioactivity and A2QQ of each fraction measured. Fractions 
containing protein were pooled, frozen and lyophilized. To ensure cleavage of the ester
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link between mandelate and the carboxymethylated protein, the protein was dissolved in 
0.1 M-Tris/HCI (pH 8.5) containing 6M-guanidine hydrochloride (1 ml) and 
28 mM-0-mercaptoethanol, and stirred for 2 h at 37°C. Then, 1M-NaOH (110 /il) was 
added and the mixture stirred for a further 6h at 37°C. The protein was separated by gel 
filtration, the radioactivity and A28Q of the fractions measured, and those containing protein 
were pooled, frozen and lyophilized.
2.14 Synthesis of tritiated NADH
Experiments involving the synthesis and use of tritiated NADH were carried out in 
collaboration with Mr E. Weinhold, Laboratory for Organic Chemistry, ETH-Zentrum, 
CH-8092, Zurich, Switzerland.
(a) Synthesis of tritiated pro- S NADH
This method relies on the fact that Leuconostoc mesenteroides glucose-6-phosphate 
dehydrogenase specifically transfers a hydride ion (H' or 3H' in the case of tritium) from 
glucose 6-phosphate to the pro-S position of NAD+ or NADP+ (Arnold et a/., 1976).
The tritiated glucose 6-phosphate was produced by phosphorylation of 
glucose[1-3H] by ATP using S. cerevisiae hexokinase. The linked assay was carried out in 
a mixture (500 /il) containing : 5mM-potassium phosphate buffer (pH 8.0),
60.5 /iM-glucose[1-3H] (specific activity 1.9 Ci mmol'1), 500 /iM-ATP, 3.7 units of 
hexokinase, 60.5 /iM-NAD+ and 55 units of glucose-6-phosphate dehydrogenase. The 
rate of NAD+ reduction was followed at 340 nm and the reaction was assumed to be at 
equilibrium when the progress curve reached a plateau. Protein was then removed from 
the mixture by ultra-filtration using a Centricon-10 microconcentrator (Amicon). The 
tritiated pro-S NADH was used immediately to reduce the incorporation of label at the 
pro-ft position, caused by random exchange with the solvent.
(b) Synthesis of tritiated pro- R NADH
This method relies on the fact that S. cerevisiae alcohol dehydrogenase specifically 
removes the pro-R hydrogen from NADH (Fisher etal., 1953; Vennesland, 1956). Tritiated 
NAD+ was produced by incubating pro-S tritiated NADH with alcohol dehydrogenase and 
acetaldehyde. The tritiated NAD+ was then incubated with non-radiolabeiled 
glucose 6-phosphate and glucose-6-phosphate dehydrogenase, which transfers a 
hydride ion to the pro-S position thereby displacing the tritium to the pro-R position.
To a filtered reaction mixture containing pro^S tritiated NADH [Methods 2.14 (a)] 
was added 1 M-acetaldehyde (10 fiI) and alcohol dehydrogenase (10 units). The rate of 
NADH oxidation was followed at 340 nm and the reaction was assumed to be at 
equilibrium when the curve reached a plateau. Protein was then removed from the 
mixture using a Centricon-10 microconcentrator. The tritiated NAD+ was then purified by 
HPLC using an LKB DEAE-5PW Glas-Pac column (75 mm x 8 mm) run isoc raticaily with 
10 mM-formic acid to elute NAD+, followed by a linear 0-500 mM-NaCI gradient to elute 
ADPandATP. Fractions containing the NAD+ were collected and lyophilized.
Tritiated pro-/? NADH was then produced in a mixture (500 jl/I) containing : 
10 mM-potassium phosphate (pH 8.0), 8.4 //M 3H-NAD+, 50 fjM-glucose 6-phosphate and 
28 units of glucose-6-phosphate dehydrogenase. The reaction was followed at 340 nm 
and the protein removed as in Methods 2.14 (a). The tritiated pro-/? NADH was used 
immediately to reduce the incorporation of label at the pro-S position, caused by random 
exchange with the solvent.
(c) Incubation of tritiated NADH with D(—)-mandeIate dehydrogenase
To a reaction mixture (1 ml) containing 10 mM-potassium phosphate buffer (pH 7.0), 
100 /iM-NADH and 100 /iM-phenylglyoxylate was added either tritiated pro-S NADH 
(1.2 nmol, 2.3 /i/Ci) or tritiated pro-/? NADH (0.84 nmol, 1.6 pCi). The reaction was initiated 
by the addition of excess D(—)-mandelate dehydrogenase (3.5 //g, 92 pmol), and once 
the reaction was at equilibrium the protein was removed using a Centricon-10 
microconcentrator. The NAD* and D(—)-mande!ate were separated by HPLC. Samples 
(500 fj\) were injected into a Brownlee Laboratories (Brownlee Laboratories, Santa Clara, 
CA, USA) Cg RP-300 reverse-phase HPLC column (220 mm x 4.6 mm) pre-equilibrated in 
0.1% TFA. The compounds were eluted at 1 ml min'1 and the effluent was monitored at 
220 nm and 260 nm. Fractions were collected and counted for incorporation of 3H as in 
Methods 2.2.8.
2.15 Protein chemistry
2.15.1 Trypsin digestion
Protein was suspended in 3 ml of 50 mM-ammonium bicarbonate (pH 8.5), and trypsin 
(10 mg ml'1 in 0.1 mM-HCI) was added at a ratio of protease: enzyme of 1: 50 (w/w). The 
digest was stirred for 4-5 h at 37°C, after which the peptides were frozen and lyophilized.
2.15.2 Separation of peptides by HPLC
Peptides were separated by HPLC using a Waters (Watford, Herts., UK) /iBONDAPAK C18 
reverse-phase column. Peptides were dissolved in the appropriate solvent and then 
centrifuged to remove insoluble material. They were then injected (100 /il) onto the 
column and separated using one of three gradient systems, unless otherwise stated. 
System 1: 90% A (0.1% TFA in water) to 50% B (0.1% TFA in acetonitrile) in 60 min.
System I I : 90% A [1 mM-sodium phosphate (pH 7.4)] to 40% B (acetonitrile) in 20 min. 
System III: 80% A [0.05% ammoniun acetate (pH 6.0)] to 50% B (acetonitrile) in 30 min. 
The flow rate throughout was 1 ml min'1 and the peptides were detected at 220 nm.
2.15.3 Protein amino acid composition
(a) Dialysis
Approximately 1.3 mg of purified D(—)-mandelate dehydrogenase was used to determine 
the amino acid composition. The enzyme was dialysed at 4°C for seven 24 h periods 
against 2 I of 5 mM-potassium phosphate buffer (pH 7.5), then dialysed for two 5 h 
periods against 2 1 of distilled water.
(b) Hydrolysis
Samples (approx. 130 /;g, 3.4 nmol) of dialysed enzyme were lyophilized and then 
dissolved in 1 ml of 5.65 M-HCI. Tubes were flushed with nitrogen, frozen and sealed 
under vacuum. Samples were hydrolysed at 110°C for 24 h, 48 h, 72 h and 96 h.
(c) Performic acid oxidation
Cysteine was detected as cysteic acid after oxidation with performic acid. Performic acid 
was prepared by mixing 30% (w/v) H20 2 (1 ml) and formic acid (9 ml) and left for 60 min at 
room temperature followed by 15 min at 0°C prior to use. Lyophilized enzyme 
(approx. 130 /jg, 3.4 nmol) was dissolved in performic acid (1 ml) and oxidised for 4 h at 
room temperature. Samples were then lyophilized and washed and dried 3 times with 
distilled water (500 /il). The oxidised enzyme was hydrolysed for 24 h as in Methods
2.15.3 (b).
(d) Analysis
After hydrolysis, ail samples were lyophilized and then washed and dried 3 times with 
distilled water (500 /il) over solid NaOH. D(—)-Mandelate dehydrogenase hydrolysates 
were dissolved in 125 /il of 0.2 N-sodium citrate buffer (pH 2.2) and samples (25 /il) 
analysed with an LKB 4400 amino acid analyser, by Mr J. Jardine, Department of 
Biochemistry, University of Glasgow. Valine, leucine and isoleucine were determined from 
their respective amounts at the end of the time course; serine and threonine were 
determined by extrapolating back to zero time. Glutamine and asparagine were 
determined as glutamate and aspartate respectively. The data were normalized to 
alanine =  23 nmol.
2.15.4 Peptide amino acid composition
Peptide amino acid analysis was carried out by Dr D. Campbell, Department of 
Biochemistry, University of Dundee, and by Dr J. Keen, SERC Sequencing Unit, 
Department of Biochemistry, University of Leeds both using a Waters PICO-TAG amino 
acid analyser. Lyophilized peptide was suspended in 6 M-HCI (200 /il) containing 
1% (w/v) phenol, evacuated, sealed and incubated for 24 h at 110°C. After hydrolysis, the 
HCI was removed under vacuum and the amino acids derivatized with 
phenylisothiocyanate. The PTC amino acids were then separated by reverse-phase (C18) 
HPLC using a gradient of acetonitrile in 139 mM-acetic acid containing
3.6 mM-triethylamine (pH 6.5), using the Waters PICO-TAG method.
2.15.5 Thin-layer electrophoresis of amino acids
Thin-layer electrophoresis was carried out essentially as described by Kieanthous et al. 
(1985). Amino acids were spotted onto 20 x 20 cm TLC plates (Polygram Sil G silica) 
along with neutral, basic and carboxymethylated amino acid standards. The plates were 
electrophoresed in a Shandon (Runcorn, Cheshire, UK) flat-bed electrophoresis tank with 
a 10% (v/v) pyridine/0.5% acetic acid buffer (pH 6.5), at 15 mA for 3 h. Plates were then
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dried, washed once with acetone, twice with acetone containing 1% (v/v) triethyiamine 
and then stained with acetone containing 0.01% fluorescamine. The amino acid spots 
were visualised by their fluorescence under ultra violet light.
2.15.6 Protein sequencing
(a) Dialysis
Purified D(—)-mandelate dehydrogenase (250 pg, 6.5 nmol) was dialysed at 4°C for six 
24 h periods against 2 I of 0.5% ammonium bicarbonate and then lyophilized. It was then 
dialysed for 24 h against 5 I of 0.1% SDS, followed by dialysis for two 24 h periods against 
5 1 of 0.05% SDS and then lyophilized.
(b) Sequencing
The amino terminal of D(—)-mandelate dehydrogenase was sequenced by Dr J. Keen at 
the SERC Sequencing Unit, Department of Biochemistry, University of Leeds, as 
described by Findlay etal. (1989).
Enzyme was dissolved in 200 mM-sodium phosphate containing 0.25% SDS, and 
coupled to p-phenylenediisothiocyanate glass. The glass-coupled enzyme was then 
sequenced by automated soiid-phase Edman degradation (Laursen, 1971). The ATZ 
amino acids produced were converted to their respective PTH derivatives, which were 
identified by reverse phase (C18) HPLC using a gradient of acetonitrile in 35 mM-sodium 
acetate buffer (pH 4.9). The PTH-amino acids were quantified at 269 nm, serine and 
threonine residues were confirmed by detection of their dehydro-derivatives at 313 nm.
2.15.7 Peptide sequencing
Peptides were sequenced by Dr D. Campbell, Department of Biochemistry, University of 
Dundee, using an Applied Biosystems (Applied Biosystems Ltd, Warrington, Cheshire, 
UK) 470 A/120 A gas-phase sequencer equipped with on-line PTH-analysis. Peptides 
were also sequenced by Dr J. Keen at the SERC Sequencing Unit, Department of 
Biochemistry, University of Leeds, using an Applied Biosystems 477-A liquid-pulse 
sequencer equipped with on-line PTH-analysis and by solid-phase sequencing as 
described in Methods 2.15.6 (b).
2.16 Safety
(a) Microbiological
Good microbiological practice was applied throughout the course of this study. All 
cultures were killed by autoclaving before disposal and spilled live cultures were 
immediately swabbed with 25% (v/v) n-propanol.
(b) Chemical
All chemicals were handled with care, especially compounds with known toxic, irritant or 
carcinogenic properties. Dusty compounds and volatile solvents were used in a fume 
cupboard.
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(c) Radioactivity
The use and disposal of radioactive compounds was in compliance with the rules and 
guidelines laid out in the Health Physics Notes of the Radiation Protection Service, 
University of Glasgow.
CHAPTER 3
PURIFICATION OF D(—)-M AN DELATE DEHYDROGENASE 
FROM RHODOTORULA GRAMINIS STRAIN KGX 39
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3.1 Introduction
Initial studies on the metabolism of mandelate by the yeast Rhodotorula graminis strain 
KGX 39 demonstrated the presence of a soluble, NAD+-dependent D(—)-mandelate 
dehydrogenase (Durham, 1984). Although some preliminary data obtained using crude 
extract were available, little was known about the enzyme as it had not been purified. 
Therefore, a method for purifying the enzyme was required, if it was to be characterized 
and a comparison of its properties made with other mandelate dehydrogenases and 
NAD+-dependent dehydrogenases.
Before any purification was attempted, experiments were carried out to optimise 
the yield of cells in liquid culture and to determine the effect of various growth media on 
the specific activity of the enzyme in crude extracts. R. graminis grown in mandelate salts 
medium [Methods 2.3.3 (a)] had a high D(—)-mandelate dehydrogenase specific activity 
[e.g. 0.37 units (mg protein)'1] but the growth yield was relatively poor. Excellent growth 
was observed when cells were grown in the carbohydrate rich, Sabouraud-dextrose broth. 
However, little or no enzymic activity could be detected even when the medium was 
supplemented with 10 mM-D,L-mandelate, indicating that synthesis of D(—)-mandelate 
dehydrogenase is subject to catabolite repression. This is supported by the observation 
that R. graminis grown in a medium containing 2 mM-glucose and 10 mM-D,L-mandelate 
show diauxic growth; preferentially using the glucose and then, after a 1.5 - 2 h lag period, 
using the mandelate as growth substrate (Durham,1984).
A complex medium giving high growth yield but which did not suppress enzyme 
induction was therefore sought, and experiments using MMB broth showed that it met 
both these criteria. Growth was substantial (350 g - 500 g wet wt. from 30 I culture) and 
the specific activity, although approximately half of that from cells grown in mandelate 
salts medium, was sufficient to finally yield mg quantities of pure enzyme.
Centrifugation experiments showed that D(—)-mandelate dehydrogenase was a 
soluble enzyme. When crude extract was centrifuged at 64 000 g  for 2 h, typically >95% 
of the total activity remained in the supernatant. The procedure pelleted approximately 
half of the protein (2-fold purification) and all crude extracts were therefore centrifuged as 
such prior to further purification.
3.2 Ammonium sulphate precipitation
Ammonium sulphate precipitation was tested as a possible first step in the purification. 
D(—)-Mandelate dehydrogenase precipitated over a relatively broad range 
(50-70% saturation) with a 50% loss in activity and only a 2-fold purification. In later 
experiments where the ammonium sulphate was added as a saturated solution at the 
same pH of the buffer, the recovery of activity increased to 80% although the enzyme 
could not be purified more than 2-fold. The use of this technique was not included in any 
further purification.
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3.3 Chromatography on DEAE-Sephacel (anionic exchange)
Anionic exchange chromatography was chosen as the first step in the purification. In a 
preliminary experiment where D(—)-mandelate dehydrogenase was eluted from 
DEAE-Sephacel with a linear 0-1 M-NaCI gradient, the enzyme eluted between 50 mM and 
70 mM-NaCI i.e. well before the main peak of protein. A shallower gradient, 
0-150 mM-NaCI, was therefore used and this gave good recovery of yield and significant 
purification. The conductivity of crude extract was approximately equal to that of the NaCI 
concentration which eluted the enzyme from the column, and it therefore proved 
necessary to dialyse the crude extract to ensure binding to the gel bed. Figure 3.1 shows 
a typical elution profile of D(—)-mandeiate dehydrogenase from a DEAE-Sephacel 
column.
3.4 Chromatography on Phenyl Sepharose (hydrophobic interaction)
Phenyl Sepharose was chosen as the second step in the purification, in a preliminary 
experiment where the DEAE-Sephacel pool was loaded onto a Phenyl Sepharose column, 
D(—)-mandelate dehydrogenase bound and remained bound after the NaCI, in which it 
had been loaded, was washed out. In contrast, the majority of contaminating proteins 
failed to bind and it was therefore a particularly useful step.
The enzyme was then eluted by including ethanediol in the buffer, a reagent that 
lowers the polarity of the eluent. The enzyme eluted strongly at 40% (v/v) ethanediol, but 
leached slowly off the column at lower concentrations. Washing the column with buffer A 
containing 25% (v/v) ethanediol did result in some leaching of enzyme, but it accounted 
for only a few percent of the total activity loaded. Figure 3.2 shows a typical elution profile 
of D(—)-mandelate dehydrogenase from a Phenyl Sepharose column.
3.5 Chromatography on DEAE-Sephacel (anionic exchange)
The second DEAE-Sephacel column usually resulted in some loss of enzyme yield with 
little purification, but it was a rapid means of removing the ethanediol from the Phenyl 
Sepharose pool, and obviated the need for extensive dialysis. The step was also useful in 
concentrating the pool to a volume easily dialysed into Buffer B, prior to loading onto the 
Orange A column.
3.6 Chromatography on Matrex Gel Orange A (dye-affinity)
D(—)-Mandelate dehydrogenase was finally purified using a Matrex Gel Orange A column. 
In preliminary studies the enzyme also bound [in 50 mM-Tris/HCI (pH 8.0) containing 
1 mM-DTT] to Matrex Gels Blue A, Green A, Red A and Blue Sepharose CL-6B (Sigma), 
but not to Matrex Gel Blue B. However, attempts to produce homogeneous enzyme using 
Blue Sepharose CL-6B and/or Matrex gel Red A, eluting with various NAD+, NADH or 
NaCI concentrations proved unsuccessful.
The effect of buffer pH on the binding of the enzyme to Orange A was 
investigated. Samples (previously dialysed into the appropriate buffer) were loaded onto 
Orange A columns and washed with either 50 mM-potassium phosphate buffer (pH 5.0,
6.0 or 7.0) containing 1mM-DTT, or 50 mM-Tris/HCI (pH 8.0 or 9.0) containing 1 mM-DTT. 
The columns were then washed with the corresponding buffer containing 0.5 mM-NADH. 
At pH 9.0 the enzyme failed to bind to the column, but at pH 8.0 and below the enzyme 
remained bound. Washing the columns with NADH eluted the enzyme at pH 7.0 and 8.0 
but not at pH 5.0 or 6.0. Therefore, pH had a marked effect on the binding of the enzyme 
to Orange A and also on the ability of 0.5 mM-NADH to elute it from the column. The pH 
dependence of binding to Orange A was exploited in the purification. Changing the buffer 
pH from 7.5 (buffer B) to pH 8.0 (buffer A) was essential in removing contaminant proteins 
from the column prior to elution with 0.5 mM-NADH. However, washing the column at the 
higher pH did produce some leaching of enzyme, but this never represented more than a 
few percent of the total activity loaded. A typical elution profile of D(—)-mande!ate 
dehydrogenase from an Orange A column is shown in Figure 3.3.
3.7 Overall purification
D(—)-Mandelate dehydrogenase from R  graminis KGX 39 has been purified to 
homogeneity 18 times with very similar results. A typical purification is summarised in 
Table 3.1. The enzyme was purified in good yield, 1-2 mg (after concentration) from 
40-50 g wet wt. of cells and the recovery was of the order of 50-60% of the original total 
activity. The enzyme was also twice successfully purified on a larger scale, yielding
9.0 mg (64% yield) and 10.4 mg (83% yield) of protein from 155 g and 186 g wet wt. of 
cells respectively. In these cases the size of the first DEAE-Sephacel column was 
increased to 9.5 cm x 5.0 cm and the total volume of the 0-150 mM-NaCi gradient 
increased from 600 ml to 2 1. The Phenyl Sepharose column was increased to 38.0 cm x
2.6 cm. Both the second DEAE-Sephacel and Matrex Gel Orange A columns remained 
the same size as in Methods 2.9.4 and 2.9.5 respectively.
3.8 Stability of purified enzyme
Purified D(—)-mandelate dehydrogenase lost negligible activity even after storage for 
several months at -20°C.
3.9 Purity of D(—)-mande!ate dehydrogenase
Purified D(—)-mandelate dehydrogenase gave a single band of protein when it was 
electrophoresed under denaturing and non-denaturing conditions. The purity of extracts 
during enzyme purification was monitored by SDS-PAGE, and a typical purification gel is 
shown in Figure 3.4. Densitometer scans of purified enzyme and Mf markers are shown in 
Figure 3.5. When purified enzyme was electrophoresed under non-denaturing conditions
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and stained for protein, a single band was observed. This co-resolved with a single band 
when either crude extract or purified enzyme were stained for D(—)-mandelate 
dehydrogenase activity (Figure 3.6).
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Figure 3.1 Chromatography on DEAE-Sephacel
Crude extract, approx. 97 ml (prepared as in Methods 2.9.1) was applied at 30 ml h'1 to a 
DEAE-Sephacel column (10.2 cm x 2.6 cm) pre-equilibrated in buffer A [50 mM-Tris/HCI 
(pH 8.0) containing 1 mM-DTT]. Once loaded, the column was washed with buffer A at 
50 ml h'1 until the A28Q of the effluent decreased to approximately 0.06, and then 
D(—)-mandelate dehydrogenase was eluted with a linear 0-150 mM-NaCI gradient (- - -) in 
buffer A (total volume =  600 ml) at a flow rate of 30 ml h*1. The A2QQ ( O ) of the effluent 
was measured (Methods 2.2.5) and fractions (10 ml) were collected, and enzyme activity 
( •  ) assayed as in Methods 2.4.2 (a).
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Figure 3.2 Chromatography on Phenyl Sepharose
The DEAE-Sephacel pool (approx. 82 ml) was applied at 30 ml h'1 to a Phenyl Sepharose 
column (10.0 cm x 2.6 cm) pre-equilibrated in buffer A. Once loaded, the column was 
washed at 40 ml h‘1 with buffer A until the A2QQ of the effluent returned to the baseline. 
The column was then washed with 130 ml of buffer A containing 25% (v/v) ethanediol, 
followed by buffer A containing 40% (v/v) ethanediol which eluted the enzyme.
Enzyme activity ( •  ), A280 ( O  )•
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Figure 3.3 Chromatography on Matrex Gel Orange A
The second DEAE-Sephacel pool, dialysed into buffer B [50 mM-potassium phosphate 
buffer (pH 7.5) containing 1 mM-DTT] was applied to a Matrex Gel Orange A column 
(15.5 cm x 2.6 cm) pre-equilibrated in buffer B. Once loaded, the pump was stopped for 
30 min. Then the column was washed with 200 ml buffer B followed by 300 ml buffer A. 
The flow was reversed and pure D(—)-mandelate dehydrogenase was eluted with buffer A 
containing 0.5 mM-NADH. Enzyme activity ( #  ), A2BQ ( O  )•
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Figure 3.4 Purification of D(—)-mandelate dehydrogenase
The purification was monitored by SDS-PAGE. A 12.5% (w/v) SDS-polyacrylamide gel 
with a 5.6% stacking gel was run and stained for protein as in Methods 2.10.1 and 
2.10.3 (a) respectively. Lanes A, Mr markers; B, 70 ( jg  of the crude extract; C, 40 f jg  of the 
DEAE-Sephacel pool; D, 22 pg of the Phenyl Sepharose pool; E, 22 f ig  of the second 
DEAE-Sephacel pool; F, 12^g of the Matrex Gel Orange A pool.
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Figure 3.5 Densitometer scans of purified D(—)-mandelate dehydrogenase 
and markers
Purified D(—)-mandelate dehydrogenase and Mr markers were electrophoresed in 
12.5% (w/v) SDS-polyacrylamide gels with 5.6% (w/v) stacking gels (Methods 2.10.1). 
They were then stained for protein [Methods 2.10.3 (a)] and scanned with a laser 
densitometer (Methods 2.10.4). (a) Control (no sample loaded); (b) Mf markers (approx. 
1 pg of each), from left to right: phosphorylase b (Mr 94 000), BSA (Mr 67 000), ovalbumin 
(Mf 43 000), carbonic anhydrase (Mr 30 000), soya bean trypsin inhibitor (Mr 20 100) and 
a-lactalbumin (Mr 14 400); (c) pure D(—)-mandelate dehydrogenase (1 fjg).
The scans are aligned at the peak marking the start of the resolving gel (far left).
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Figure 3.6 Purity of D(—)-mandelate dehydrogenase
The final purity of D(—)-mandelate dehydrogenase was monitored using non-denaturing 
PAGE. A 7.5% (w/v) polyacrylamide gel with a 5.6% stacking gel was run as in Methods 
2.10.2. It was then cut into two and one half stained for protein [Methods 2.10.3 (a)], 
whilst the other half was stained for D(—)-mandelate dehydrogenase activity [Methods 
2.10.3 (b)]. Lanes A, 40 /jg of the crude extract stained for protein; B, 2 ^g of pure 
D(—)-mandelate dehydrogenase stained for protein; C, 40 /jq of the crude extract stained 
for activity; D, 2 /jg of pure D(—)-mandelate dehydrogenase stained for activity.
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3.10 Discussion
A reliable and reproducible method for the purification of mg quantities of homogeneous 
D(—)-mandelate dehydrogenase has been developed, and the procedure used only three 
types of chromatographic interaction; anionic exchange, hydrophobic and dye-affinity 
steps.
The DEAE-Sephacel column proved a useful first step as a result of the enzyme 
eluting at a relatively low NaCI concentration. The Phenyl Sepharose column also 
produced significant purification because the enzyme remained bound to the column in 
the absence of added salt, unlike most of the contaminating proteins which ran straight 
through. The behaviour of D(—)-mandelate dehydrogenase differs from that of many 
proteins which can bind to hydrophobic columns only in the presence of high 
concentrations of salt e.g. NaCI or (NH4)2S04. Although proteins that adsorb strongly to 
hydrophobic matrices are generally insoluble in water e.g. globulins, 
membrane-associated proteins and those that precipitate at low ammonium sulphate 
saturation (Scopes, 1987), D(—)-mandelate dehydrogenase is a soluble enzyme which 
precipitates at 50-70% ammonium sulphate. Its ability to bind to Phenyl Sepharose in the 
absence of added salt may therefore represent a high proportion of hydrophobic residues 
exposed on the protein surface or, alternatively, strong interaction between specific 
surface residues and the matrix phenyl groups.
Immobilised textile dyes have been used extensively in the purification of 
NAD(P)+/NAD(P)H-dependent oxidoreductases, as well as other enzymes and proteins. 
Generally, the dye-affinity step forms a part of the overall purification scheme, as above, 
although some enzymes have been purified using dye-affinity as the sole type of 
interaction e.g. Candida nitratophila assimilatory nitrate reductase (Hipkin et a/., 1986). 
The success of this type of chromatography is due, in part, to the high degree of 
specificity between the dye molecule and the enzyme. The ability of cofactors such as 
NAD(P)+ or NAD(P)H to elute the enzymes from the dye-matrix, and the similarity between 
the chemical structures of the dyes and natural cofactors suggests the dye interacts with 
the cofactor binding site. However, other factors such as pH, ionic strength and the 
presence of divalent cations also affect the binding of enzymes to dye-affinity media 
(Subramanian, 1984).
The use of Matrex Gel Orange A was central to the purification of D(—)-mandelate 
dehydrogenase. However, it has been successful in relatively few cases when compared 
to the number of proteins purified using red and blue dye-ligands (Amicon, 1980). The 
failure of Blue Sepharose CL-6B or Matrex Gel Red A to yield homogeneous 
D(—)-mandelate dehydrogenase can be attributed to a lower degree of specificity 
between the dyes and the proteins present. Blue and red dye-ligands usually bind 
30-60% of the proteins in a heterogeneous mixture, whereas Orange A typically binds less 
than 5% (Amicon, 1980) and, therefore, Orange A may be regarded as being more 
specific towards the proteins it will bind.
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The successful characterization of D(—)-mandelate dehydrogenase depended 
largely on the ability to produce mg quantities of the enzyme. The purification procedure 
was scaled up with only minor modification, and it should be possible to scale up further if 
greater quantities were to be required. The enzyme was also very stable when stored in 
50% (v/v) glycerol at -20°C, and therefore frequent purification was unnecessary.
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CHAPTER 4
PHYSICAL, CHEMICAL AND KINETIC CHARACTERIZATION 
OF D(—)-MANDELATE DEHYDROGENASE
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4.1 Introduction
A preliminary characterization of the D(—)- and L(+)-mande!ate dehydrogenases of 
Rhodotorula graminis strain KGX 39 had previously been reported, but was limited to only 
those properties which could be determined using crude extract (Durham, 1984). The 
oxidation of D(—)-mande!ate was shown to be mediated by a soluble, NAD+-dependent 
enzyme, whereas the oxidation of the L(+)-enantiomer was catalysed by an 
NAD(P)+-independent enzyme that differed with respect to its intracellular location, 
substrate and cofactor specificities, heat stability, electrophoretic mobility and pH 
optimum (Durham, 1984). This was the first clearly reported case of an NAD+-dependent 
enzyme being involved in the oxidation of mandelate, and so a more thorough 
characterization of the enzyme was required if detailed comparisons were to be made with 
other mandelate dehydrogenases, as well as with other prokaryotic and eukaryotic 
NAD+-dependent dehydrogenases. Various physical, chemical and kinetic properties of 
the purified enzyme from R. graminis were determined and are reported in this chapter.
4.2 Physical and chemical characterization
4.2.1 Relative molecular mass
The native M f , estimated under non-denaturing conditions by gel filtration 
chromatography using a calibrated FPLC (Pharmacia) Superose 6 column, was 
77 200 (76 900, 77 500)(Figure 4.1).
The subunit Mr under denaturing conditions was estimated using calibrated 
SDS-PAGE gels. Gels were scanned and the electrophoretic mobilities with respect to 
a-lactalbumin calculated using the equation:
R a-iactaibumin =  d'stance travelled by protein/distance travelled by a-lactalbumin
A representative standard curve of Ra.iacta|bumin against lg10 Mf is shown in Figure 4.2. 
The estimated subunit Mf of D(—)-mandelate dehydrogenase was 38 000 ±  1400 
(n =  13 batches of enzyme). Comparison of the native and subunit Mr values suggests 
that D(—)-mandelate dehydrogenase exists as a dimer.
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Figure 4.1 Determination of the native of D(—)-mandelate dehydrogenase by gel 
filtration through a Superose 6 FPLC column
The native Mf of D(—)-mandelate dehydrogenase was estimated under non-denaturing 
conditions using a Superose 6 (Pharmacia) gel filtration column (30 cm x 1 cm), 
pre-equilibrated in 50 mM-Tris/HCI buffer (pH 8.0) containing 1 mM-DTT and 
100 mM-NaCI. Proteins were eluted at 0.5 ml min"1 and the A2Q0 of the effluent was 
monitored (Methods 2.2.5). When D(—)-mandelate dehydrogenase was eluted, fractions 
(250 /lzI) were collected and assayed for enzymic activity [Methods 2.4.2 (b)]. Samples 
were run in duplicate and all data points are shown. Where only one point is given, both 
values were identical.
(1) 25 pg of cytochrome c {Mf 12 500)
(2) 100 pg of ovalbumin (Mf 45 000)
(3) 50 pg of lactate dehydrogenase (Mf 140 000)
(4) 200 pg of aldolase (Mf 158 000)
(5) 100 pg of pyruvate kinase (M{ 237 000)
(6) 50 pg of ferritin {Mf 450 000)
( O ) 50 pg of D(—)-mandelate dehydrogenase
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Figure 4.2 Determination of the subunit Mf of D(—)-mandelate dehydrogenase by 
SDS-polyacrylamlde gel electrophoresis
The subunit Mf of D(—)-mandelate dehydrogenase was estimated under denaturing 
conditions using 12.5% (w/v) SDS-polyacrylamide gels calibrated with proteins of known 
Mx . Gels were run and stained for protein as in Methods 2.10.1 and 2.10.3 (a) 
respectively. They were then scanned using a laser densitometer (Methods 2.10.4) and 
the value of Ra.iactaibumin calculated. A representative standard curve is shown.
(1) soya bean trypsin inhibitor {Mf 20100)
(2) carbonic anhydrase (Mf 30 000)
(3) ovalbumin (Mr 43 000)
(4) bovine serum albumin (Mr 67 000)
(5) phosphorylase b {Mf 94 000)
( O ) D(—)-Mandelate dehydrogenase
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4.2.2 Amino acid composition
Table 4.1 shows the amino acid composition of D(—)-mandelate dehydrogenase as the 
mean value from two independent experiments. Although tryptophan cannot be 
determined after acid hydrolysis, two residues have so far been identified from sequence 
analysis (See Tables 4.2 and 5.4). The most notable feature of the amino acid 
composition was the low number of cysteine residues i.e. only one per subunit. Assuming 
a subunit Mf of 38 000, the number of residues in the complete polypeptide based on the 
amino acid composition data is 354 and the average residue Mf is 107.
4.2.3 Amino terminal sequence
The sequence of the first 57 residues from the amino terminus is given in Table 4.2 along 
with the recovery of each PTH-amino acid. The first residue could not be determined by 
solid-phase sequencing, as it remained attached to the column via its a-amino group, and 
lysine gave comparatively poor recoveries as the majority remained attached to the 
column, via the e-amino group, after the degradation cycle.
The recent cloning and sequencing of the mdlB gene, which encodes the 
membrane-bound L(+)-mande!ate dehydrogenase of P. putida, and confirmation of the 
open reading frame by amino terminal sequencing of the protein electroeluted from 
polyacrylamide gels, enabled comparison of the R. graminis D(—)-mandelate 
dehydrogenase amino terminal sequence with that of the only other mandelate 
dehydrogenase for which sequence is available (Tsou etal., 1990; C. A. Fewson, personal 
communication). However, comparison of the 57 residue yeast sequence with the 
bacterial amino terminal sequence revealed no obvious homology. Likewise, there was no 
homology between the R. graminis D(—)-mandelate dehydrogenase amino terminal 
sequence and that of the corresponding sequence of mandelate racemase from P. putida 
(Ransom etal., 1988).
The R. graminis D(—)-mandelate dehydrogenase sequence was also compared 
with the protein sequences in the University of Leeds OWL Composite Database 
(Release 1.1), which contains all the protein sequences in the NBRF PIR and NEW 16.0, 
SWISS-PROT 6.0, GenBank 54, NEWAT 86, JIPID and Brookhaven (October 1987) data 
bases (Akrigg et a/., 1988). Although the database contains the amino acid sequences of 
over 10 000 proteins, including many dehydrogenases, no significant homologies were 
found. The sequence was later compared with the sequences in the OWL Composite 
Database (Release 6.0), but again no homologies were found.
4.2.4 Isoelectric point
The isoelectric point of D(—)-mandelate dehydrogenase was determined by 
chromatofocussing using an FPLC Mono P chromatofocussing column (Pharmacia) 
(Figure 4.3), and was found to be 5.9 (5.85, 5.95).
Table 4.1 Amino acid composition of D(—)-mandelate dehydrogenase
The amino acid composition of D(—)-mandelate dehydrogenase was determined as 
described in Methods 2.15.3. The mean values from two independent determinations 
using separate batches of enzyme are given with individual values in parentheses. The 
individual values were determined as the mean of 8 replicates, except for valine, leucine, 
isoleucine, serine, threonine and cysteine (see footnote) which were the mean of 
2 replicates. The data were normalized to alanine =  23 nmoles and the approximate 
number of amino acids per subunit was calculated from the subunit Mx of 38 000.
Approx. no of residues
Amino acid Mean % (by wt.) per subunit
Ala 7.98 (7.94, 8.01) 43
Val^ 6.00 (5.76, 6.24) 23
Leu^ 11.36 (10.81,11.90) 38
lle^ 4.59 (4.41, 4.76) 16
Phe 6.30 (6.26, 6.33) 16
Met 1.21 (1.31,1.10) 4
Pro 4.38 (4.22, 4.53) 18
Gly 4.15 (4.06, 4.24) 28
Ser00 4.98 (5.06, 4.90) 22
Thr“ 4.54 (4.59, 4.49) 17
Cys* 0.32 (0.33, 0.31) 1
Tyr 2.83 (3.01, 2.64) 7
Asx 9.94 (10.73, 9.14) 33
Glx 12.15(12.48,11.81) 36
Lys 6.28 (6.16, 6.39) 19
Arg 8.25 (8.12, 8.38) 20
His 4.79 (4.74, 4.83) 13
Total n° =  354
^ Mean of 96 h values. 00 Extrapolated to zero time. ‘ Determined as cysteic acid.
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Table 4.2 The amino terminal sequence of D(—)-mande!ate dehydrogenase
The amino terminal sequence of D(—)-mandelate dehydrogenase was determined by 
Dr J. Keen at the SERC Sequencing Unit, Department of Biochemistry, University of Leeds 
as described in Methods 2.15.6. Approximately 1 nmole of enzyme was sequenced, and 
the PTH-amino acid identified at each cycle is given, along with the amount recovered in 
pmoles.
Cycle PTH-amino acid pmole Cycle PTH-amino acid pmole
1 Unk — 30 Pro 136
2 Arg 952 31 Ala 107
3 Pro 310 32 Asn 92
4 Arg 613 33 Leu 43
5 Val 547 34 Thr* 55
6 Leu 469 35 Thr* 78
7 Leu 612 36 His 77
8 Leu 689 37 Asp 47
9 Gly 443 38 Gly 43
10 Asp 403 39 Phe 68
11 Pro 218 40 Lys? 6
12 Ala 368 41 Gin 69
13 Arg 508 42 Ala 34
14 His 347 43 Leu 71
15 Leu 348 44 Arg 41
16 Asp 227 45 Glu 45
17 Asp 286 46 Lys? 3
18 Leu 298 47 Arg 16
19 Trp 113 48 Tyr 23
20 Ser* 83 49 Gly 32
21 Asp 135 50 Asp 14
22 Phe 174 51 Phe 19
23 Gin 168 52 Unk —
24 Gin 240 53 Ala 13
25 Lys 17 54 lie? 9
26 Phe 93 55 lie 18
27 Glu 73 56 Lys? 4
28 Val 98 57 Lys? 5
29 lie 106
Unk - Residue unknown. ‘ Residue confirmed at 313 nm. ? Identification tentative.
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Figure 4.3 Elution profile of D(—)-mandelate dehydrogenase from a Mono P 
chromatofocussing column
Purified D(—)-mandelate dehydrogenase (100 fig) in 25 mM-Bistris/HCI buffer (pH 6.7) 
was applied to an FPLC Mono P chromatofocussing column pre-equilibrated in the same 
buffer. The column was washed with 8 ml of Bistris/HCI buffer before the enzyme was 
eluted with Polybuffer PB 74 made 1:10 with water and adjusted to pH 3.8. Fractions 
(1 ml) were collected and assayed for enzymic activity [Methods 2.4.2 (b)]. Thei4280 of the 
effluent was monitored (Methods 2.2.5) and the pH of each fraction determined 
(Methods 2.2.1). Enzyme activity ( # ) ,  pH ( O ) and^280 (------).
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4.2.5 Absorption spectrum
The absorption spectrum of D(—)-mandelate dehydrogenase (Figure 4.4) had maxima at 
about 220 nm and at 280 nm (characteristic of tryptophan absorbance), but no 
absorbance above 340 nm indicating that the enzyme is neither associated with nor 
contains bound flavin, haem or cytochrome as prosthetic group.
4.3 Preliminary kinetic characterization
4.3.1 Assay development
In initial experiments designed to measure the rate of D(—)-mandelate oxidation, the 
enzyme was assayed as described by Durham (1984). The reaction mixture contained 
200 mM-Tris/HCI (pH 8.0), 500 /iM-NAD+, 500 /iM-D(—)-mandelate and extract. However, 
the rate was non-linear and the progress curve rapidly reached a plateau as the reaction 
approached its equilibrium. Therefore, an assay was required which would give linear 
rates over a 3 to 5 min period and allow accurate measurement of the enzymic activity. 
Although compounds such as hydrazine and semicarbazide have been used successfully 
to prevent non-linearity of some enzyme assays e.g. the oxidation of benzyl alcohol to 
benzaldehyde by benzyl alcohol dehydrogenase (MacKintosh & Fewson, 1988a), use of 
these carbonyl trapping reagents in the D(—)-mandelate dehydrogenase assay proved 
unsuccessful. The rate of D(—)-mandelate oxidation was finally made linear by assaying 
the enzyme at a higher pH i.e. 9.5, and at a D(—)-mande!ate concentration 10-fold greater 
than described by Durham (1984). D(—)-Mandelate dehydrogenase catalyses the
reversible oxidation of D(—)-mandelate:
D(—)-Mandelate +  NAD+ < ------------------------ >  Phenylglyoxylate +  NADH +  H+
By increasing the concentration of D(—)-mandelate and decreasing the 
concentration of H+, i.e. increasing the pH, the equilibrium was shifted in favour of 
D(—)-mandelate oxidation and thus allowed accurate measurement of the forward 
reaction. No such problems were encountered when assaying in the reverse direction 
(i.e. reduction of phenylglyoxylate) as described in Methods 2.4.2 (c). The reverse assay 
was more sensitive than the forward assay and generally required 10 times less enzyme.
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Figure 4.4 Absorption spectrum of D(—)-mandelate dehydrogenase
D(—)-Mandelate dehydrogenase (400 fig) in 50 mM-Tris/HCI (pH 8.0) was scanned in a 
1 ml quartz cuvette using a Pye-Unicam SP8-100 spectrophotometer at 2 nm s'1.
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4.3.2 The pH optima of D(—)-mandelate dehydrogenase
The pH optimum of the D(—)-mandelate dehydrogenase oxidation reaction was initially 
determined in appropriate buffers (200 mM) between pH 4.9 and 10.8 [Figure 4.5 (a)]. 
The enzyme was active over a broad range of pH, but was optimally active between about 
pH 9 and 10. The enzyme was then assayed in 200 mM-giycine/NaOH buffer between 
pH 8.1 and 11.1, and in 200 mM-Bicine/NaOH buffer between pH 8.05 and 9.89. Again 
the enzyme was optimally active between pH 9 and 10, but showed maximal activity at pH
9.5 in both cases.
The pH optimum of the reduction reaction was determined in appropriate buffers 
(200 mM) between pH 4.6 and 9.6 [Figure 4.5 (b)]. The enzyme catalysed the reduction 
reaction over a broad range of pH, but was maximally active at pH 5.85 in 
200 mM-potassium phosphate/NaOH buffer.
All assays used for kinetic characterization were carried out at the respective pH 
optima for the oxidation and reduction reactions.
4.3.3 Assay reproducibility and linearity with respect to protein concentration
The reproducibility of the D(—)-mandelate dehydrogenase assay (forward/oxidation 
reaction) was determined by assaying ten identical amounts of enzyme as in Methods
2.4.2 (b). The standard deviation as a percentage of the mean value was ±  2.8% in one 
experiment and ±  1.6% in another, indicating that the assay was reproducible.
The rate of D(—)-mandelate oxidation was proportional to the protein 
concentration, up to the maximum measured concentration of 400 ng ml'1. Assays 
designed to measure the rate of D(—)-mandelate oxidation contained less than this 
amount, unless otherwise stated.
4.3.4 Reaction stoicheiometry and equilibrium constant
D(—)-Mandelate dehydrogenase catalyses the oxidation of D(—)-mandelate and the 
reduction of phenylglyoxylate. The reaction stoicheiometry and apparent equilibrium 
constant (K ' ) were determined by following the progress curve of the reaction. The 
concentration of substrates and products were presumed to be at equilibrium when the 
curve reached a plateau. Four progress curves, starting with different NAD+ and 
D(—)-mande!ate concentrations, are shown in Figure 4.6.
The concentration of NADH at equilibrium was determined from the change in 
A340 [Methods 2.5 (a)]; the concentration of NAD+ at equilibrium was calculated by 
deducting the concentration of NADH from the concentration of NAD+ initially added. The 
initial amount of NAD+ added was determined enzymically as described in 
Methods 2.5 (b).
An HPLC system was developed to measure the concentrations of 
D(—)-mandelate and phenylglyoxylate in assay mixtures (Methods 2.6). The calibration 
curves for D(—)-mandelate and phenylglyoxylate are shown in Figures 4.7 and 4.8 
respectively. The absorbance of phenylglyoxylate at 210 nm (i.e. the monitoring
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wavelength) was approximately 10-fold greater than for D(—)-mandelate and the 
phenylglyoxylate calibration curve therefore covered the range 0-5 nmoles, whereas the 
D(—)-mande!ate curve covered the range 0-50 nmoles. In each case the lines of best fit 
were linear, although there was a greater degree of scatter amongst replicates at the 
higher D(—)-mandelate concentrations.
The concentrations of D(—)-mandelate, NAD+, phenylglyoxylate and NADH at 
equilibrium (Table 4.3) indicate that D(—)-mandelate dehydrogenase produced 
approximately equimolar amounts of phenylglyoxylate and NADH. The enzyme therefore 
catalyses a reaction with a stoicheiometry of 1 mole of D(—)-mandelate oxidised per mole 
of NAD+ reduced. The apparent equilibrium constant for each of the 4 experiments was 
calculated using the equation:
K - =  [phenylglyoxylate].[NADH]/[D(—)-mandelate].[NAD+] x 1/antilog pHM
The mean equilibrium constant was 1.59 x 1O'11 M at pH 9.2.
The standard free energy change of the reaction was calculated using the equation:
Standard free energy change AG°' =  —RT In K '
where R is the gas constant =  8.303 J deg."1 mol*1, and T is the temperature =  300 K.
The standard free energy for the reaction was +  61.9 KJ mol'1, and the reduction of 
phenylglyoxylate and oxidation of NADH is therefore thermodynamically favoured at this 
pH.
Page 90
100-1
90 -
80
■P
70
60
50 -
40
30
0>
2 0 -
10
8 9 10 116 7
100-1
95-
90-
85-
80
75-
70
65-
60-
55-
5 0 -
45
64 5 7 8 9
pH
Figure 4.5 Effect of pH on the oxidation and reduction reactions of D(—)-mande!ate 
dehydrogenase
(a) The oxidation reaction was measured in a reaction mixture (1 ml) containing
200 mM-buffer, 1 mM-NAD+, 5 mM-D(—)-mandelate and D(—)-mandelate dehydrogenase 
(63 ng or 127 ng). The pH of the mixture was determined shortly after the assay, as 
described in Methods 2.2.1. The maximum (100%) velocity was 125 units (mg protein)'1.
( □ )  Mes/NaOH buffer, pH 4.9-6.9 
( A ) Potassium phosphate buffer, pH 5.3 - 7.4 
( A ) Mops/NaOH buffer, pH 6.5 - 7.85 
( • )  Bicine/NaOH buffer, pH 7.35 - 9.6 
( O ) Glycine/NaOH buffer, pH 8.9 -10.8
(b) The reduction reaction was measured in a reaction mixture (1 ml) containing 
200 mM-buffer, 1 mM-phenylglyoxylate, 200 /jM-NADH and D(—)-mandelate 
dehydrogenase (6 ng). The pH of the mixture was determined shortly after the assay, as 
described in Methods 2.2.1. The maximum (100%) velocity was 497 units (mg protein)'1.
( A )  Potassium phosphate buffer, pH 4.6 - 8.0 
( 0 )  Bicine/NaOH buffer, pH 7.65 - 9.6
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Figure 4.6 Progress curves of the D(—)-mandelate dehydrogenase oxidation 
(forward) reaction
The oxidation reaction of the enzyme was measured in 200 mM-Bicine/NaOH buffer 
(pH 9.2) in the presence of the following starting concentrations of D(—)-mande!ate and 
NAD+ :
Reaction mixture 1 :1.1 mM-D(—)-mande!ate +  169//M-NAD+
Reaction mixture 2:1.1 mM-D(—)-mandelate +  338 /iM-NAD+
Reaction mixture 3 :2 .2  mM-D(—)-mandelate +  169 fjM-NAD+
Reaction mixture 4 :2 .2  mM-D(—)-mandelate +  338 /iM-NAD+
Each reaction mixture contained 774 ng of enzyme in the 1 ml reaction mixture.
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Figure 4.7 Calibration curve for the estimation of D(—)-mandelate by HPLC
Known amounts of D(—)-mandelate were injected onto a C4 RP-304 reverse-phase 
column and eluted in 0.1% TFA at 1 ml min'1. The effluent was monitored at 210 nm and 
the peak areas determined by an on-line integrator (Methods 2.6). Two to four injections 
at each D(—)-mandelate concentration were made and where only one point is given, the 
replicates were identical. Error bars indicate ±  1 standard deviation about the mean.
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Figure 4.8 Calibration curve for the estimation of phenylglyoxylate by HPLC
Known amounts of phenylglyoxylate were injected onto a C4 RP-304 reverse-phase 
column and eluted in 0.1% TFA at 1 ml min'1. The effluent was monitored at 210 nm and 
the peak areas determined by an on-line integrator (Methods 2 .6). Two to four injections 
at each phenylglyoxylate concentration were made and where only one point is given, 
replicates were identical. Error bars indicate ±  1 standard deviation about the mean.
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Table 4.3 Concentrations of D(—)-mandelate, NAD+, phenylglyoxylate and NADH at 
equilibrium
The oxidation (forward) reaction of the enzyme was measured in 200 mM-Bicine/NaOH 
buffer (pH 9.2) in the presence of the following starting concentrations of D(—)-mandelate 
and NAD+. The results refer to the experiment illustrated in Figure 4.6.
Reaction mixture 1 :1.1 mM-D(—)-mandelate +  169/iM-NAD+
Reaction mixture 2:1.1 mM-D(—)-mandelate +  338 /jM-NAD+
Reaction mixture 3 :2 .2  mM-D(—)-mandelate +  169 /iM-NAD+
Reaction mixture 4 :2 .2  mM-D(—)-mandelate +  338 //M-NAD+
Reaction mixture Concentration at equilibrium (jt/M) Apparent K
GC|
D(—)-mandelate NAD+ phenylglyoxylate NADH (M)
1 925 113 53.7 56.0 1.82 X10 '11
2 920 257 75.0 80.4 1.43 x 10'11
3 2150 100 76.2 69.0 1.53 x 10‘11
4 1980 227 102.5 110.3 1.58 x10 ‘11
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4.3.5 Cofactor specificity
(a) Electron acceptor specificity
D(—)-Mandelate dehydrogenase is an NAD+-dependent enzyme and could neither 
reduce NADP+ (in the forward reaction) nor oxidise NADPH (in the reverse reaction) at 
detectable rates when assayed as in Methods 2.4.2 (b) and (c), with NADP+ (1 mM) and 
NADPH (200 fjM) replacing the NAD+ and NADH respectively. The enzyme was also 
unable to use the dye DCIP (53 jl/M) or DCIP (53 /iM) plus PMS (1 mM) as electron 
acceptors when assayed as in Methods 2.4.2 (b), with the dyes replacing the NAD+.
(b) Stereospecificity of hydride transfer
The stereospecificity of hydride transfer was determined by measuring the ratio of label 
(3H) incorporated into NAD+ and D(—)-mande!ate after the enzyme had been incubated 
in the presence of phenylglyoxylate and either pro^S 3H-NADH or pro-S 3H-NADH 
(Methods 2.14).
The stereospecificity of the enzyme was designated according to the following 
criteria : starting with pro-S SH-NADH, if the enzyme transferred the pro-S hydrogen from 
NADH to phenylglyoxylate, then ail of the label would be incorporated into 
D(—)-mandelate, but if it transferred the pro-S hydrogen then the label would remain in 
the NAD+. On the other hand, starting with pro-S 3H-NADH, if the enzyme transferred the 
pro-5 hydrogen from NADH to phenylglyoxylate, then all of the label would be 
incorporated into D(—)-mandelate, but if it transferred the pro-5 hydrogen then the label 
would remain in the NAD+.
When D(—)-mandelate dehydrogenase was incubated with phenylglyoxylate and 
pro-S 3H-NADH, the ratio of total counts incorporated into the resultant NAD+ and 
D(—)-mandelate was 95.7% : 4.3% respectively, indicating that the enzyme transferred the 
pro-S hydrogen. This result was confirmed when the enzyme was incubated with 
phenylglyoxylate and pro-S 3H-NADH, where the ratio of total counts incorporated into the 
NAD+ and D(—)-mandelate was 2.4% : 97.6% respectively. Final confirmation that the 
label from the pro-S 3H-NADH was covalently incorporated into D(—)-mandelate was 
obtained after recrystallization. The tritiated D(—)-mandelate (44 nmol, 0.7 juCi) purified 
by HPLC [Methods 2.14 (c)], was diluted with non-radiolabelled D(—)-mandelic acid 
(678 mg, 4.5 mmol) and recrystallized from toluene. The needle-shaped crystals were 
washed thoroughly with ice-cold pentane and then lyophilized. This procedure was 
repeated twice and the specific activities of the D(—)-mandelic acid after recrystallization 
were 131 pCi mol'1 and 130 /iCi mol"1 i.e. it had recrystallized with a constant specific 
activity.
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4.3.6 Substrate and inhibitor specificity
D(—)-Mandelate dehydrogenase showed absolute stereospecificity for its substrate and 
could not oxidise L(+)-mandelate, even at a concentration of 70 mM. However, the 
L(+)-enantiomer was an inhibitor of the enzyme, in order to determine the nature of this 
inhibition, the enzyme was assayed at various concentrations of D(—)-mande!ate at a 
series of fixed L(+)-mandelate concentrations. The effect of increasing the 
L(+)-mandelate concentration on the primary double-reciprocal plots {MV against 
1/[D(—-)-mande!ate], Figure 4.9 (a)} was indicative of competitive inhibition i.e. the slopes 
increased whilst leaving the ordinate intercepts essentially unchanged. The apparent /C, 
value for L(+)-mande!ate was obtained by plotting the slopes from the primary plots 
against the L(+)-mandelate concentration [Figure 4.9 (b)], and was found to be 8.2 mM.
The ability of D(—)-mandelate dehydrogenase to use a number of ring-substituted 
mandelates and mandelate analogues as substrates was tested. However, velocity values 
could not be determined for two reasons, (a) Some of the corresponding substituted 
phenylglyoxylates absorbed strongly at 340 nm (i.e. the monitoring wavelength), unlike 
phenylglyoxylate which had negligible absorbance at this wavelength. The molar 
absorption coefficients at 340 nm of these compounds could, in principle, be used to 
determine correction factors (as in similar work by MacKintosh & Fewson, 1988b) but this 
was not possible as these compounds were not commercially available, and it was not 
considered worthwhile synthesizing them, (b) Most of the compounds were tested as 
racemic mixtures and it is possible that some of the L-enantiomers were inhibitory. 
Compounds which were substrates in the oxidation and reduction reactions are given in 
Table 4.4.
Other compounds which were not substrates for the enzyme but which inhibited 
activity are given in Tables 4.5 and 4.6. The enzyme was assayed in the presence of 
inhibitor at the calculated Km value for D(—-)-mande!ate or the apparent Km value for 
phenylglyoxylate.
D(+)-Malate, citrate and glyoxylate at 10 mM were neither substrates nor 
inhibitors of activity.
The effect of possible metabolic inhibitors on D(—-)-mandelate dehydrogenase 
activity was also tested. The enzyme was neither inhibited nor stimulated by 1 mM 
concentrations of benzaldehyde, benzoate, succinate, glucose, ATP/Mg2+, ADP/Mg2+ or 
acetyl-CoA when the enzyme was assayed as in Methods 2.4.2 (b), suggesting that 
enzymic activity is not regulated in vivo by these compounds. However, the enzyme was 
apparently inhibited 44% by 0.5 mM-phenylgiyoxylate and was progressively inhibited by 
increasing the concentration until, at 10 mM-phenylglyoxylate, the activity was virtually 
abolished (96% inhibition). As D(—)-mandelate dehydrogenase catalyses a reversible 
reaction and the equilibrium strongly favours the reverse reaction (Section 4.3.4), this is 
likely to be due to an equilibrium effect rather than inhibition of activity caused by the 
binding of phenylglyoxylate at a possible regulatory site.
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Figure 4.9 Competitive Inhibition of the D(—)-mandelate dehydrogenase oxidation 
reaction by L(+)-mandelate
(a) Primary double-reciprocal plots of the initial velocities against D(—-)-mandelate 
concentration at a series of fixed L(+)-mandelate concentrations:
( 0  ), none; ( O ). 20 mM; ( A  ). 30 mM; ( A  )» 40 mM; ( ■ ) ,  50 mM; ( □  ) 60 mM. 
Enzyme (154 ng) was assayed in 200 mM-Bicine/NaOH buffer (pH 9.5), containing 
1 mM-NAD+. Assays were carried out in duplicate and where only one point is given, the 
replicates were identical.
(b) Replot of slopes from Figure 4.9 (a) as a function of L(+)-mandelate concentration.
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Table 4.4 Substrates of D(—)-mandelate dehydrogenase
Although velocity values cannot be given (Section 4.3.6), the observed rates of change in 
A340 with time, as a percentage of the value obtained with D(—)-mandelate or 
phenylglyoxylate as substrate, are given. The oxidation reaction was assayed in 
200 mM-Bicine/NaOH buffer (pH 9.5) containing enzyme (154 ng or 15.4 ng for assays 
with D,L-4-hydroxymandelate and D,L-4-hydroxy-3-methoxymandelate), 1 mM-NAD+ and 
substrate. The reduction reaction was measured in 200 mM-potassium phosphate/NaOH 
buffer (pH 5.85) containing enzyme (13.4 ng), 190 /l/M-NADH and substrate. Values in 
parentheses represent values from two individual experiments, except for 
thiopheneglyoxylate where the value in parentheses represents the number of individual 
experiments.
Oxidation reaction
Compound 
1 mM-D,L-3-Hydroxymandelate 
1 mM-D,L-4-Hydroxymandelate 
1 mM-D,L-4-Hydroxy-3-methoxymande!ate 
10 mM-D,L-3-Hydroxy-4-methoxymandelate 
10 mM-D,L-2-Methoxymandelate 
1 mM-D,L-4-Fluoromandelate 
1 mM-D,L-4-Chloromande!ate 
1 mM-D,L-4-Bromomandelate 
10 mM-D(—)-Hexahydromandelate
Percentage rate of change A340
79.4 (78.4, 80.3) 
1322 (1289, 1355) 
705 (698,711)
23.4 (23.0,23.8) 
7.0 (7.3, 6 .6)
69.7 (69.3,70.0)
26.7 (26.7,26.7)
14.8 (14.4,15.2)
13.4 (13.0, 13.7)
Reduction reaction
Compound 
1 mM-Phenylpyruvate 
1 mM-Thiopheneglyoxylate
Percentage rate of change A340
13.2 (13.2,13.2)
10.1 ± 1 .5  (5)
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Table 4.5 Inhibition of the oxidation reaction of D(—)-mandelate dehydrogenase by 
compounds which are not substrates
The enzyme was assayed in 200 mM-Bicine/NaOH buffer (pH 9.5) containing enzyme 
(154 ng), 1 mM-NAD+, 319 /iM-D(—)-mandelate and inhibitor. The initial velocity in the 
absence of inhibitor was taken as the 100% value. Values in parentheses represent 
results from two individual experiments.
Table 4.6 Inhibition of the reduction reaction of D(—-)-mandelate dehydrogenase by 
compounds which are not substrates
The enzyme was assayed in 200 mM-potassium phosphate/NaOH buffer (pH 5.85) 
containing enzyme (13.4 ng), 200 pM-NADH, 51.2 /iM-phenylglyoxylate and inhibitor. The 
initial velocity in the absence of the inhibitor was taken as the 100% value. Values in 
parentheses represent results from two individual experiments.
Compound Percentage inhibition
10 mM-D(—)-Lactate 
10 mM-D,L-Phenyllactate 
5 mM-D,L-4-Hydroxyphenyllactate 
10 mM-D,L-2-Hydroxyvalerate 
10 mM-D,L-2-Hydroxy isovalerate 
1 mM-D.L-2-Hydroxycaproate 
1 mM-D,L-2-Hydroxyisocaproate 
10 mM-Oxalate
17.4 (17.4,17.4)
47.1 (46.4, 47.9)
44.2 (43.5, 45.0)
67.4 (68.2, 66.7) 
31.9 (30.5, 33.4) 
63.8 (63.8, 63.8)
55.1 (53.7, 56.6)
63.1 (63.8, 62.4)
Compound Percentage inhibition
10 mM-Pyruvate 
10 mM-Oxa!oacetate 
10 mM-Oxamate 
10 mM-2-Oxoglutarate 
10 mM-2-Oxovalerate 
10 mM-2-Oxoisovalerate 
1 mM-2-Oxoisocaproate 
2.5 mM-2-Oxooctanoate 
5 mM-2-Oxo-3-methylvalerate
17.4 (17.4,17.4)
38.5 (35.8, 41.3)
77.1 (78.0, 76.2)
44.1 (43.2, 45.0)
43.1 (41.3, 45.0)
44.1 (43.2, 45.0)
40.4 (43.2, 37.7)
28.5 (30.3, 26.7)
54.1 (54.1, 54.1)
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4.3.7 Effects of salts, metal ions and metal chelators
D(—)-Mandelate dehydrogenase activity was neither stimulated nor inhibited (after a 5 min 
pre-incubation at 27°C) by 1 mM concentrations of NaCI, NagS04 , KCI, MgCI2 , NH4CI, 
CaCI2 , ZnCI2 , CoCI2 , FeCI3 , KH2P04 , NaH2P04 , MnS04 , MnCI2 or CuS04 .
Enzyme activity was also not inhibited (after a 5 min pre-incubation at 27°C) by 
the following metal-chelating agents each at 1 mM concentration : EDTA, 
diethyldithiocarbamic acid, bathophenanthroline disulphonic acid, dihydroxybenzene 
disulphonic acid, pyrazole, 8-hydroxyquini!one or 2 ,2 -dipyridyl, indicating that the enzyme 
has no absolute requirement for salts or metal ions.
4.3.8 Effects of thiol reagents
D(—)-Mandeiate dehydrogenase was inhibited by 10 mM-A/-ethylmaleimide, resulting in a 
90% loss of activity after a 5 h incubation at 27°C. However, there was little or no 
inhibition of enzyme activity by 5 mM-4-(chloromercuri) benzoate, 10 mM-iodoacetate, 
10 mM-iodoacetamide or 6.65 mM-5,5,-dithiobis(2-nitrobenzoic acid), even after a 6 h 
pre-incubation at 27°C.
4.4 Steady state kinetics
4.4.1 Kinetic coefficients of the oxidation reaction of D(—)-mandelate  
dehydrogenase with D(—)-mandelate and NAD+
When D(—)-mandelate dehydrogenase was assayed in the presence of several 
non-saturating concentrations of the first substrate at a fixed high concentration of the 
second substrate, the enzymic rate showed a hyperbolic dependence on the substrate 
concentration, indicating that the enzyme obeys Michaelis-Menten kinetics. Figure 4.10 
shows typical primary double-reciprocal plots of the initial velocities of the oxidation 
reaction against D(—)-mande!ate concentration at a series of fixed NAD+ concentrations. 
The spread of plots indicates that the reaction catalysed by D(—)-mandelate 
dehydrogenase proceeds by a sequential mechanism, although product inhibition studies 
would be required to determine the order in which the cofactor and substrate bind.
The Km and V values of D(—)-mandelate dehydrogenase with respect to 
D(—)-mandelate and NAD+ were determined by the two-substrate method described by 
Engel (1981). The enzyme was assayed in the presence of several non-saturating 
concentrations of both substrates. The K value for each substrate and the V value werem
determined when the concentration of the other substrate had been extrapolated to 
infinity. The initial velocity data were analysed using the Direct Linear method (Eisenthal & 
Cornish-Bowden, 1974) using the Enzpack computer program (Williams, 1985), from 
which secondary plots of slopes and intercepts against the reciprocal NAD+ and 
D(—)-mandelate concentrations were constructed, enabling the Km and V values at infinite 
substrate concentration to be determined. Figure 4.11 shows typical secondary plots of 
slopes and intercepts against the reciprocal NAD+ concentration. At pH 9.5, the Km for
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D(—)-mandelate was 319 nM (327, 310) and the Km for NAD+ was 71 /iM (73, 69). The 
maximum velocity was 123 units (mg protein)'1 (127, 118, 123), which equates to a 
turnover number (frcat) of 78 s'1.
Although the kinetic data presented here were analysed using the Direct Linear 
method, they were also analysed and compared with the values obtained with the linear 
plotting methods (Lineweaver-Burk, Hanes-Woolf and Eadie-Hofstee) using the Enzpack 
computer program. The values obtained for a typical set of initial velocity data with all four 
methods are given in Table 4.7, and comparison shows that they were generally in good 
agreement.
4.4.2 Effect of pH on the apparent kinetic coefficients of the oxidation and reduction 
reactions of D(—)-mandelate dehydrogenase with D(—)-mandelate, NAD+ , 
phenylglyoxylate and NADH
The apparent Km and V values were determined by measuring the initial velocities in the 
presence of several non-saturating concentrations of the first substrate, at a fixed, single 
high concentration of the second substrate. The apparent kinetic coefficients of 
D(—)-mandelate dehydrogenase with D(—)-mandelate, NAD+, phenylglyoxylate and 
NADH at pH 5.85 (the optimum for the reduction reaction), pH 7.0, pH 8.0 and pH 9.5 
(the optimum for the oxidation reaction) are given in Table 4.8. Values for 
D(—)-mandelate and NAD+ at pH 5.85 could not be determined because the rate of the 
oxidation reaction was too low, especially at non-saturating concentrations, to allow 
accurate estimation of the kinetic coefficients.
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Table 4.7 Comparison of the apparent Km values (for D(—)-mandeiate) and V values 
obtained when Initial velocity data were analysed by the Direct Linear method and the 
Lineweaver-Burk, Hanes-Woolf and Eadie-Hofstee plotting methods using the 
Enzpack computer program
Enzyme was assayed at several D(—)-mandelate concentrations (175 [jM, 350 pM, 
700 (jM, 1400 pM and 2800 fiM) at a series of fixed NAD+ concentrations given in the 
table.
D-L L-B H-W E-H
[NAD+] K 'm V ' K m V ' K m V ' K ' m V '
38 /jM 702 34.9 723 34.8 755 35.3 683 33.8
76 /jM 682 55.0 517 47.9 753 57.4 596 51.8
153juM 591 77.0 549 74.0 597 76.9 557 74.8
307 /iM 377 86.8 375 86.3 385 87.1 375 86.5
615/iM 316 97.9 327 99.8 310 97.6 306 97.4
D-L, Direct Linear; L-B, Lineweaver-Burk; H-W, Hanes-Woolf; E-H, Eadie-Hofstee
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Table 4.8 Apparent Km and V values of D(—)-mandelate dehydrogenase with 
D(—)-mandelate, NAD+, phenylglyoxylate and NADH at pH 5.85, pH 7.0, pH 8.0 and 
pH 9.5
The numbers of individual experiments are given in parentheses, except where only two 
experiments were done in which case both values are given in parentheses. Assays were 
carried out 200 mM-potassium phosphate/NaOH buffer (pH 5.85; the optimum for the 
reduction reaction), 200 mM-potassium phosphate/NaOH buffer (pH 7.0), 50 mM-Tris/HCI 
buffer (pH 8.0) and 200 mM-Bicine/NaOH buffer (pH 9.5; the optimum for the oxidation 
reaction).
Reaction : D(—)-Mandelate +  NAD+ --------------- > phenyiglyoxylate +  NADH +  H+
PH K 'm D(—)-mandelate (pM) K m NAD+ (pM) V ' [units (mg protein)'
5.85 ND ND ND
7.0 3050 (3120, 2980) 309 (336, 281) 35.8 ±  5.0 (4)
8.0 372 (380, 364) 72.8 (single expt) 67.4 ±  7.4 (3)
9.5 325 (318, 332) 77.5 (77, 78) 86.7 ±  14.3 (4)
Reaction: Phenylglyoxylate +  NADH + H+ > D(—)-mandelate +  NAD+
PH K ' phenylglyoxylate (pM) K 'm NADH (pM) V ' [units (mg protein)'
5.85 51.5(41,62) 38 (37, 39) 572 ±119.3  (4)
7.0 45.5 (42, 49) 36 (35, 37) 490 ±  109.4 (4)
8.0 43.5 (42.1, 44.9) 14.2 (15.4,12.9) 311 ± 5 2 .3 (4 )
9.5 70.7 (65.4, 76) 26.3 (26.6, 26) 310 ±4 1 .5  (4)
ND, Not detectable
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4.5 Discussion
4.5.1 Quaternary structure, amino acid composition and sequence
D(—)-Mandelate dehydrogenase is a soluble, dimeric enzyme with an estimated Mf of 
77 200 (2 x 38 000 subunits) and the detection of a single amino terminal sequence 
(Section 4.2.3, Table 4.2) indicates that both subunits are identical.
The Mf is similar to that of other NAD+-dependent, D(—)-enantiomer specific 
2-hydroxy acid dehydrogenases. The D(—)-lactate dehydrogenases of lactic acid bacteria 
and staphylococci are dimers with native Mf values between 70 000 and 80 000 
(Garvie, 1980), the D(—)-2-hydroxyisocaproate dehydrogenase of S. faecalis is a dimer 
with a native Mr of 72 000 (Yamazaki & Maeda, 1986) and the D(—-)-mandelate 
dehydrogenase of L. curvatus is also a dimer, although it has a somewhat lower Mr of 
60 000 (Hummel et al., 1988). The native Mr is also very similar to those of a number of 
NAD+-dependent, L(+)-specific 2-hydroxyacid dehydrogenases. Malate dehydrogenase 
from E. coli is a dimer of Mx 65 000 (Fernley et al., 1981), the cytoplasmic and 
mitochondrial isoenzymes of S. cerevisiae are dimers of MT 75 000 and 68 000 respectively 
(Hagele et a/., 1978), as are their mammalian counterparts e.g. from pig heart, where the 
enzymes are dimers of Mx 70 000 and 66 000 respectively (Banaszak & Bradshaw, 1975; 
Birktoft et al., 1982; Birktoft et al., 1987). However, not all malate dehydrogenases are 
dimeric; the enzyme from Bacillus subtllis is a tetramer (Mf 117 000) with a subunit Mx 
slightly smaller than that of the dimeric forms (Murphey et al., 1967). Likewise, many 
L(+)-lactate dehydrogenases are tetramers (Mx 140 000), although as with the malate 
dehydrogenases the subunit Mf values are of the order of 35 000 (Holbrook ef al., 1975; 
Garvie, 1980; Turunen ef al., 1987).
In contrast to the soluble, dimeric D(—)-mandelate dehydrogenase of R. graminis, 
the D(—)- and L(+)-mandelate dehydrogenases of A. calcoaceticus are monomeric, 
integral membrane proteins located in the inner cytoplasmic membrane, and have 
Mx values of 60 000 and 44 000 respectively (Allison et al., 1985a,b; Hoey et al., 1987). 
The analogous enzymes of P. putida are presumably also monomeric, integral membrane 
proteins, and although the D(—-)-enantiomer specific enzyme has not been purified, the 
L(+)-mandelate dehydrogenase has recently been purified to near homogeneity and has 
a Mx, estimated by SDS-polyacrylamide gel electrophoresis, of 44 000 which is in good 
agreement with the Mx of 43, 352 deduced from the nucleotide sequence (Gunsalus et al., 
1953; Stanier etal., 1953; Hegeman ef al., 1970; Tsou eta!., 1990; C. A. Fewson, personal 
communication). The L(+)-mandelate dehydrogenase of R. graminis also differs from the 
yeast’s D(—)-specific enzyme in that it has a subunit Mx of 60 000 and, although it is 
readily solubilised during extraction, results from centrifugation experiments suggest that 
it is membrane "associated*. However, the quaternary structure of the enzyme and its 
intracellular location are as yet unknown (Durham, 1984; M. Yasin, personal 
communication).
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The subunit Mf and quaternary structure of the R. graminis D(—)-mandelate 
dehydrogenase are therefore comparable with those of many other NAD+-dependent, 
2 -hydroxyacid dehydrogenases but are quite distinct from those of the 
NAD(P)+-independent mandelate dehydrogenases.
The amino acid composition revealed a particularly low abundance of cysteine i.e. 
only one per subunit (Section 4.2.2). This precludes the existence of intra-subunit 
disulphide bonds, and it is also unlikely that cysteine plays a major role, if any, in 
inter-subunit contact as the enzyme remains as a dimer in the presence of DTT 
(Section 4.2.1). Some bacterial lactate dehydrogenases also have a low cysteine content 
e.g. the enzymes from Lactobacillus acidophilus, Lactobacillus plantarum and 
Lactobacillus casei (Hensel etal., 1977), although most lactate dehydrogenases usually 
contain between 3 and 10 residues per subunit (Holbrook etal., 1975; Garvie, 1980).
Comparison of nucleotide and amino acid sequences offers the best opportunity 
to determine whether two or more proteins are related, although comparison of amino 
acid composition can, in some cases, be used to determine whether a possible 
relationship exists. The recent cloning and sequencing of the mdlA and mdlB genes of 
P. putida, which encode mandelate racemase and the membrane-bound L(+)-mande!ate 
dehydrogenase respectively (Ransom etal., 1988; Tsou etal., 1990), enabled their amino 
acid compositions to be deduced, and comparisons made with the amino acid 
composition of the R. graminis D(—)-mandelate dehydrogenase. The number of residues 
of each amino acid type, with the exception of tryptophan, were compared and a value for 
the index of similarity determined according to the method of Cornish-Bowden (1979) 
which satisfies a formal 92.5% significance test (Cornish-Bowden, 1983). Comparison of 
the mandelate racemase with the D(—)-mandelate dehydrogenase gave a value of 0.6 , 
and comparison of the two mandelate dehydrogenases resulted in a value of 0.7. 
Both these values fall between the two threshold values of 0.42, below which relatedness 
is "strongly" indicated, and 0.93, above which the compositions do not provide grounds 
for believing a relationship to exist. Therefore, on the basis of amino acid composition 
data, there is a "weak* indication that the three proteins are related, although for some 
amino acids D(—)-mandelate dehydrogenase differs significantly from the other two 
enzymes e.g. in D(—)-mandelate dehydrogenase there are 1 cysteine and 4 methionine 
residues, whereas in mandelate racemase there are 12 methionines and in 
L(+)-mandelate dehydrogenase there are 5 cysteine and 11 methionine residues, even 
though all three proteins are of a comparable size. Furthermore, if there is a "weak" 
sequence relationship it is likely to occur in stretches of the polypeptides other than their 
amino termini which show no obvious homology (Section 4.2.3).
The D(—)-mandelate dehydrogenase amino terminal sequence was compared 
with the sequences in the University of Leeds, OWL composite database (Section 4.2.3). 
There was no significant homology between any of the archived sequences and that of 
the amino terminus. Matrix scans, designed to identify particular structural motifs also 
failed to elucidate any significant homology and, in particular, scanning of the sequence
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failed to show the "fingerprint" motif G-X-G-X-X-G...D/E, which is found in the amino 
terminal sequences of numerous NAD+-dependent dehydrogenases and, moreover, is 
known to exist in all known structures of /3a/3-folds which interact with the ADP moeity of 
NAD+ (Wierenga et al., 1986). However, the amino terminal sequence represents only 
16% of the entire polypeptide and the complete sequence would be required for a more 
detailed analysis. Besides, even if little or no sequence homology exists between 
D(—)-mandelate dehydrogenase and other dehydrogenases this would not preclude the 
existence of homology at higher structural levels. For example, the main chain of pig 
heart cytoplasmic and mitochondrial malate dehydrogenases are folded in a very similar 
manner, resulting in homologous tertiary structures, even though they share only 20% 
homology at the primary level (Birktoft et al., 1982; Roderick & Banaszak, 1986). 
D(—)-Mandelate dehydrogenase may well share structural homology with other 
NAD+-dependent dehydrogenases but, ultimately, only the determination of the enzyme’s 
three dimensional structure will allow a comparison with other enzymes for which crystal 
structures are available.
The amino terminal sequence was also analysed to determine whether it 
contained any runs of amino acids with minimal degeneracy. Such a sequence could 
then be used in the design of an oligonucleotide "probe" for cloning the D(—)-mandelate 
dehydrogenase gene. One particularly useful sequence was found, running from 
tryptophan-19 through to glutamate-27:
Position 19 20 21 22 23 24 25 26 27
Amino acid Trp Ser Asp Phe Gin Gin Lys Phe Glu
Degeneracy 1 6 2 2 2 2 2 2 2
Although extensive work has been done on yeast genetics, most has been 
concentrated on a few species, namely Saccharomyces cerevisiae and 
Schizosaccharomyces pombe (Rose, 1989), with comparatively little known about the 
genetic organisation in other genera. There seem to be no reports of genes cloned and 
sequenced from R. graminis and very few from the genus as a whole, notable exceptions 
being the leu gene from R. glutinis (Ho & Chang, 1988) and the phenylalanine ammonia 
lyase gene from R. rubra (Filpula et al., 1988; Vaslet et al., 1988). Although there are 
insufficient data to determine codon utilisation in the genus, it has been noted that for 
other fungal genes, codons ending in A are used infrequently and, moreover, in the 
phenylalanine ammonia lyase gene of the related yeast Rhodosporidium toruloides, this 
does not seem to be a consequence of its high GC content (65%), as a similar bias 
against codons ending in T is not apparent (Orbach etal., 1986; Anson etal., 1987). This 
observation, along with the fact that R. graminis also has a high GC content of 70%
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(Storck et al., 1969), which is the highest of all the species in the genus (Fell et al., 1984), 
may therefore be of assistance when selecting the base sequence for a ■probe", especially 
with respect to the more degenerate third position of each codon.
4.5.2 Cofactors, prosthetic groups and active site metals
D(—-)-Mandeiate dehydrogenase from R. graminis shows the same cofactor specificity as 
the D(—)-mandelate dehydrogenase from L  curvatus and the D(—-)-2 -hydroxyisocaproate 
dehydrogenase from S. faecalis, with all three enzymes being able to couple the reduction 
of NAD+ to the oxidation of D(—)-mandelate and, in the reverse direction, the oxidation of 
NADH to the reduction of phenylglyoxylate. They are also identical with respect to their 
inability to use NADP(H) as a cofactor (Yamazaki & Maeda, 1986; Hummel etal., 1988).
The ability of these enzymes to reversibly catalyse the oxidation of mandelate is in 
contrast to the NAD(P)+-independent D(—)- and L(+)-mandelate dehydrogenases of 
A. calcoaceticus, which essentially catalyse only the oxidation of mandelate. The 
prosthetic groups of these two bacterial enzymes are flavins, with the D(—)-mandelate 
dehydrogenase containing FAD and the L(+)-mandelate dehydrogenase containing FMN 
(Allison et al., 1985b; Hoey et al., 1987). The prosthetic group of the P. putida 
L(+)-mandelate dehydrogenase is also likely to be FMN, as the carboxy terminus of this 
enzyme has extensive sequence homology with the carboxy terminal regions of spinach 
glycolate oxidase and S. cerevisiae cytochrome b2 lactate dehydrogenase, two enzymes 
which are known to bind FMN and, moreover, in both these enzymes the carboxy terminal 
regions are associated with similar ap barrel domains that contain the FMN binding site 
(Lindqvist & Branden, 1985; Xia et al., 1987; Tsou et al., 1990). Likewise, the 
L(+)-mandelate dehydrogenase of R. graminis is NAD(P)+-independent, and is likely to 
contain flavin as prosthetic group as the purified enzyme is distinctly yellow in colour, is 
inhibited by mepacrine and is assayed using 2,6-dichloroindophenol as an artificial 
electron acceptor; a dye routinely used in the assay of the flavin-dependent lactate and 
mandelate dehydrogenases of A  calcoaceticus (Hills & Fewson, 1983a; Allison et al., 
1985a,b; Hoey etal., 1987; M. Yasin, personal communication).
Therefore, on the basis of cofactor specificity there are at least two clearly 
definable groups of mandelate dehydrogenase; pyridine nucleotide-dependent enzymes 
and flavin-dependent enzymes, which differ with respect to their modes of electron 
transport.
Both A  calcoaceticus and R. graminis can grow on D(—)- or L(+)-mandelate as 
the sole source of carbon and energy (Kennedy & Fewson, 1968a; Hills & Fewson, 1983a; 
Durham etal., 1984) and, as chemoheterotrophes, they must be able to derive energy (in 
the form of ATP) from the breakdown of these aromatic substrates. Although the oxidation 
of mandelate is only one of the steps in the pathway yielding reducing equivalents, it is an 
energetically important reaction because oxidation of the reduced cofactor/prosthetic 
group can be coupled to electron transport and oxidative phosphorylation. This has been 
confirmed experimentally with A  calcoaceticus wild type strain NCIB 8250, which gave a
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higher maximum molar growth yield (in continuous culture) when grown on 
L(+)-mandelate [70.6 g dry wt. (mol substrate)'1] than it did when grown on 
phenylglyoxylate [66.5 g dry wt. (mol substrate)'1] (Fewson, 1985). However, a 
comparison of growth yield on D(—)-mandelate could not be made as this strain is unable 
to utilise this enantiomer (Kennedy & Fewson, 1968b), although a similar higher growth 
yield would presumably be obtained for strains that can grow on this substrate e.g. wild 
type strain EBF 65/65 (Hills & Fewson, 1983a). Unlike the prosthetic groups of the 
A  calcoaceticus mandelate dehydrogenases, the NADH formed by the R. graminis 
D(—)-mandelate dehydrogenase can dissociate from the enzyme, whereupon it 
presumably feed electrons to the FMN prosthetic group of NADH dehydrogenase in the 
inner mitochondrial membrane. Electron transport along the respiratory chain, to oxygen 
as the terminal acceptor, probably yields 3 moles of ATP per mole of D(—)-mandelate 
oxidised. However, the A  calcoaceticus mandelate dehydrogenases feed electrons from 
the substrate to the enzyme-bound flavin, which presumably forms part of an electron 
transport system in the inner cytoplasmic membrane with cytochromes o or a2 (d) as 
terminal oxidases and 0 2 as the terminal electron acceptor (Hardy & Dawes, 1985; 
Fewson, 1988b). As the bacterial enzymes feed electrons into the respiratory chain at the 
level of reduced flavin the overall maximum net production of ATP is therefore probably 
lower, at only 2 ATP per mole of mandelate oxidised. Although growth yield experiments 
like those carried out with A  calcoaceticus have not been carried out with R. graminis, the 
validity of the above argument could be tested by growing the yeast in continuous culture 
on either D(—)-mandelate or L(+)-mande!ate. As the organism has an NAD+-dependent 
D(—)-mandelate dehydrogenase and a flavin-dependent L(+)-mandelate dehydrogenase, 
the growth yield on each enantiomer could be compared to determine whether 
NAD+-dependent oxidation of mandelate is more productive in terms of ATP yield than is 
flavin-dependent oxidation.
As R. graminis D(—)-mandelate dehydrogenase is an NAD(H)-dependent 
enzyme, it can be classified according to which of the two hydrogens at the C4 position of 
the dihydronicotinamide ring of NADH it transfers to the substrate (phenylglyoxylate) 
during the reduction reaction. The two hydrogens attached at the C4 position of the ring 
are termed pro-R (A hydrogen) and pro-S (B hydrogen), and lie on the re and si faces of 
the ring respectively; the two faces of the dihydronicotinamide ring being labelled 
according to the RS convention as the carbon at position 4 is prochiral (Fersht, 1985).
The two hydrogens, apart from being sterically different are also enzymicaliy 
non-equivalent with individual dehydrogenases transferring only one of them. 
Approximately 200 dehydrogenases have so far been examined, of which about half 
transfer the pro-R hydrogen with the other half transferring the pro-S hydrogen 
(Benner et ai., 1987, 1989). Crystallographic studies have shown that in the case of 
enzymes that transfer the pro-R hydrogen, e.g. dogfish lactate dehydrogenase, porcine 
cytoplasmic malate dehydrogenase and horse liver alcohol dehydrogenase, the 
dihydronicotinamide ring is orientated in an anti conformation with respect to the
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glycosidic bond, whereas an enzyme like lobster glyceraldehyde-3-phosphate 
dehydrogenase, which transfers the pro-S hydrogen has the ring orientated in the syn 
conformation (Rossmann et al., 1975; You et al., 1978). It is therefore likely that 
R. graminis D(—)-mandelate dehydrogenase, which transfers the pro-/? hydrogen 
[Section 4.3.5 (b)], binds NADH in the anti conformation, thereby orientating the re face of 
the dihydronicotinamide ring and pro-/? hydrogen towards the bound substrate. It is also 
likely, according to Bentley (1970), that the D(—)-mandelate dehydrogenase of L  curvatus 
and the D(—)-2-hydroxyisocaproate dehydrogenase of S. faecalis [which has marked 
D(—)-mandeiate dehydrogenase activity (Yamazaki & Maeda, 1986)] should also transfer 
the pro-/? hydrogen because he concluded that "the stereospecrficity of a particular 
enzyme does not depend on the source of the enzyme*. It would be of significant interest 
to determine the stereospecificity of hydride transfer of these two other enzymes, to 
determine whether Bentley’s generalisation is true for NAD(H)-dependent mandelate 
dehydrogenases.
An example that clearly does fit this generalisation is that of malate 
dehydrogenase, as the enzymes from a diverse range of organisms including 
archaebacteria (Sulfobolus acidocaldarius, Thermoplasma acidophilum  and 
Halobacter halobium), eubacteria (Bacillus subtilis and Pseudomonas putida), fungi 
(Neurospora crassa), plants (potato and w heat germ ), arthropods  
(Drosophila melanogaster), birds (chicken) and mammals (pig) all transfer the pro-R 
hydrogen (Loewus etal., 1955; Graves etal., 1956; Davies etal., 1972; Do Nascimento & 
Davies, 1975; Arnold et al., 1976; Bernstein & Everse, 1978; Goerisch et al., 1985; 
Allemann etal., 1988). Likewise, lactate dehydrogenases from an equally diverse range of 
organisms all transfer the pro-R hydrogen (You, 1982 and references therein). Although 
Bentley’s rule holds true for the majority of comparisons, not all enzymes catalysing the 
same reaction, but which come from different sources, share the same stereospecificity 
with respect to hydride transfer. For example, alcohol dehydrogenases from S. cerevisiae 
and horse liver transfer the pro-/? hydrogen, whereas the enzyme from 
Drosophila melanogaster transfers the pro-S hydrogen (Fisher et al., 1953; Vennesland, 
1956; Levy & Vennesland, 1957; Benner et al., 1985). Examples such as alcohol 
dehydrogenases which show heterogeneity with respect to hydride transfer contradict 
historical models that assume that stereospecificity and substrate specificity in 
dehydrogenases are highly conserved traits, and that enzymes from all organisms that act 
on the same substrate are homologous. Such discrepancies led Benner (1982) to 
propose an alternative functional model that correlates stereospecificity with the redox 
potential (or thermodynamic stability) of the substrate, and more recently Benner et al. 
(1985) updated this model to include three hypotheses which state : (1) which hydrogen 
is transferred is controlled by the conformation of the bound NADH, (2) different 
confomers of NADH have different redox potentials, and therefore (3) functionally optimal 
enzymes have evolved to match the redox potential of bound NADH to the redox potential 
of the natural substrate. These models assume that dehydrogenases which reduce
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unstable carbonyls evolved to transfer the pro-R hydrogen but those which reduce stable 
carbonyls evolved to transfer the pro-S hydrogen, but neither stereospecificity is strongly 
selected in those enzymes which reduce carbonyl substrates with "intermediary stability" 
i.e. those with an equilibrium constant of approximately 10‘11 M (Allemann etal., 1988). 
Therefore, with alcohol dehydrogenases which have an equilibrium constant close to this 
value (K ' =  8 x 10‘12 M, Allemann et al.,1988), neither stereospecificity is stronglyeq
selected and this has resulted in both pro-R and pro-S enzymes. Examination of a 
number of enzymes (Table 4.9) shows that an equilibrium constant of 10'11 M falls at the 
•break* in correlation between the equilibrium constant and stereochemistry 
(Benner et al., 1989). Interestingly, R. graminis D(—)-mandelate dehydrogenase has an 
equilibrium constant of 1.59 x 10'11 M (Section 4.3.4) which also falls at this "break* in the 
correlation, and this might indicate that the stereospecificity of hydride transfer has not 
been strongly selected during the evolution of the NAD(H)-dependent mandelate 
dehydrogenases, as apparently seems the case with alcohol dehydrogenases or, 
alternatively, transfer of the pro-R hydrogen may reflect a functional advantage in the 
reaction catalysed by the ancestral enzyme of D(—)-mande!ate dehydrogenase, and 
although the modern enzyme has retained pro-R specificity, it might not necessarily be 
optimal for the interconversion of D(—)-mandelate and phenylglyoxylate.
Although some bacterial and fungal 2-hydroxyacid dehydrogenases have been 
shown to require divalent metal ions for activity e.g. the Zn2+-dependent D(—)-lactate 
d eh yd ro g en a s e  of M eg asp h aera  e ls d e n ii and the  Z n 2 + -d e p e n d e n t  
D(—-)-lactate : cytochrome c oxidoreductase of S. cerevisiae (Hatefi & Stiggall, 1976; 
Olson & Massey, 1979), the activity of R. graminis D(—)-mandelate dehydrogenase was 
not effected by a range of salts, metal ions or metal chelating agents (Section 4.3.7) 
suggesting that, like the mandelate dehydrogenases of A. calcoaceticus, the 
D(—)-mandelate dehydrogenase of L. curvatus and the D(—)-2-hydroxyisocaproate 
dehydrogenase of S. faecalis, its activity is independent of metals or other ions 
(Allison etal., 1985b; Yamazaki & Maeda, 1986; Hoey etal., 1987; Hummel et al., 1988). 
However, although sensitivity to metal chelating agents is a general indicator of metal 
dependence, insensitivity does not prove that the enzyme does not have bound metal, as 
the chelators may be sterically prevented from removing the metal ion.
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Table 4.9 Stereospecificity of dehydrogenases arranged by the p Keq values 
for their physiological reaction
Information is taken from this thesis and Benner et al. (1989).
Name cr
£
Stereochemistry
Glyoxylate reductase 17.5 pro -R
Glyoxyiate reductase (NADP+) 17.5 pro -R
Tartronate semialdehyde reductase 13.3 pro -R
Glycerate dehydrogenase 13.3 pro -R
Glycerol dehydrogenase (NADP+) 12.8 pro -R
Hydroxypyruvate reductase 12.4 pro -R
Malate dehydrogenase (NADP+) 12.1 pro -R
Malate dehydrogenase 12.1 pro -R
Malic enzyme 12.1 pro -R
Malic enzyme (NADP+) 12.1 pro -R
L(+)-Lactate dehydrogenase 11.6 pro -R
D(—)-Lactate dehydrogenase 11.6 pro-R
Alcohol dehydrogenase (S. cerevisiae) 11.4 pro -R
Alcohol dehydrogenase (Drosophila) 11.4 pro-S
GIycerol-2-dehydrogenase 11.3 pro -R
Glycerol-3-phosphate dehydrogenase 11.1 pro-S
Homoserine dehydrogenase 10.9 pro -R
Carnitine dehydrogenase 10.9 pro-S
D(—)-MandeIate dehydrogenase 10.8 pro-S
3-Hydroxyacyl CoA dehydrogenase 10.5 pro-S
3-Hydroxybutyrate dehydrogenase 8.9 pro-S
3-Hydroxysteroid dehydrogenase 8.0 pro-S
Estradiol 17-/3-dehydrogenase 7.7 pro-S
Testosterone /3-dehydrogenase 7.6 pro-S
3-Oxoacyl ACP reductase 7.6 pro-S
/3-Hydroxysteroid dehydrogenase 7.6 pro-S
4.5.3 Substrate and inhibitor specificity
R. graminis D(—)-mandelate dehydrogenase is completely stereospecific for its substrate, 
a property shared with all other purified mandelate dehydrogenases (Allison etal., 1985b; 
Yamazaki & Maeda, 1986; Hoey et al., 1987; Hummel et al., 1988), and although 
L(+)-mande!ate cannot be oxidised by the enzyme, it is a competitive inhibitor and is 
therefore able to bind at the active site. Similarly, A  calcoaceticus D(—)-mandelate 
dehydrogenase activity is inhibited by L(+)-mandelate (80% inhibition in the presence of 
an equimolar concentration of the two enantiomers) as is the L(+)-mandelate 
dehydrogenase activity by D(—)-mandelate, although it is a relatively weaker inhibitor 
(Allison etal., 1985b; Hoey etal., 1987). L(+)-Mandelate appears also to be an inhibitor of 
the D(—)-2-hydroxyisocaproate dehydrogenase of S. faecalis as the enzymic activity in 
the presence of 10 mM-D,L-mandelate is only 93% of the activity with 
5mM-D(—)-mandelate (Yamazaki & Maeda, 1986).
R. graminis D(—)-mandelate dehydrogenase was active with a number of 
ring-substituted mandelates and could tolerate substitutions at the 2, 3, 4 and 3,4 
positions of the phenyl ring (Table 4.4). Unfortunately, determination of the appropriate 
specificity constants (kceX /apparent Km ) and subsequent comparison of the various 
substrates could not made for the reasons outlined in Section 4.3.6. The only other 
compounds which the enzyme could use as substrates [apart from D(—)-mandelate and 
phenylglyoxylate] were thiopheneglyoxylate and phenylpyruvate. Phenyllactate, the 
2 -hydroxy form of phenylpyruvate was found not to be a substrate but did act as an 
inhibitor (Table 4.5). This apparent discrepancy in being able to assay the enzyme for 
phenylpyruvate reduction but not for phenyllactate oxidation can be explained when one 
considers the difference in velocity between phenylglyoxylate reduction and 
D(—)-mandelate oxidation at their respective pH optima. The maximum velocity of 
phenylglyoxylate reduction is 6.6 times greater than D(—)-mandelate oxidation [572 units 
(mg protein) '1 against 86.7 units (mg protein)'1, Section 4.4.2], and if the same ratio exists 
with the phenylpyruvate/phenyllactate pair then the observed change in when 
assaying for the oxidation of phenyllactate (reduction of NAD+) would barely be 
detectable as the rate with phenylpyruvate was itself low.
Comparison of the compounds that are substrates show them to contain some 
form of ring structure (an aromatic ring, a non-aromatic six carbon ring or a thiophene 
ring), and it is possible that binding of the ring plays an important role in orientating the 
substrate at the active site. Correct binding of the ring may also confer specificity to 
these compounds, by contributing to the binding energy and therefore to the energy 
required for catalysis. In the active site of mandelate racemase the aromatic side chains 
of tyrosine and phenylalanine residues solvate the aromatic ring of mandelate 
(G. Petsko, personal communication), and similar specific interactions in the 
D(—)-mandelate dehydrogenase active site may account for the enzyme’s specificity for 
ring-containing substrates. The possibility of a specific interaction between the active site 
residues and the hydrophobic ring seems more likely when one considers that a range of
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aliphatic 2-hydroxy and 2-oxocarboxylic acids are not substrates but are inhibitors of 
enzymic activity (Tables 4.5 & 4.6) i.e. although they bear hydrophobic side chains and 
can bind at the active site, they lack a ring structure and are therefore incorrectly 
orientated for catalysis. Certain-ring containing compounds were also substrates of the 
S. faecalis D(—)-2 -hydroxyisocaproate dehydrogenase and the L. curvatus 
D(—)-mandelate dehydrogenase. In addition to D(—)-mandelate and phenylglyoxylate, 
the S. faecalis enzyme can also oxidise D(—)-phenyllactate (61% of the mandelate rate) 
and reduce phenylpyruvate (94% of the phenylglyoxylate rate) and, likewise, the 
L  curvatus enzyme uses phenyllactate (22% of the mandelate rate) and phenylpyruvate 
(63% of the phenylglyoxylate rate). However, both enzymes show poor, if any, activity with 
ring-hydroxylated analogues; the S. faecalis enzyme being unable to use 
4-hydroxyphenylglyoxylate even though it shows marked activity with phenylglyoxylate, 
and the activity of the L. curvatus enzyme drops from 63% of the mandelate rate with 
phenylpyruvate to only 4% with 4-hydroxyphenylpyruvate (Yamazaki & Maeda, 1986; 
Hummel et al., 1988). This indicates that the bacterial enzymes, unlike the R. graminis 
D(—)-mandelate dehydrogenase, do not readily tolerate ring-hydroxylation.
Both the L  curvatus D(—)-mandelate dehydrogenase and the S. faecaiis 
D(—)-2-hydroxyisocaproate dehydrogenase also differ from the R. graminis 
D(—)-mandelate dehydrogenase, in that many of the aliphatic 2-hydroxy and 
2 -oxocarboxylic acids which inhibit activity of the yeast enzyme are good substrates of the 
bacterial enzymes (Yamazaki & Maeda, 1986; Hummel etal., 1988). In order to compare 
the relative specificities of the bacterial enzymes for each of the substrates, the kinetic 
data presented by the authors were used to determine the specificity constant (/ccat IK ' ) 
(Table 4.10). Of the 13 substrates of the L. curvatus D(—)-mandelate dehydrogenase, the 
highest specificity constant was obtained with 2-oxo-3-methylvaIerate, with one 
straight-chain and three other branched-chain 2-oxocarboxylic acids all giving values 
significantly higher than phenylglyoxylate. Of the 10 substrates of the S. faecalis 
D(—)-2-hydroxyisocaproate dehydrogenase, the highest value was obtained with 
2-oxoisocaproate which also gave the highest relative velocity (Yamazaki & Maeda, 1986), 
and like the Lactobacillus enzyme other branched-chain acids gave higher values than 
phenylglyoxylate e.g. 2-oxoisovalerate and 2-oxo-3-methylvalerate. It is usually 
considered that the higher the specificity constant the closer the structure of the substrate 
transition-state intermediate is to the enzyme’s active site (Fersht, 1985), and therefore it 
is probable that the substrates of these enzymes in vivo are branched 2-oxocarboxylic 
acids such as 2-oxoisovalerate, 2-oxoisocaproate and 2-oxo-3-methyl valerate which are 
formed by the oxidative deamination of valine, leucine and isoleucine respectively. 
Moreover, there is no evidence to suggest that L  curvatus, S. faecalis or a number of 
other bacteria from the genera Lactobacillus and Leuconostoc which show marked 
NAD+-dependent mandelate dehydrogenase activity are capable of growing on 
D(—)-mandelate as the sole source of carbon and energy (Yamazaki & Maeda, 1986; 
Hummel et al., 1988; Smith, 1989). These organisms therefore seem to have a fortuitous
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ability to oxidise D(—)-mandelate/reduce phenylglyoxylate endowed by the broad 
specificity of these enzymes, which unlike the f t  graminis enzyme do not form part of a 
metabolic pathway for the catabolism of D(—)-mandelate.
A  calcoaceticus, on the other hand, can grow not only on D(—)- or 
L(+)-mandelate as the sole source of carbon and energy but also on a number of 
ring-substituted mandelates. The wild type strain NCIB 8250 can grow on 
D,L-2-hydroxymandelate, D,L-4-hydroxy mandelate, D,L-3,4-dihydroxy mandelate and 
D,L-4-hydroxy-3-methoxymandelate. Other ring-substituted mandelates do not support 
growth but can be partially metabolised e.g. D ,L-4-brom om andelate, 
D,L-4-ch!oromandelate, D,L-3-hydroxymandelate and D,L-3-hydroxy-4-methoxymandelate 
are degraded to the level of their corresponding ring-substituted benzoate, whereas 
D,L-4-fluoromandelate is oxidised beyond the benzoate level (Kennedy & Fewson, 1968b). 
Although the substrate specificity of the purified mandelate dehydrogenases of 
A  calcoaceticus with respect to these compounds has not been tested, the ability of this 
bacterium to grow on or partially metabolise these compounds is presumably due to 
substrate ambiguity of the mandelate dehydrogenases and other enzymes of the 
mandelate pathway (Fewson, 1988b). The only substrates with which the purified 
enzymes from A  calcoaceticus have been tested are D(—)- and L(+)-Iactate and these 
were of particular interest because of the striking similarities between the 
NADP+-independent mandelate and lactate dehydrogenases in this organism 
(Hoey et al., 1987). The L(+)-mandelate dehydrogenase cannot use L(+)-lactate as a 
substrate but the D(—)-mandelate dehydrogenase can use D(—)-lactate, albeit with an 
apparent Km 12.5 times higher and a maximum velocity 5 times lower than with 
D(—)-mandelate (Allison etal., 1985b; Hoey etal., 1987).
The inability of a number of potential metabolic inhibitors to affect the 
D(—)-mandeIate dehydrogenase of f t  graminis (Section 4.3.6) is similar to other 
NAD+-dependent dehydrogenases of the mandelate pathway e.g. benzyl alcohol 
dehydrogenase and benzaldehyde dehydrogenase II from A  calcoaceticus 
(MacKintosh & Fewson, 1988b), and this supports the view that feedback inhibition is not 
an important mechanism in the regulation of peripheral metabolic pathways 
(Fewson, 1988b). In contrast, NAD+-dependent dehydrogenases of central metabolic 
pathways often show regulation of activity by small effector molecules e.g. lactate 
dehydrogenase of Bacillus stearothermophilus is activated by fructose 1,6-bisphosphate, 
which builds up when glucose is plentiful and thereby increases flux to lactate, and the 
D(—)-lactate dehydrogenase of the fungus Pythium debaromyces is allosterically inhibited 
by GTP thereby diverting the flux of pyruvate away from D(—-)-lactate towards 
oxaloacetate during gluconeogenesis (Clarke etal., 1989b; Le John, 1971).
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Table 4.10 Substrate specificity of the L  curvatus D(—)-mandelate dehydrogenase 
and the S. faecalis D(—)-2-hydroxyisocaproate dehydrogenase.
Information is taken from Yamazaki & Maeda (1986) and Hummel etal. (1988). The values 
of fr were determined from the maximum velocities of 2122 units (mg protein)'1 and 
897 units (mg protein)'1, and subunit Mf values of 30 000 and 34 000 for the L. curvatus 
and S. faecalis enzymes respectively.
L. curvatus D(—)-mandelate dehydrogenase
Compound V (relative %) fccat(S'1> K 'm (mM)
Phenylglyoxylate 100 1060 0.22 4.8 x10s
2-Oxobutyrate 51 541 0.55 9.8 x10s
2-Oxoxvalerate 76 806 0.17 4.7 x10s
2-Oxocaproate 74 784 0.10 7.8 x10s
2-Oxooctanoate 6 64 0.35 1.8 x 10s
2-Oxo-3-methylbutyrate 176 1866 0.18 1.0 x 107
2-Oxo-3-methylvalerate 119 1261 0.095 1.3 x107
2-Oxoisocaproate 76 806 0.090 9.0 x10s
2-Oxo-4-methyl-
mercaptobutyrate 68 721 0.11 6.6 x 10s
Trimethylpyruvate 15 159 5.4 2.9 X104
Phenylpyruvate 63 668 0.15 4.5 x10s
4-Hydroxyphenylpyruvate 4 42 0.65 6.5 x104
3-(3,4)-Dihydrophenylpyruvate 4 42 0.37 1.1 x 10s
S. faecalis D(—-)-2-hydroxyisocaproate dehydrogenase
Compound V (relative %)
Phenylglyoxylate 100
2-Oxobutyrate 4
2-Oxovalerate 22
2-Oxocaproate 29
2-Oxoisovalerate 53
2-Oxoisocaproate 121
2-Oxo-3-methylvalerate 63
Phenylpyruvate 94
Chloropyruvate 66
Bromopyruvate 82
*cat(s'1> K' m(rn M) * c a /* m <M'1
510 3.2 1.6 x10s
20 7.7 2.6 x10s
112 3.3 3.4 x104
148 2.3 6.4 x104
270 0.4 6.8 x10s
617 0.7 8.8 x10s
321 0.5 6.4 x10s
479 7.0 6.8 X104
337 33.0 1.0 x 104
418 7.3 5.7 x104
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4.5.4. Kinetics
R. graminis D(—)-mandelate dehydrogenase is similar to both the L. curvatus 
D(—)-mandelate dehydrogenase and the S. faecalis D(—)-2-hydroxyisocaproate 
dehydrogenase, but not the R. graminis L(+)-mandelate dehydrogenase or 
A  calcoaceticus mandelate dehydrogenases with respect to the pH values at which they 
show optimal activity. The three NAD+-dependent enzymes catalyse a reversible reaction 
and show two pH optima, with a higher pH optimum for the oxidation reaction than the 
reduction reaction. The optimum pH for the oxidation reaction of the f t  graminis, 
L. curvatus and S. faecalis enzymes are 9.5, 8.5 and 9.2 respectively, whereas for the 
reduction reaction they are 5.85, 6.0 and 4.5 respectively (Figure 4.5; Yamazaki & Maeda, 
1986; Hummel et al., 1988). These results are also very similar to a number of other 
bacteria! and fungal NAD+-dependent, 2-hydroxyacid dehydrogenases where the 
oxidation of the 2-hydroxyacid shows a higher pH optimum than the reduction of the 
corresponding 2-oxoacid (Le John, 1971; Garvie, 1980). By contrast, each of the 
NAD(P)+-independent mandelate dehydrogenases which catalyse an essentially 
irreversible reaction show a single pH optimum, and these are similar to each other with 
values of 7.5, 8.0 and 7.5 for the R. graminis L(+)-mandelate dehydrogenase and 
A. calcoaceticus D(—)- and L(+)-mandelate dehydrogenases respectively (Allison et al., 
1985b; Hoey etal., 1987; M. Yasin, personal communication).
The pH was also shown to have a marked effect on the apparent Km values for the 
substrates and cofactors of the yeast enzyme, especially those for D(—)-mande!ate and 
NAD+ (Table 4.8). Although there was relatively little change in the apparent K values for 
phenylglyoxylate or NADH, a change from pH 9.5 to neutrality resulted in an almost 
10-fold increase in the apparent Km value for D(—)-mande!ate and a 4-fold increase for 
NAD+. Furthermore, at all of the pH values tested, the apparent K values for 
phenylglyoxylate and NADH were significantly lower than for D(—)-mande!ate and NAD+, 
and the apparent maximum velocities were significantly greater in the reverse (reduction) 
reaction than in the forward (oxidation) reaction (Section 4.4.2). Therefore, even at pH 9.5 
(the optimum for the forward reaction), the enzyme is a better phenylglyoxylate reductase 
than it is a D(—)-mandelate dehydrogenase. However, D(—)-mandelate dehydrogenase 
is induced during the growth of R. graminis on mandelate (Durham et al., 1984) and 
presumably the reaction is driven in the physiological forward direction by the 
decarboxylation of the product by phenylglyoxylate decarboxylase and by the oxidation of 
the NADH formed.
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4.5.5 Active site thiols
One property in which the R. graminis D(—)-mandelate dehydrogenase clearly differs from 
all other purified mandelate dehydrogenases is its marked insensitivity to a range of thiol 
reagents (Section 4.3.8), which suggests that the single cysteine residue identified by 
amino acid analysis (Section 4.2.2) is not essential for catalysis. Alternatively, this 
residue might be involved In catalysis but is inaccessible to these reagents. However, this 
seems unlikely as 4-(chloromercuri)benzoate, a reagent not too dissimilar in structure to 
mandelate, should be able to gain access to the active site, especially as several aromatic 
and aliphatic mandelate analogues can do so.
The insensitivity of the yeast enzyme is in stark contrast to the mandelate 
dehydrogenases of A. calcoaceticus, which are susceptible to these reagents; in 
particular the D(—)-m andelate dehydrogenase is strongly inhibited by 
4-(chloromercuri) benzoate; less than 1 fiM producing 50% inhibition after only a 10 min 
incubation at 27°C (Allison et al., 1985b; Hoey et al., 1987). The R. graminis enzyme also 
differs from the S. faecalis D(—)-2-hydroxyisocaproate dehydrogenase [complete 
inhibition at 0.5 mM-4-(chloromercuri) benzoate], the L. curvatus D(—)-mandelate 
dehydrogenase [94% inhibition at 100 j/M-4-(chloromercuri)benzoate] and many lactate 
dehydrogenases which are inhibited by thiol reagents (Holbrook etal., 1975; Yamazaki & 
Maeda, 1986; Hummel etal., 1988). These results suggest that the bacterial mandelate 
dehydrogenases may have active site cysteine residue(s), although sensitivity to thiol 
reagents does not prove the involvement of cysteine side chain(s) in the catalytic 
mechanism (especially in the absence of substrate protection and stoicheiometry studies) 
and can neither differentiate between a catalytically essential residue and a structurally 
essential residue, modification of which leads to inactivation due to steric or other effects.
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CHAPTER 5
AFFINITY LABELLING OF D(—)-MANDELATE DEHYDROGENASE 
WITH D(—)-2-(BROMOACETYL)MANDELATE
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5.1 Introduction
In the absence of X-ray crystallographic data, chemical modification offers an opportunity 
to investigate the active site of an enzyme, and may yield information as to the topology of 
the active site as well as the role of specific amino acid side chains in substrate binding 
and catalysis (Plapp, 1982; Fersht, 1985). However, chemical modification is not 
restricted to the study of the active site and has proved useful in the investigation of other 
aspects of protein structure and function e.g. allosteric and cooperative properties, 
alteration of enzyme specificity and determination of an enzyme’s quaternary structure 
(Eyzaguirre, 1987). Numerous chemicals are available to modify proteins and they may 
be divided into two broad categories; the group-specific reagents and the affinity labels 
although, in some cases, a group-specific reagent may also act as an affinity label. 
Although many of the former group are selective towards the amino acids with which they 
react few, if any, are absolutely specific (Eyzaguirre, 1987). For example the reagent 
N-ethylmaleimide reacts primarily with the thiolate anion of the cysteine side chain, but will 
also react with amino groups, and likewise A/-bromosuccinamide which reacts primarily 
with tryptophan will also react with tyrosine (Means & Feeney, 1971). Furthermore, even if 
a reagent is group-specific it may react at more than one site on a protein, making 
identification of the active site residue(s) difficult.
An alternative method is to use an affinity label which is a chemically reactive 
compound analogous to the natural substrate. The enzyme binds the label in a manner 
similar to that of the substrate and, therefore, brings a reactive group into close proximity 
with the amino acid side chains at or near the active site. Once bound, the label may 
dissociate from the enzyme or it may react with an active site residue, leading to covalent 
bond formation and enzyme inactivation. The inactivation of an enzyme by an affinity label 
is described by the following equation (Meloche, 1967) :
E +  I < --------------- >  E.l---------------->  E-X
where E is the enzyme, I is the inhibitor, E.l is the reversible enzyme.inhibitor complex and 
E-X is the inactive, covalently modified enzyme. The dissociable complex formed between 
the enzyme and inhibitor prior to covalent modification is analogous to the 
enzyme.substrate complex formed during catalysis. If a compound is to be considered as 
an affinity label it must satisfy four important criteria (Meloche, 1967):
(1) It should inhibit the enzyme completely and irreversibly.
(2) The inactivation should show rate saturation i.e. there is a maximum finite of 
inactivation.
(3) The inactivation should be protected by the substrate or by reversible inhibitors of the 
enzyme i.e. if the affinity label is binding at the active site, the presence of competing 
substrate or reversible inhibitor will reduce the rate of inactivation.
(4) The binding of the inhibitor should be stoicheiometric i.e. one inhibitor molecule should 
bind per active site.
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D(—)-Mandelate dehydrogenase catalyses the reversible interconversion of 
D(—)-mandelate and phenylglyoxylate, removing two hydrogens from D(—)-mandelate in 
the oxidation reaction and transferring two hydrogens to phenylglyoxylate in the reduction 
reaction (Section 4.3.1). The overall reaction is analogous to that of the NAD+-dependent 
lactate dehydrogenases which catalyse the reversible interconversion of lactate and 
pyruvate (Holbrook etal., 1975). In the oxidation of lactate by lactate dehydrogenase, the 
two hydrogens are removed from lactate in the form of a hydride ion from the central chiral 
carbon and a proton from the hydroxyl group; the hydride ion being transferred to the C4 
position of the dihydronicotinamide ring of NAD+, and the proton abstracted by the 
unprotonated imidazole group of an active site histidine (Clarke et al., 1989a). Since 
D(—)-mandelate dehydrogenase is also an NAD+-dependent enzyme [Section 4.3.5 (a)] 
and part of the overall reaction involves hydride transfer [Section 4.3.5 (b)], an attempt 
was made to identify the active site residue which might be involved in removing the 
proton from the mandelate hydroxyl group during the oxidation reaction.
In order to probe the active site for reactive and accessible nucleophilic groups 
which might mediate this function, the compound D(—)-2-(bromoacetyl)mande!ic acid 
was chosen as a potential affinity label as it retains both the phenyl and carboxylate 
groups found in the natural substrate, but also includes a reactive and electrophilic 
bromoacetyl group (Figure 5.1). The bromoacetyl group was incorporated at the position 
normally occupied by the hydroxy/carbonyl groups of D(—)-mandelate/phenylglyoxylate 
respectively. If the phenyl and carboxylate groups of D(—)-2-(bromoacetyl)mandelate 
bind to the enzyme in the same positions as the corresponding groups of 
D(—)-mandelate, the bromoacetyl function should be positioned to intercept the 
nucleophilic amino acid side chain involved in proton transfer.
In the course of the present work, methods have been developed for the synthesis 
and purification of D(—)-2-(bromoacetyl)mandelic acid, and its physical and chemical 
characteristics were determined to confirm the synthesis of the compound. Although the 
synthesis of this compound had been reported using a different chemical route, no 
attempt had previously been made to characterize it (Tacwor, 1956). Furthermore, it had 
been synthesized as a general bacteriocide/fungicide and not as an inhibitor of any 
specific enzyme. The inactivation of D(—)-mandelate dehydrogenase by the label is 
reported, along with the procedures used to isolate and characterize the labelled active 
site peptides. Attempts were also made identify the modified amino acid.
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D(—)-Mandelic acid D(—)-2-( Bromoacetyl)mandeiic acid
Figure 5.1 Structure of D(—)-mandelic acid and D(—)-2-(bromoacetyi)mandeIic acid
5.2 Synthesis and purification of D(—-)-2 -(bromoacetyl)mandellc acid 
Tw o m e th o d s  w ere  s u c c e s s fu l ly  e m p lo y e d  for th e  s y n th e s is  of 
D(—)-2(bromoacetyl)mandelic acid. Method 1 [Methods 2.12.1 (a)], used for the 
synthesis of non-radiolabelled compound, involved the bromoacetylation of 
D(—)-mandelic acid by bromoacetylbromide in the presence of pyridine as a base catalyst 
(Figure 5.2). The reaction was monitored by TLC on silica gel plates, eluting with 
toiuene/ethyl acetate/formic acid at 5:1:1 (v/v) and a typical synthesis is shown in 
F ig u re  5 .3 .  T h e  s y n th e s is  y ie ld e d  tw o  p r o d u c t  c o m p o u n d s ,
D(—)-2-(bromoacetyl)mandelic acid which migrated with an Rf value of 0.43 (0.43, 0.43) 
and an unknown minor contaminant with an value of 0.50 (0.50, 0.49). Both products 
were well separated from unreacted D(—)-mandelic acid [F^  =  0.14 (0.14, 0.13)] and 
pyridine which remained on the origin (Rf =  0).
When the solvent system was used for "flash* chromatography (Methods 2.12.2) it 
was again successful in separating the two products from unreacted D(—)-mandelic acid 
and pyridine, but it could not separate D(—)-2-(bromoacetyl)mandelic acid from the minor 
contaminant (Lane 4, Figure 5.3). Modifying the solvent system by using different ratios of 
toluene/ethyl acetate/formic acid resulted in loss of resolution. Formic acid was found to 
be essential as omission or an insufficient amount resulted in smearing, presumably 
because the carboxylate groups of the acids were not fully protonated. Furthermore, the 
amount of ethyl acetate could not be lowered significantly as an insufficient amount of 
ethyl acetate prevented the formic acid from being miscible in the solvent system. 
Therefore, several other TLC solvent systems were tested in an attempt to increase the 
separation between the two compounds. These included various combinations of 
chloroform/methanol, chloroform/methanol/formic acid, benzene or toluene/ethanol/formic 
acid and benzene or toluene/ethyl acetate/ethanol/formic acid, but none gave better 
separation than toluene/ethyl acetate/formic acid at 5:1:1 (v/v). All attempts at purifying 
D(—)-2-(bromoacetyl)mandelic acid to homogeneity using other techniques e.g. 
preparative TLC and crystallizing the compound from a number of single and double 
solvent systems also proved unsuccessful.
Method 2 [Methods 2 .12.1 (b)], using bromo[1-14C]acetic acid was developed for 
the synthesis of D(—)-2-(brom o[14C]acetyl)mandelic acid as radiolabelled 
bromoacetylbromide was not commercially available. This involved a more complex two 
step reaction; in the first step, an anhydride was formed from the reaction of 
brom o[1-14C]acetic acid with isobutylchloroformate in the presence of
4-methylmorpholine and then, in the second step, D(—)-mandelic acid was reacted with 
the anhydride to yield D(—)-2-(bromo[14C]acetyl)mandelic acid, tertiary butanol and C 02 
as products (Figure 5.4). Although, in principle, the products should only have been 
those shown in Figure 5.4, again the same minor contaminant, as judged by its Rj value 
on TLC, appeared as with Method 1. After autoradiography of the TLC plate 
(Methods 2.2.8), both products were found to be radioactive although the number of 
counts incorporated into the contaminant was only about 9% of those incorporated into
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D(—)-2 -(bromo[14C]acetyl)mandelic acid. However, despite the presence of the 
contaminant in the radioactive and non-radioactive preparations, preliminary inactivation 
experiments had shown that the product appeared suitable for further work.
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Figure 5.2 Synthesis of D(—)-2-(bromoacetyl)mandelic acid
Non-radiolabelled D(—)-2-(bromoacetyl)mandelic acid was synthesized from 
D(—)-mandelic acid and bromoacetylbromide in the presence of pyridine as a base 
catalyst as described in Methods 2.12.1 (a).
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Figure 5.3 Synthesis and purification of D(—)-2-(bromoacetyl)mandelic acid 
(Method 1) monitored by TLC
The synthesis and purification of D(—)-2-(bromoacetyl)mandelic acid were monitored by 
TLC on silica gel plates, eluting with toluene/ethyi acetate/formic acid at 5:1:1 (v/v). The 
plates were then visualised under an ultra violet light source.
Lanes : 1, pure D(—)-mandelic acid; 2, pyridine; 3, crude product mixture; 4, purified 
D(—)-2-(bromoacetyl)mandelic acid and minor contaminant.
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Figure 5.4 Synthesis of D(—)-2-(bromo[14C]acetyl)mandeIic acid
Radiolabelled D(—)-2-(bromoacetyl)mandelic acid was synthesized in a two step reaction 
which involved (1) formation of an anhydride from the reaction of bromo[1-14C]acetic acid 
with isobutylchloroformate in the presence of 4-methylmorpholine, followed by (2) reaction 
of the anhydride with D(—)-mandelic acid to yield D(—)-2-(bromo[14C]acetyl)mandelic 
acid, tertiary butanol and C02 as products, as described in Methods 2.12.1 (b).
5.3 Characterization of D(—)-2-(bromoacetyl)mandeIIc acid
The mass spectrum of D(—)-2-(bromoacetyl)mandelic acid confirmed the synthesis of the 
compound. The parent ions with mass to charge ratios of 272 and 274, corresponding to 
C10HgO4Br were detected (Peaks 1 & 2, Figure 5.5). Two peaks were detected as natural 
bromine exists as a diisotopic mix with 79Br and 81 Br in an approximate 1:1 ratio, and 
therefore any molecular ion or fragment containing one bromine will give rise to a pair of 
peaks differing by 2 mass units (Williams & Fleming, 1973). Furthermore, high resolution 
analysis of the smaller parent ion gave a mass to charge ratio of 271.9684, exactly that 
required for C1QHg0 4Br.
The 1H-NMR spectrum (Figure 5.6) was also consistent with the structure of 
D(—)-2-(bromoacetyI)mandelic acid given in Figure 5.1. The resonances, relative to 
chloroform at 7.25 ppm, were at 3.96 ppm (2 H, singlet; methylene protons), 6.0 ppm 
(1 H, singlet; HC-proton), 7.39 - 7.52 ppm (5 H, multiplet; aromatic protons) and 
12.01 ppm [1 H, singlet; consistent with an acidic proton resonating at very low field 
strength (Abraham & Loftus, 1978)]. There was also a resonance at 3.85 ppm (singlet) 
which presumably represented a signal from the contaminant, and a resonance at 
1.97 ppm (singlet), consistent with the signal from acetonitrile (Aldrich, 1983), indicating 
that residual solvent from the purification had remained even after extensive lyophilization. 
Confirmation that the resonance at 3.96 ppm were those of the methylene protons was 
obtained after analysis of the spectrum in the presence of benzene (25% v/v). As the 
methylene group forms part of the bromoacety! side chain which is bonded to a chiral 
carbon, the two methylene protons experience different magnetic fields and are therefore 
diasterically not equivalent. As a consequence, they resonate at slightly different 
frequencies, although in the presence of deuterochloroform alone this difference is 
insufficient to be detected as two separate signals. However, in the presence of benzene, 
which can increase the diasteriotopic effect by slowing down the rotation of the methylene 
carbon, the methylene proton resonances were detected as discrete signals at 3.563 ppm 
and 3.559 ppm relative to benzene at 7.15 ppm as is shown in Figure 5.6, inset. It was 
also apparent that the methylene protons resonated at higher frequency in the presence 
of benzene, although solvents containing aromatic groups such as benzene and pyridine 
may cause large changes in the observed chemical shifts of the solute when compared 
with the spectra run in non-aromatic solvents (Derome, 1987).
The elemental composition of D(—)-2-(bromoacetyl)mande!ic acid was also 
consistent with the analytical calculation for C1£)Hg0 4Br:
Element Expected (%) Found (%)
Carbon 44.1 42.6 (42.6, 42.6)
Hydrogen 3.3 2.7 (2.6, 2.8)
Bromine 29.0 30.4 (single expt.)
Oxygen 23.5 not determined
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The CD spectrum of D(—)-2-(bromoacetyl)mandelic acid was analysed to 
determine the stereochemistry of the compound relative to that of D(—)- and 
L(+)-mandelic acid (Figure 5.7). D(—)-Mandelic acid gave a negative cotton effect,
resulting in a maximum at 223 nm whereas L(+)-mandelate gave the positive mirror 
image. D(—)-2-(Bromoacetyl)mandelic acid also gave a negative cotton effect with an 
identical maximum to D(—)-mandelic acid but at approximately 220 nm, and therefore it 
had the same stereochemistry as D(—)-mandelic acid, the precursor used for its 
synthesis.
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Figure 5.5 Mass spectrum of D(—)-2-(bromoacetyl)mandelic acid
The mass spectrum of D(—)-2-(bromoacetyl)mandelic acid was obtained using electron 
impact mass spectrometry with a Kratos MS-30 mass spectrometer by Dr T. Bugg and 
colleagues, Department of Organic Chemistry, University of Cambridge.
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Figure 5.6 1H-NMR spectrum of D(—)-2-(bromoacetyl)mandelic acid
The 1H-NMR spectrum of D(—)-2-(bromoacetyl)mandelic acid was obtained using a 
Bruker model WP 220 SY (200 MHz) NMR spectrometer, by Mr J. Gall, Department of 
Chemistry, University of Glasgow. The compound was dissolved in deuterochloroform 
and the resonances referenced to chloroform at 7.25 ppm (for the main spectrum) and 
benzene [25% (v/v) in deuterochloroform] at 7.15 ppm for the inset spectrum.
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Figure 5.7 CD spectrum of D(—)-2-(bromoacetyl)mande!ic acid, D(—)-mandelic acid 
and L(+)-mandelic acid
Circular dichroism was carried out by Ms S. Kelly using a JASCO J-600 
Spectropolarimeter at the Scottish CD Facility, School of Biological Sciences, University of 
Stirling. D(—)-2-(Bromoacetyl)mandelic acid (0.2 mg ml*1, 0.74 mM) and D(—)- and 
L(+)-mandelic acids (0.2 mg ml*1, 1.3 mM) dissolved in acetonitrile (HPLC grade), were
scanned from 190-250 nm in a 0.02 cm pathlength cuvette. D(—)-mandelic acid (---------),
L(+)-mandelic acid (-----------------) and D(—)-2-(bromoacetyl)mandelic acid (-----------).
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5 .4  K inetics  of Inactivation  of D (—)-m andelate  dehydrogenase by 
D(—)-2-(bromoacetyl)mandelate
In preliminary experiments, D(—)-mandeiate dehydrogenase was found to be inactivated 
by D(— )-2 -(bromoacetyl)mandelate, and incubation of the enzyme with 
8 mM-D(—)-2-(bromoacetyl)mandelate typically resulted in >95% inactivation after 2 h at 
27°C. When the enzyme was incubated under the same conditions in the absence of 
D(—)-2-(bromoacetyl)mandelate but in the presence of 0.95 M-acetonitrile (the 
concentration in the inactivation mix), the enzyme remained fully active indicating that the 
solvent alone did not inhibit enzymic activity. Moreover, when enzyme, inactivated with 
D(—)-2-(bromoacetyl)mandelate, was diaiysed extensively against 50 mM-Tris/HCI buffer 
(pH 8.0), there was no restoration of enzymic activity indicating that modification of the 
enzyme was probably covalent.
T h e  in a c t iv a t io n  of D (— ) - m a n d e la t e  d e h y d r o g e n a s e  w ith  
D(—)-2-(bromoacetyI)mandelate in the absence and presence of D(—)-mandelate, 
followed pseudo-first-order kinetics. The half-times of inactivation were measured for 5 
different concentrations of inhibitor, and the curves obtained are shown in Figure 5.8. A 
plot of half-time of inactivation (f1/2) against the reciprocal D(—)-2-(bromoacetyl)mandelate 
concentration according to the equation (Meloche, 1967):
*1/2 =  14° (—)-2-(bromoacetyl)mandelate] fm|n
gave two straight lines with positive ordinate intercepts, indicating that the inactivation of 
D(—)-mandelate dehydrogenase obeyed rate saturation kinetics (Figure 5.9). 
The inhibitor therefore forms a dissociable complex with the enzyme prior to inactivation, 
since the secondary plot in the absence of D(—)-mandelate has an intercept giving a finite 
inactivation half-time (f , ) of 22.7 min (21.1, 24.3), and the inhibitor concentration giving 
the half-maximal rate of inactivation (Kj) was 2.4 mM (2.4,2.3) (See Figure 5.9).
The affinity of D(—)-2-(bromoacetyl)mandelate for the substrate binding site/active 
site was demonstrated by the increase in the slope of the secondary plot when the 
enzyme was inactivated in the presence of D(—)-mandelate. This resulted in a 
half-maximal rate of inactivation (Kj) of 4.8 mM i.e. the apparent affinity for the inhibitor 
decreased in the presence of competing substrate (Kitz & Wilson, 1962). The ordinate 
intercept increased slightly (See Figure 5.9), resulting in a finite inactivation half-time 
(f , ) of 29.1 min, although in other experiments the ordinate intercepts of secondary 
plots in the absence and presence of D(—)-mandelate remained unchanged.
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Figure 5.8 Inactivation of D(—)-mande!ate dehydrogenase by various concentrations 
of D(—)-2-(bromoacetyl)mandelate in the absence and presence of D(—)-mandelate
(a) Inactivation of D(—)-mandelate dehydrogenase in the absence of D(—)-mandelate. 
The inactivation mix (100 pi) contained D(—)-mandelate dehydrogenase (19 pg, 5 pM), 
D(—)-2-(bromoacetyl)mandelate (1-4 mM) and acetonitrile (0.95 M). Immediately after 
addition of the label, the inactivation mix was vortexed and a sample (10 pi) removed and 
diluted into 990 pi of 50 mM-Tris/HCI (pH 8.0). Samples (10-40 pi) were then assayed for 
residual phenylglyoxylate reductase activity as in Methods 2.4.2 (c). At 15 min intervals 
throughout the 2 h time course (27°C), samples (10 pi) were removed, diluted and 
assayed for residual enzymic activity. The activity of the sample taken immediately after 
addition of the label was taken as the 100% value. Concentrations of 
D(—)-2-(bromoacetyl)mandelate : 4 mM ( #  ), 3 mM ( O )» 2 mM ( A  ). 1-5 mM ( A ) 
and 1 mM ( □ ) .
(b) Inactivation of D(—)-mande!ate dehydrogenase in the presence of D(—)-mandelate. 
The inactivation was carried out exactly as described above except that the inactivation 
mix also contained 5 mM-D(—)-mandelate.
Concentrations of D(—)-2-(bromoacetyl)mandelate : 8 mM ( #), 4 mM (O )> 3 mM (A). 
2 mM ( A ) and 1 mM ( □ ) .
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Figure 5.9 Secondary plots of half-time of inactivation (f1/2) as a function of the 
reciprocal D(—)-2-(bromoacetyl)mandelate concentration
The half-times of inactivation of D(—)-mandelate dehydrogenase at several concentrations 
of D(—)-2-(bromoacetyI) mandelate were determined from the primary plots shown in 
Figure 5.8. The enzyme was inactivated in the presence of inhibitor in the absence ( O ) 
and presence ( # )  of 5mM-D(—)-mandelate.
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5.5 Stoicheiometry of inactivation
W h e n  D ( — ) - m a n d e l a t e  d e h y d r o g e n a s e  w a s  i n c u b a t e d  w i t h  
D(—)-2-(bromo[14C]acetyl)mandelate, radioactivity was incorporated into the protein. The 
incorporation of radioactivity into the enzyme followed a linear relationship with the 
concomitant loss of enzymic activity (Figure 5.10). The enzyme was inactivated to 12.5% 
remaining activity and extrapolation of the line of best fit to total inactivation gave a 
stoicheiometry of 1.27 moles of inhibitor bound per mole of enzyme i.e. a value 
approximating to a stoicheiometry of 1:1, indicating that the inhibitor reacts at a single site 
on the enzyme although some secondary sites are also reacting before all of the active 
sites are modified.
Page 138
100 o
80 -
O)
c  
c
'<u
£  60 -
<v1-
>
+■»
40 -
a
<
0
0.6 0.8 1.2 1.40.2 0.40 1.0
Mol label bound/mol subunit
Figure 5.10 Incorporation of D(—)-2-(b rom o[14C]acetyl)m andelate Into 
D(—)-mandelate dehydrogenase as a function of the residual enzymic activity
The inactivation mix (1125 pi) contained D(—)-mandelate dehydrogenase 
(1.3 mg, 30.4 pM), D(—)-2-(bromo[14C]acetyl)mandelate (1.4 mM) and acetonitrile 
(420 mM). Immediately after addition of the label, the inactivation mix was vortexed and a 
sample (5 pi) removed and diluted into 995 pi of 50 mM-Tris/HCI (pH 8.0). This was further 
diluted (250 pi into 750 pi of the same buffer) before samples (10 pi) were assayed for 
phenylglyoxylate reductase activity as in Methods 2.4.2 (c). At intervals throughout the 
3 h inactivation, 5 pi were removed, diluted and appropriate samples (10-100 pi) assayed 
for residual activity. The activity of the sample taken immediately after addition of the 
label was taken as the 100% value. Covalent incorporation of label was monitored by a 
filter disc method ( Q ) and gel filtration ( # )  as described in Methods 2.13.2.
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5.6 Identification and purification of active site labelled peptides
Before D(—)-mandelate dehydrogenase was inactivated for peptide purification, 
preliminary experiments were carried out to optimise peptide separation on reverse-phase 
HPLC. D(—)-Mandelate dehydrogenase peptides were separated initially with a gradient 
system of 100% A (0.1% TFA in water) to 100% B (0.1% TFA in acetonitrile) in 60 min, but 
in subsequent experiments this was modified to shallower gradients of 100% A to 70% B 
and later to 90% A to 50% B over the same time scale (Methods 2.15.2), which resulted In 
better separation, especially of the early eluting peptides, without significant loss of 
resolution. Recovery of radiolabel from the column was generally 70%-90% of the total 
counts loaded.
The location of the active site labelled peptides was determined by substrate 
protection experiments, where the peptide profiles and distribution of radiolabel from 
enzyme inactivated in the absence of D(—)-mande!ate were compared with those from 
enzyme inactivated in the presence of D(—)-mandelate. As D(—)-mandelate protects the 
enzyme from inactivation by D(—)-2-(bromoacetyl)mandelate (Section 5.4), incorporation 
of radiolabel into the active site peptides should be reduced in the presence of the 
substrate. Two samples of D(—)-mandelate dehydrogenase (500 /ig, 13.2 nmol) were 
inactivated with D(—)-2-(bromo[14C]acetyl)mandelate, one in the absence of substrate 
and the other in the presence of substrate [Methods 2.13.3 (a,b)]. After incubation for 4 h 
at 27°C the unprotected sample had lost 76% of its original activity, whilst the protected 
sample had lost only 27%. After gel filtration, NaOH treatment and trypsin digestion 
[Methods 2.13.3 (d) & 2.15.1] the peptides were separated by reverse-phase HPLC 
(system I, Methods 2.15.2) and the location of radiolabel determined by scintillation 
counting (Methods 2.2.8). Comparison of the HPLC chromatographs (Figure 5.11) shows 
that for an equal loading of protein, incorporation of radiolabel into tryptic peptides 1 
(TP 1) and 2 (TP 2) was clearly reduced in the presence of the substrate. Once the 
location of the labelled active site peptides had been determined, the enzyme was 
inactivated on a larger scale for peptide purification and sequencing. Initially, 2.8 mg 
(73.7 nmol) of D(—)-mandelate dehydrogenase was inactivated, but there was only 
sufficient material to purify enough TP 1 for a single sequencing run. TP 2 could not be 
purified, not only because of lack of material but also because the resolution of the 
column (column 1) had deteriorated after extensive use. Therefore, a new column 
(column 2) was used and a fresh batch of enzyme purified for inactivation.
D(—)-Mandelate dehydrogenase (5 mg, 132 nmol) was inactivated to 15% 
remaining activity with D(—)-2-(bromo[14C]acetyl)mandelate [Methods 2.13.3 (c)] and, 
after gel filtration, NaOH treatment and trypsin digestion [Methods 2.13.3 (d) & 2.15.1], the 
peptides were separated on reverse-phase HPLC (System I, Methods 2.15.2). Prior to 
large scale injection, a small sample was run on column 2  to check that the radiolabelled 
peptides eluted at the same relative positions in the profile as they did from column 1, 
which had been used to identify their location. Figure 5.12 shows the HPLC 
chromatograph of this sample, and comparison with the elution profiles given in
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Figure 5.11 (column 1) clearly shows that the resolution of the new column was better, 
and although the absolute positions at which TP 1 and TP 2 eluted were slightly different 
from that of the first column, their relative positions in the profile remained essentially 
unchanged. After preparative injection (13.2 nmol) of D(—)-mandelate dehydrogenase 
peptides, the peaks corresponding to TP 1 and TP 2 were collected manually and, in 
addition, a third peptide (TP 3) was also collected for sequencing (Figure 5.12). TP 3 was 
the last to elute from the column, suggesting that it was hydrophobic in nature, and was 
sufficiently separated from neighbouring peptides that further purification was 
unnecessary. The pooled fractions from system I containing TP 1 were lyophilized, 
resuspended in water and the peptides separated using solvent system II 
(Methods 2.15.2, Figure 5.13). The peak corresponding to radiolabel was collected 
manually and, after multiple injections, the fractions were pooled and lyophilized. Pure TP 
1 was resuspended in water and desalted using solvent system I modified from 60 min to 
25 min (Methods 2.15.2, Figure 5.14), and again, after multiple injections, the pooled 
fractions were finally lyophilized for sequencing.
When attempts were made to purify TP 2 further using system II, it co-eluted with a 
number of other peptides and even modified gradients failed to separate it from the 
contaminants. Better separation was achieved when TP 2 was eluted using system III 
(Methods 2.15.2). However, unlike TP 1 it could not be purified to homogeneity even 
though a number of modified gradients were again tested. The best separation achieved 
is shown in Figure 5.15 and although the counts were spread, making it impossible to 
assign the radiolabel to any one peptide, fractions 8 and 9 were pooled and lyophilized. 
The pooled fractions from system III containing TP 2 were then resuspended in water and 
desalted with a shallow system I gradient (70% A to 60% B in 30 min, Methods 2.15.2), 
which resulted in the co-elution of two peptides as indicated by a distinctive shoulder to 
the main peak (Figure 5.16).
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Figure 5.11 Reverse-phase HPLC chromatographs of tryptic digests of 
D(—)-mandelate dehydrogenase inactivated in the absence and presence of 
D(—)-mandelate (column 1)
Tryptic peptides (5.2 nmol) were prepared as in Methods 2.13.3 (d) and 2.15.1 from 
enzyme inactivated with D(—)-2-(bromo[14C]acetyl)mande!ate in (a) the absence and (b) 
the presence of D(—)-mandelate [Methods 2.13.3 (a) & (b) respectively]. The peptides 
were then separated by reverse-phase HPLC with an acetonitrile gradient of 90% A 
(0.1% TFA in water) to 50% B (0.1% TFA in acetonitrile) in 60 min. Fractions (1 ml) were 
collected and the location of radiolabel was determined by scintillation counting as 
described in Methods 2.2.8.
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Figure 5.12 Reverse-phase HPLC chromatograph of a tryptic digest of Inactivated 
D(—)-mandelate dehydrogenase (column 2)
Tryptic peptides (2.5 nmol) prepared as in Methods 2.13.3 (d) and 2.15.1 from enzyme 
inactivated with D(—)-2-(bromo[14C]acetyl)mandelate [Methods 2.13.3 (c)], were 
separated by reverse-phase HPLC with an acetonitrile gradient of 90% A 
(0.1% TFA in water) to 50% B (0.1% TFA in acetonitrile) in 60 min. The location of 
radiolabel was determined by scintillation counting (Methods 2.2.8). During large scale 
injection (13.2 nmol), the peaks corresponding to TP 1, TP 2 and TP 3 were collected 
manually.
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Figure 5.13 Purification of TP 1 by reverse-phase HPLC (column 2)
The pooled fractions from system I containing TP 1 were lyophilized, resuspended in 
water and the peptides separated with an acetonitrile gradient of 90% A 
[1 mM-sodium phosphate (pH 7.4)] to 40% B (acetonitrile) in 20 min.
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Figure 5.14 Desalting TP 1 by reverse-phase HPLC (column 2)
Fractions from system II containing pure TP 1 were lyophilized, resuspended in water and 
desalted with an acetonitrile gradient of 90% A (0.1% TFA in water) to 50% B 
(0.1% TFA in acetonitrile) in 25 min.
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Figure 5.15 Partial purification of TP 2 by reverse-phase HPLC (column 2)
The pooled fractions from system I containing TP 2 were lyophilized, resuspended in 
water and the peptides separated with an acetonitrile gradient of 80% A 
[0.05% ammonium acetate (pH 6.0)] to 50% B (acetonitrile) in 30 min.
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Figure 5.16 Desalting TP 2 by reverse-phase HPLC (column 2)
Fractions from system III containing partially pure TP 2 were lyophilized, resuspended in 
water and desalted with an acetonitrile gradient of 70% A (0.1% TFA in water) to 60% B 
(0.1% TFA in acetonitrile) in 30 min.
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5.7 Peptide sequencing
The amino acid composition and sequence of TP 1 were first determined at the 
Department of Biochemistry, University of Dundee. The amino acid composition 
(Methods 2.15.4) indicated that TP 1 was composed of 7 different types of amino acid : 
Glx, Gly, Val, lie, Leu, Lys and an unidentified acidic residue. The sequence of TP 1 
(Table 5.1) confirmed the amino acid composition and, moreover, showed that the Glx 
identified by amino acid analysis was in fact a glutamate. The peptide was found to be 
7 residues in length although the second residue, presumably the modified amino acid, 
could not be identified. Although sufficient peptide was supplied for sequencing and 
detection of radiolabel (2 nmol, 4000 cpm) no counts above the background level were 
detected in any of the fractions eluting from the sequencer.
A larger sample of TP 1 (4 nmol, 8000 cpm), along with TP 2 (approx. 1 nmol, 
1250 cpm) and TP 3 (approx. 100 nmol) were then sequenced at the SERC Sequencing 
Unit, Department of Biochemistry, University of Leeds. In an attempt to identify the 
position of the modified/radiolabelled residue in TP 1, the peptide was sequenced using 
solid-phase and liquid-pulse sequencing (Methods 2.15.6 and 2.15.7). The sequences 
and recovery of radiolabel are given in Table 5.2. The unidentified residue at position 2 
eluted from the column between the standards aspartic acid and
S-carboxymethylcysteine, confirming its acidic nature, but also indicating that the single 
cysteine residue identified by amino acid analysis (Section 4.2.2) is not modified by 
D(—)-2-(bromoacetyl)mandeIate. In addition to the unknown residue at position 2, 
solid-phase sequencing could neither identify the amino terminal residue nor the lysine at 
position 7 as they remained bound to the support matrix after the degradation cycle, via 
their a-amino and e-amino groups respectively. The radiolabel eluted with the unidentified 
residue at position 2 although the counts were too low to be more than indicative of this 
residue being labelled. However, more significant counts were detected using the 
liquid-pulse sequencer, and although there was a spread of radiolabel in several fractions, 
it did not begin to elute until the second residue had been cleaved. In the light of both 
these results it seems likely that the radiolabel has been incorporated into the residue at 
position 2 although its identity remains unknown. The sequence of TP 1 purified with 
column 1 was also determined and proved identical to the sequence of TP 1 purified with 
column 2 .
The sequence of TP 2 was also determined using the liquid-pulse sequencer, but 
unfortunately no radiolabel was detected presumably because the total number of counts 
was insufficient. As expected from the purification, the sample contained two peptides, 
indicated by two initial sequences later decaying to a single sequence (Table 5.3). The 
longer peptide was 14 residues in length, whilst the shorter one was only 4 residues long 
and they presumably represented the main peak and shoulder respectively of Figure 5.16. 
All of the residues were identified except for residue 7 of the longer peptide which
Page 148
presumably is the site of modification. Although the sequence of the tetrapeptide and the 
first 4 residues of the 14 residue peptide cannot be determined, residues 5 to 14 of the 
longer peptide represent additional sequence to that already determined.
The sequence of the 20 residue TP 3 was also determined (Table 5.4), and its 
hydrophobic nature indicated by its late elution from the reverse-phase column was 
confirmed as it contained a high proportion of hydrophobic residues such as alanine, 
leucine, phenylalanine, tryptophan and valine with a notably hydrophobic amino terminal 
half.
The tryptic peptide sequences were compared with the protein sequences in the 
University of Leeds OWL Composite Database (Release 6.0) (See Section 4.2.3). 
Although TP 1 and TP 2 (residues 5-14) were too short for a full database search, the TP 3 
sequence was analysed but no significant homology with other proteins was apparent. 
Manual scanning of the TP 1 and TP 2 sequences did not produce any significant 
homology, even when the sequences were aligned with the active site regions of 
8 homologous lactate and malate dehydrogenases, 10 residues either side of their 
catalytic histidines (Birktoft et al., 1982), or with the sequence around the presumed active 
site histidine of cucumber NADH-dependent hydroxypyruvate reductase, E  coli 
D-3-phosphoglycerate dehydrogenase and the E  coli pdxB gene product; three proteins 
which have been proposed to form a family of 2-hydroxyacid dehydrogenases distinct 
from the lactate and malate dehydrogenase family (Grant, 1989). Furthermore, none of 
the tryptic peptides contained any known structural motifs as judged by comparison with 
a suite of structural motif matrices.
However, when the TP 1 sequence was aligned against the sequence of P. putida 
L(+)-mandelate dehydrogenase and mandelate racemase, a match of 4 out of the 7 
residues was detected at the carboxy termini of both bacterial enzymes:
P. putida L(+)-mandelate dehydrogenase T380 A P V D H L I G K
R. graminis D(—)-mandelate dehydrogenase V XL E I G K
P. putida mandelate racemase I ^ W R E K E I G K
G T H A393-COO“
|Y l  V359-COO—
Finally, none of the tryptic peptide sequences was found within the amino terminal 
sequence of this enzyme (Section 4.2.3), and therefore the sequence of 94 residues, 
representing 27% of the polypeptide, has so far been determined.
Table 5.1 Amino acid sequence of TP 1
The sequence was determined by Dr D. Campbell, Department of Biochemistry, University 
of Dundee using an Applied Biosystems 470 A/120 A gas-phase sequencer equipped with 
on-line PTH-analysis. Approximately 0.2 nmole of pure peptide (400 cpm) was 
sequenced, and the PTH-amino acid identified at each cycle is given, along with the 
amount recovered in pmoles.
Cycle PTH-amino acid pmole
1 Val 53
2 Unk —
3 Leu 65
4 Giu 24
5 lie 64
6 Gly 24
7 Lys 64
Unk - Residue unknown
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Table 5.2 Recovery of radiolabel and amino acid sequence of TP 1
The sequence was determined by Dr J. Keen at the SERC Sequencing Unit, Department 
of Biochemistry, University of Leeds using a solid-phase sequencer [Methods 2.15.6 (b)] 
and an Applied Biosystems 477-A liquid-pulse sequencer equipped with on-line 
PTH-analysis and scintillation counting. Approximately 0.2 nmole of peptide (400 cpm) 
was sequenced using the solid-phase sequencer, and approximately 1 nmole (2000 cpm) 
was sequenced using the liquid-pulse sequencer. The PTH-amino acid identified at each 
cycle is given, along with the amount recovered in pmoles.
Solid-phase sequencing
Cycle PTH-amino acid pmole cpm above background
1 Unk — 0
2 Unk — 40
3 Leu 85 0
4 Giu 69 0
5 lie 61 0
6 Gly 59 0
Liquid-pulse sequencing
Cycle PTH-amino acid pmole cpm above background
1 Val 1060 0
2 Unk — 105
3 Leu 925 94
4 Giu 575 114
5 He 767 131
6 Gly 723 41
7 Lys 496 0
Unk - Residue unkown
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Table 5.3 Amino acid sequence of partially pure TP 2
The sequence was determined by Dr J. Keen at the SERC Sequencing Unit, Department 
of Biochemistry, University of Leeds using an Applied Biosystems 477-A liquid-pulse 
sequencer equipped with on-line PTH-analysis. The PTH-amino acid identified at each 
cycle is given along with the amount recovered in pmoles.
Cycle PTH-amino acid pmole PTH-amino acid pmoie
1 Leu 20 Gly 12
2 Val 36 Ala 15
3 Val 48 Thr 20
4 Leu 49 Giu 10
5 Thr 30
6 Thr 29
7 Unk —
8 lie 29
9 Gly 29
10 Gly 36
11 Val 23
12 Ala 26
13 lie 17
14 Giu? 13
Unk - Residue unknown. ? Identification tentative
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Table 5.4 Amino acid sequence of TP 3
The sequence was determined by Dr J. Keen at the SERC Sequencing Unit, Department 
of Biochemistry, University of Leeds using an Applied Biosystems 477-A liquid-pulse 
sequencer equipped with on-line PTH-analysis. Approximately 1 nmole of peptide was 
sequenced, and the PTH-amino acid identified at each cycle is given, along with the 
amount recovered in pmoies.
Cycle PTH-amino acid pmole
1 Val 490
2 Phe 686
3 Ala 677
4 Ala 720
5 Ala 556
6 Gly 449
7 Ala 400
8 Gly 377
9 Phe 427
10 Asp 116
11 Trp 82
12 Leu 382
13 Asp 106
14 Leu 426
15 Asp 141
16 Ala 255
17 Leu 229
18 Asn 115
19 Glu 59
20 Arg 25
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5.8 Analysis of modified amino acids by thin-layer electrophoresis
As sequence analysis had failed to determine the identity of the modified amino acid(s), 
thin-layer electrophoresis was used as a potential means of identification. 
D(—)-Mandelate dehydrogenase inactivated with D(—)-2-(bromo[14C]acetyl)mandelate 
was acid hydrolysed for 24 h [Methods 2.15.3 (b)], a procedure which converts 
a-(halo ester)-modified amino acids to their carboxymethylated derivatives 
(Adamson et a/., 1984). After lyophilization, the hydrolysate was electrophoresed on 
thin-layer silica plates (Methods 2.15.5), and a typical plate is shown in Figure 5.17. 
Although more than one type of amino acid had been modified, as indicated by the 
presence of radiolabel in several fractions, the major peak co-migrated with the standard 
/^-(carboxymethyl) histidine. This result suggests, but does not prove, that a histidine 
residue at the active site of D(—)-mandelate dehydrogenase might be the principal 
residue with which D(—)-2-(bromoacetyl)mandelate reacts.
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Figure 5.17 Thin-layer electrophoresis of an acid hydrolysate of D(—)-mandelate 
dehydrogenase inactivated with D(—)-2-(bromo[14C]acetyl)mandelate
D (— )-M an d e la te  dehydrogenase (800 fig, 21 nmol) inactivated  with 
D(—)-2-(bromo[14C]acetyl)mandelate was acid hydrolysed for 24 h [Methods 2.15.3 (b)], 
lyophilized and a 4 nmol sample (5000 cpm) spotted onto a thin-layer silica plate along 
with neutral, basic and carboxymethylated amino acid standards. The plate was 
electrophoresed, dried, washed and the amino acids visualised as described in Methods 
2.15.5. The plate was autoradiographed for 7 days (Methods 2 .2 .8), and then the lane 
containing the enzyme hydrolysate cut into 40 x 0.5 cm strips and each strip counted 
(Methods 2 .2 .8). The shaded area represents the most radioactive portion of the plate as 
determined by autoradiography.
Lane 1 ,1 0  nmol arginine; lanes 2 & 5, 100 nmol mixture of (from right to left) histidine, 
A/ 1 - ( c a r b o x y m e t h y l )  h i s t i d i n e ,  A/3 - ( c a r b o x y m e t h y l )  h i s t i d i n e ,  
A/1,A/3-(dicarboxymethyl)histidine; lane 3, 10 nmol S-carboxymethylcysteine; 
lane 4, 4 nmol D(—)-mandelate dehydrogenase hydrolysate; lane 6 , 10 nmol histidine; 
lane 7,13 nmol glycine.
Page 155
5.9 Discussion
As described in Section 5.1, for a compound to be considered as an affinity label or 
active-site-directed inhibitor it must satisfy the following criteria (Meloche, 1967) : 
It should inhibit the enzyme completely and irreversibly, the inactivation should show rate 
saturation, the inactivation should be prevented by the substrate or by reversible inhibitors 
of the enzyme, and the binding of the inhibitor should be stoicheiometric. 
D(—)-2-(Bromoacetyl)mandelate satisfies all these criteria in its action upon 
D(—)-mandelate dehydrogenase from R. graminis, and it can therefore be classified as an 
affinity label of this enzyme.
The affinity of the enzyme for the inhibitor was clearly demonstrated by the 
protection afforded by D(—)-mandelate. A comparison of the apparent Km for 
D(—)-mandelate at pH 8.0 (372 pM, Section 4.4.2) with the dissociation constant, K j, for 
D(—)-2-(bromoacetyl)mandelate at the same pH (2.4 mM, Section 5.4) shows that 
although the enzyme binds the substrate more tightly, its affinity for the inhibitor is not 
too dissimilar, especially when considering that D(—)-2-(bromoacetyl)mande!ate is 
notably larger than the natural substrate. Indeed, the relative stereochemistry of the 
affinity label, rather than its size, seems to be a more important determinant for binding, as 
the K. for D(—)-2-(bromoacetyl)mandelate (2.4 mM) is lower than that of L(+)-mande!ate 
(8.2 mM, Section 4.3.6), which has exactly the same functional groups as D(—)-mandelate 
but is of opposite configuration.
The importance of the groups for which the enzyme shows affinity, in orientating 
the bromoacetyl moeity for alkylation, is supported by the observation that the 
non-specific alkylating reagents, iodoacetic acid and iodoacetamide do not inhibit the 
enzyme (Section 4.3.8), and although they possess a similar electrophilic group to 
D(—)-2-(bromoacetyl)mandelate they presumably lack the structural features necessary 
for specific association at the mandelate binding site. This enhanced reactivity or 
•facilitation" (Plapp, 1982) is a common feature of affinity labels, and often a simple 
reagent possessing the reactive group but which lacks the affinity group(s) is either not 
inhibitory or is a much less potent inhibitor. For example, the importance of the 
carboxylate and phenyl groups of the affinity label a-phenylglycidate was demonstrated 
by the lack of inhibition or poorer inhibition of mandelate racemase by a series of related 
epoxide compounds. Glycidate, bearing a carboxylate group but no aromatic ring was 
not inhibitory whilst styrene oxide, bearing an aromatic ring but no carboxylate group was 
only partially inhibitory. However, frans-^-phenylglycidate and a-phenylglycidate which 
possess both carboxylate and phenyl groups showed marked inhibition. When 
mandelate racemase (0.5 mM) was incubated at 30°C in the presence of 3 mM-inhibitor, 
25% of the original activity remained after 1 h with frans-^-phenylglycidate but in the 
presence of the same concentration of a-phenylglycidate the enzyme was completely 
inactive after only 30 min (Fee et al., 1974b; Kenyon & Hegeman, 1977). Similarly, the 
affinity label 3-(bromoacetyI)chloramphenicol is a much more potent inhibitor of the E. coli
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type Hi chloramphenicol acetyltransferase than is iodoacetamide, resulting in an 
enhancement of the apparent bimolecular rate constant to 6 orders of magnitude greater 
than with the non-specific reagent (Kleanthous etal., 1985).
In all of the inactivation experiments reported in this chapter, D(—)-mandelate 
dehydrogenase was inactivated with D(—)-2-(bromoacetyl)mandelate in the absence of 
added NAD(H). This alone, suggests that the enzyme can bind its aromatic substrate in 
the absence of the cofactor, and therefore may use a different reaction mechanism to that 
of other NAD+-dependent dehydrogenases such as lactate and malate dehydrogenase 
which obey ordered mechanisms with the cofactor binding first (Banaszak & Bradshaw, 
1975; Holbrook et al., 1975). However, as the last step in the purification of the enzyme 
involved elution from Matrex Gel Orange A with NADH, it is likely that the preparation of 
enzyme used for inactivation contained small amounts of the cofactor and thereby allowed 
the affinity label to bind. A similar phenomenon has been observed with the inactivation of 
E. coli isocitrate dehydrogenase with phenylglyoxal. The enzyme is protected against 
inactivation by NADP+ or isocitrate, even though the reaction the enzyme catalyses is 
known to obey an ordered mechanism with the cofactor binding first (Nimmo, 1986; 
McKee, 1989). This anomaly has been explained by the presence of small amounts of 
cofactor in the preparation after NADP+-eiution from the final column during purification 
(Nimmo & Craig, 1989), and this was later confirmed when the enzyme, derived from a 
recombinant over-expressing strain and purified without the use of cofactor elution, was 
found to be no longer protected by isocitrate (McKee, 1989).
Substrate protection experiments in which D(—)-mandelate dehydrogenase was 
inactivated with D(—)-2-(bromo[14C]acetyl)mandelate in the absence and presence of 
substrate, indicated that radiolabel was incorporated into two active site peptides. 
However, comparison of the TP 1 and TP 2 sequences shows that neither sequence is 
found within the other, indicating that two different regions at or near the active site have 
been modified. If one was a partial cleavage product of the other from trypsin digestion, a 
stretch of homology would be detected. As the enzyme is inactivated by 
D(—)-2-(bromo[14C]acetyl)mandelate with a stoicheiometry of 1.27 moles of label bound 
per mole of subunit, the possibility exists that the minor contaminant also modifies the 
enzyme and may therefore be responsible for the incorporation of radiolabel at a second 
site. On the other hand, the dual labelling might be accounted for by 
D(—)-2-(bromo[14C]acetyl)mandelate modifying both TP 1 and TP 2, either by the enzyme 
being able to bind the inhibitor in more than one orientation, thereby pointing the 
bromoacetyl side chain towards different reactive groups or, alternatively, it might bind the 
inhibitor in a single orientation but the flexibility of the bromoacetyl group [which can move 
up to several angstroms (Plapp, 1982)] and/or polypeptide chain, may put the reactive 
group within the reach of more than one amino acid side chain. Indeed, such a labelling 
pattern has been observed for the inactivation of pig kidney D-amino acid oxidase 
modified with 1-fluoro-2,4-dinitrobenzene. Peptide analysis of enzyme labelled with this 
reagent indicated that two active site residues, tyrosine-55 and lysine-204 found on
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different peptides, were modified and although both modifications contributed to the 
overall loss of enzymic activity, the residues were labelled in a mutually exclusive manner 
(Swenson et al., 1981). However, further work, especially inactivation of the enzyme with 
homogeneous inhibitor, is required to determine whether the labelling of two regions at or 
near the active site of D(—)-mandelate dehydrogenase is due to either labelling by the 
contaminant or dual labelling by D(—)-2-(bromo[14C]acetyl)mandelate.
The detection of sequence similarity between TP 1 and residues at the carboxy 
termini of the P. putida mandelate racemase and L(+)-mande!ate dehydrogenase 
(Section 5.7), raises the possibility that the yeast and bacterial enzymes may share other 
limited sequence similarity, as suggested by comparison of their amino acid compositions 
(Section 4.5.1). As TP 1 represents sequence at or near the active site of the R. graminis 
D(—)-mandelate dehydrogenase the residues might be involved in binding the substrate 
or promoting the necessary active site conformation and, moreover, as both mandelate 
racemase and L(+)-mandelate dehydrogenase also bind mandelate, the similar bacterial 
sequences could possibly represent residues which act in an analogous manner. 
Although crystal structures are not available for either of the mandelate dehydrogenases, 
the mandelate racemase crystal structure has recently been determined (G. A. Petsko, 
personal communication), and it will be of interest to see whether the carboxy terminal 
sequence of this enzyme forms part of the active site. Therefore, although the three 
enzymes are quite distinct proteins; a soluble, NAD+-dependent dehydrogenase, a 
membrane-bound, flavin-dependent dehydrogenase and a metal-dependent racemase, 
which lack homology at their amino termini (Section 4.2.3) they may nevertheless share 
some limited sequence similarity dependent upon their common ability to bind mandelate 
i.e. they may have evolved common structure by a process of convergent evolution.
The inability to detect S-carboxymethylcysteine by amino acid analysis, peptide 
sequencing or electrophoresis of the modified amino acids, coupled with the marked 
insensitivity of the enzyme to a range of thiol reagents (Section 4.3.8) seems to rule out a 
direct role for the cysteine side chain in the catalytic mechanism of D(—)-mandeiate 
dehydrogenase. Of the other likely nucleophiles that could participate in abstracting a 
proton from the hydroxyl group of D(—)-mandelate, histidine is an attractive candidate as 
the main peak of radiolabel, from a hydrolysate of inactivated enzyme, co-migrated with 
A/3-(carboxymethyl)histidine. Furthermore, other NAD+-dependent 2-hydroxyacid 
dehydrogenases such as lactate and malate dehydrogenase are known to have an active 
site histidine residue which acts as an acid/base catalyst and, as part of a 
histidine-aspartate couple, participates in proton abstraction (Birktoft & Banaszak, 1983; 
Roderick & Banaszak, 1986; Clarke et al., 1988). However, the lack of confirmatory 
evidence to support the identification of the modified residue as a histidine leaves this a 
matter for further investigation. The identity of the unknown residues of TP 1 and TP 2 will, 
ultimately, be determined by comparison of the peptide sequences with the complete 
amino acid sequence of D(—)-mandelate dehydrogenase.
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CHAPTER 6
MANDELATE-UTILISING MICROORGANISMS AND IMMUNOLOGICAL 
RELATIONSHIPS AMONGST MANDELATE DEHYDROGENASES
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6.1 Introduction
(a) Utilisation of mandelate by yeasts
Before the present study the only yeast to have been positively identified as being able to 
grow on D(—)- or L(+)-mandelate as its sole source of carbon and energy was 
Rhodotorula graminis strain KGX 39 (Durham et al., 1984), although an unidentified yeast, 
isolated by selective enrichment, had also been reported to grow on L(+)-mandelate 
(Hegeman et al., 1970). The ability of a number of yeasts and yeast-like fungi to utilise 
various aromatic compounds as their sole source of carbon had been the focus of several 
previous studies. However, they concentrated mainly on the metabolism of 
monophenolic compounds such as benzoate, catechol, phenol, and protocatechuate, 
and those compounds related to lignin and humic acid breakdown such as 
4-hydroxybenzoate, coumarate, ferulate, syringaldehyde, vanillin and vanillate 
(Henderson, 1961a,b; Harris & Ricketts, 1962; Cain et al., 1968; Mills ef al., 1971).
As mandelate had not previously been used as a test substrate, a limited survey 
was made of a number of yeasts from culture collections in order to determine whether 
other species were capable of growth on D,L-mandelate. In addition, attempts were made 
to isolate mandelate-utiiising yeasts by selective enrichment from natural environments. 
Samples of plant origin, presumably rich in aromatic compounds, were used as the 
starting material for enrichment and included garden compost, silage, soil, rotting leaves 
and humus as well as the faeces from various herbivorous animals including cattle, deer, 
horse, rabbit, and sheep. These were inoculated into a selective medium in which 
D,L-mandelate was the only source of carbon, and once organisms had been identified as 
being able to grow on mandelate, crude extracts were prepared and assayed for 
mandelate dehydrogenase activity.
(b) Immunological comparison of mandelate dehydrogenases
In the absence of sequence data for the mandelate dehydrogenases of A  calcoaceticus 
and L. curvatus as well as the D(—)-2-hydroxyisocaproate dehydrogenase of S. faecalis, 
immunological techniques can be used as an indirect, but nevertheless reasonably 
reliable, method of indicating whether sequence homology exists between two or more 
proteins (Chalmers & Fewson, 1989b). An immunological comparison of the various 
mandelate dehydrogenases was therefore carried out using polyclonal antisera raised 
against two distinct forms of the enzyme; the soluble, NAD+-dependent D(—)-mandelate 
dehydrogenase from R. graminis KGX 39 and the membrane-bound, FAD-dependent 
D(—)-mandelate dehydrogenase from A  calcoaceticus C1123. By incubating antisera 
with crude extracts of A  calcoaceticus C1219 [constitutive for D(—)- and L(+)-mandelate 
dehydrogenase], R. graminis KGX 39, L. curvatus and S. faecalis containing mandelate 
dehydrogenase, in their native forms and after having been denatured on Western blots, it 
was possible to determine whether any immunological relationship existed between the 
two groups of enzyme. Both native and denatured enzymes were tested since the 
antisera were polyclonal, and may therefore have contained antibodies specific for both 
continuous epitopes i.e. antigenic determinants comprised of peptide segments from the
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linear amino acid sequence, and discontinuous epitopes i.e. antigenic determinants 
formed from segments distant in the primary structure but which are brought into close 
proximity by the folding of the polypeptide chain.
6.2 Enrichment and growth of mandelate-utilising yeasts
(a) Isolation of mandelate-utilising yeasts
In a preliminary experiment in which the chloramphenicol was omitted from the medium, 
the culture became rapidly overgrown with oval-shaped Gram negative bacteria, 
presumably species of Acinetobacter. Although microscopic observation of the culture 
showed that yeasts were growing and dividing, they were vastly outnumbered by the 
bacteria, and addition of chloramphenicol to inhibit bacterial growth proved essential for 
the isolation of yeasts.
Although 18 representative colonies were originally picked from the enrichment 
plates only 5 yeasts were subsequently found to grow on D,L-mande!ate as their sole 
source of carbon and energy. Two of these (DB 2, isolated from rabbit faeces, and DB 3, 
isolated from garden compost) were indistinguishable from each other and were pink, 
budding yeasts growing on solid medium as smooth, shining, circular, raised colonies. 
A third pink yeast (DB 11, isolated from sheep faeces) also grew on solid medium with a 
similar colony morphology although it was distinguishable from DB 2 and DB 3 by its 
darker colour. The other two isolates (DB 10, isolated from sheep faeces and DB 18, 
isolated from deer faeces) were both white/cream in colour and grew on solid medium as 
smooth, shining, circular, raised colonies although the former had a less shiny 
appearance.
(b) Growth of yeasts on D,L-mandelate
All those yeasts tested for their ability to grow on D,L-mandelate as the sole source of 
carbon and energy are given in Table 6.1. Of the 34 strains tested, which represented at 
least 28 species and 17 different genera, only 11 yeasts could grow on D,L-mandelate. Of 
these, 6 were bona fide strains of Rhodotorula and although the other 5 were of unknown 
identity, 3 of these (DB 2, DB 3 and DB 11) were pink in colour and presumably members 
of this genus.
Table 6.1 Growth of yeasts on D,L-mandelate as the sole source of carbon and 
energy.
Cells previously grown on Sabouraud-dextrose agar were inoculated into 50 ml of yeast 
nitrogen base/mandelate medium (in 250 ml conical flasks) prepared as described in 
Methods 2.3.3 (b). The cultures were shaken (200 rev. min"1) for 96 h at 23°C. 
Immediately after inoculation and at 24 h, 48 h, 72 h and 96 h, samples were aseptically 
removed and the ODgg5 determined as described in Methods 2.3.6.
Yeast 24 h
Growth after 
48 h 72 h
DB 2 
DB 3 
DB 10
+ + +
+ + +
+
+ + +
+ + + *
+ +
*
+ +
DB 11 + + + +
DB 18 + + + + +
Candida nitratophiia NCYC 556 — — —
C. pseudotropicalis NCPF 3234 — — —
C. tropicalis NCYC 1503 — — —
C. utilis NCYC 321 — — —
Debaromyces hansenii CBS 767 — — —
Endomycopsis capularis CBS 2519 — — —
Hanseniaspora valbyensis CBS 479 — — —
Hansenula anomala NCYC 432 — — —
Lodderomyces elongisporus NCYC 928 — — —
Pachysolen tannophilus NCYC 614 — — —
Pichia membranaefaciens CBS 107 — — —
Rhodosporidium toruloides NCYC 819 — — —
Rhodotorula glutinis NCYC 59 + + + + +
ft  graminis KGX 39 
f t  graminis NCYC 502
+ + *+ +
f t  graminis NCYC 980 + + *+
ft  graminis NCYC 1401 + + *+
f t  grinbergsii IJFM 6000 + + + +
ft  minuta NCYC 931 — — —
ft  nothofagii CCY 20-19-1 — — —
R. piliminae NCYC 759 — — —
ft  rubra NCYC 758 + + +
Saccharomyces bayanus CBS 380 — — —
Sporoboiomyces roseus NCYC 1609 — — —
Torulopsis colliculosa CBS 133 — — _
Trichosporon cutaneum CBS 2466 
Trigonopsis variabilis CBS 1040 
Wickerhamia fluorescens CBS 4565 
Wingia robertsii CBS 2934 
— no growth detected 
+  growth up to 5x the original OD595 
+ +  growth between 5x and 10x the original OD£ 
+ + +  growth above 10x the original ODgg5 
* no increase in O D ^  from the previous time point
595
6.3 Identification of mandelate dehydrogenase activities in yeast
The 11 yeasts identified as being able to grow on D,L-mandeIate were grown in yeast 
nitrogen base/mandelate medium, harvested and crude extracts prepared for assay. The 
extracts were not only assayed for the NAD+-dependent D(—)-mandelate dehydrogenase 
and dye-linked L(+)-mandelate dehydrogenase already established in R. graminis KGX 39 
(Durham, 1984), but also for NAD+-dependent L(+)-enantiomer specific activity, 
NADP+-dependent D(—)- and L(+)-enantiomer specific activities as well as for dye-linked 
D(—)-enantiomer specific activity, in some cases the nicotinamide nucleotide-dependent 
enzymes were also assayed for their phenylglyoxylate reductase activity i.e. the 
reverse/reduction reaction, especially where the oxidation reaction was low or 
undetectable.
Mandelate dehydrogenase activity could be demonstrated in only 7 of the 11 
yeasts which grew on D,L-mandelate as the sole source of carbon and energy. Those in 
which no activity could be measured were DB 10, DB 11 and DB 18 as well as 
R. rubra NCYC 758. All of the yeast extracts with mandelate dehydrogenase activity 
contained a dye-linked L(+)-mandelate dehydrogenase, and in R. glutinis NCYC 59 and 
R. grinbergsii IJFM 6000 this constituted the only activity detected (Table 6.2). 
NAD+-dependent D(—)-mandelate dehydrogenase activity was found in R. graminis 
KGX 39, NCYC 980, DB2 and DB3 and could be measured by the oxidation of 
D(—)-mandelate with NAD+, as well as by the reduction of phenylglyoxylate with NADH. 
However, in R. graminis NCYC 1401 only the reduction of phenylglyoxylate with NADH 
could be measured, presumably because of the low specific activity of the mandelate 
dehydrogenase which could be detected only using the more sensitive reverse assay 
(Section 4.3.1). In addition, a previously unreported NADPH-dependent phenylglyoxylate 
reductase activity was found in R. graminis NCYC 1401, DB2 and DB3 although it 
accounted for only 5.8%, 3.7% and 5.3% respectively of their NADH-dependent 
phenylglyoxylate reductase activities. As these enzymes were assayed in crude extract it 
is unclear whether this represents dual-specificity with respect to the cofactor used or 
whether it is an independent enzyme.
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Table 6.2  Mandelate dehydrogenase activities of Rhodotorula graminis KGX 39, 
NCYC 980 and NCYC 1401, f t  glutinis NCYC 59, f t  grinbergsii IJFM 6000, and yeasts 
DB 2 and DB 3
Cells previously grown on Sabouraud-dextrose agar [Methods 2.3.5 (a)], were inoculated 
into 2 x 400 ml volumes of yeast nitrogen base/mandelate medium [Methods 2.3.3 (b)], 
and grown as described in Methods 2.3.5 (a). The cultures were then harvested 
(Methods 2.3.7) and crude extracts prepared as in Methods 2.9.1, except that the high 
speed centrifugation was omitted. The extraction buffer also contained the following 
protease inhibitors; benzamidine (15.6 mg T1), leupeptin (0.5 mg I*1), pepstatin 
(0.68 mg I'1), and PMSF (35 mg I'1). The mandelate dehydrogenases were assayed as 
described in Methods 2.4.2 (b),(c) and 2.4.3. Values in parentheses represent the results 
from two independent experiments.
NAD+-dependent D(—)-mandelate dehydrogenase activity 
Yeast units (mg protein)*1
R. graminis KGX 39 0.44 (0.43, 0.44)
R. graminis NCYC 980 0.03 (0.03,0.03)
DB 2 0.20 (0.19,0.20)
DB 3 0.13 (0.12,0.14)
NADH-dependent phenylglyoxylate reductase activity 
Yeast units (mg protein) '1
R. graminis KGX 39 2.28 (2.12,2.43)
R. graminis NCYC 980 1.09 (1.08,1.09)
R. graminis NCYC 1401 0.17 (0.16, 0.17)
DB 2 1.09 (1.03,1.14)
DB 3 0.76 (0.69, 0.83)
NADPH-dependent phenylglyoxylate reductase activity 
Yeast units (mg protein)*1
R. graminis NCYC 1401 0.01 (0.01,0.01)
DB 2  0.04 (0.04, 0.04)
DB 3 0.04 (0.04,0.04)
dye-linked L(+)-mandelate dehydrogenase activity 
Yeast units (mg protein)*1
R. graminis KGX 39 0.08 (0.08, 0.08)
R. graminis NCYC 980 0.03 (0.03, 0.03)
R. graminis NCYC 1401 0.01 (0.01,0.009)
R. glutinis NCYC 59 0.07 (0.07, 0.07)
R. grinbergsii IJFM 6000 0.008 (0.007,0.009)
DB 2 0.03 (0.03, 0.03)
DB 3 0.03 (0.03, 0.03)
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6.4 Immunological cross-reactivity
6.4.1 Immuno-lnhlbltlon of activity
The ability of polyclonal antisera raised against the D(—-)-mandelate dehydrogenase of 
f t  graminis KGX 39 and the D(—)-mandelate dehydrogenase of A  calcoaceticus C1123 to 
inhibit the D(—)-mandelate dehydrogenase activity of A  calcoaceticus C1219, the D(—)- 
and L(+)-mandelate dehydrogenases of R. graminis KGX 39, the D(—)-mandelate 
dehydrogenase of L. cunratus and the D(—)-2-hydroxyisocaproate dehydrogenase of 
S. faecalis was investigated. The effect of the anti-A calcoaceticus D(—-)-mandelate 
dehydrogenase serum on the activity of the A  calcoaceticus L(+)-mandelate 
dehydrogenase was not tested as it had already been shown not to inhibit the enzyme 
(Fewson et al., 1988). The various yeast and bacterial crude extracts were incubated in 
the presence of antiserum or rabbit normal serum, and the remaining enzymic activities in 
the supernatants, before and after centrifugation, were determined (Table 6.3). Of the 
various combinations of enzymes and antisera tested, the only positive cross-reactions, as 
indicated by inhibition of activity, were between the antisera and their homologous 
antigens to which they were raised. However, some of the enzymes gave higher activities 
after incubation with the antisera e.g. the D(—)-mandelate dehydrogenases of 
A  calcoaceticus and L. curvatus and the D(—)-2-hydroxyisocaproate dehydrogenase of 
S. faecalis (Table 6.3), although a similar effect was produced when the A  calcoaceticus 
L(+)-m andelate dehydrogenase was incubated with anti-A. calcoaceticus 
D(—)-mandelate dehydrogenase serum (Fewson et al., 1988). This may therefore be a 
non-specific enhancement of activity dependent upon the protein concentration and, 
moreover, the S. faecalis D(—)-2-hydroxyisocaproate dehydrogenase is known to be 
stabilised in the presence of BSA (Yamazaki & Maeda, 1986).
Further inhibition studies were then carried out to determine if the 
D(—)-mandelate dehydrogenase of R. graminis KGX 39 was immunologically similar to 
any of the mandelate dehydrogenases identified in the other species of Rhodotorula and 
yeasts isolated from the wild. In a preliminary experiment, antiserum raised against the 
f t  graminis KGX 39 D(—-)-mandelate dehydrogenase (batch 253) inhibited the enzymic 
activity of its homologous antigen by 88%, and also inhibited the D(—)-mandelate 
dehydrogenases of f t  graminis NCYC 980, DB 2 and DB 3 by 80%, 77% and 75% 
respectively. However, as for strain KGX 39, there was no inhibition of the dye-linked 
L(+)-mandelate dehydrogenases of DB 2 and DB 3. The positive cross-reactions were 
then quantified by immuno-titration with batches 253 and 319 of the antisera, as well as 
with rabbit normal serum as a control (Figure 6.1 & 6.2). The strongest cross-reactions 
were observed between the antisera and the D(—)-mandelate dehydrogenase of 
f t  graminis KGX 39, the antigen to which it had been raised, although batch 253 had a 
higher titre than batch 319 as indicated by its ability to inhibit the enzyme at higher 
dilution. The patterns of inhibition of the f t  graminis NCYC 980, DB 2 and DB 3 enzymes
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were remarkably similar to each other, although the antisera showed less specificity 
towards them compared to the homologous cross-reactions, as indicated by the dilutions 
at which the enzymes were inhibited 50% :
DB 2 
DB3
R. graminis NCYC 980 
R. graminis KGX 39
50% inhibition of activity 
antiserum 253 antiserum 319 
1 :1 6 -1 :3 2  1 :3 2 -1 :6 4
1 :1 6 -1 :3 2  1 :1 6 -1 :3 2
1 :1 6 -1 :3 2  1: 8 -1 :1 6
1:256-1:512 1:64-1:128
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Table 6.3 Effect of antisera raised against the ft. graminis KGX 39 D(—)-mandelate 
dehydrogenase and A. calcoaceticus C1123 D(—)-mandelate dehydrogenase on the 
activities of the A. caicoaceticus C1219 D(—)-mandelate dehydrogenase, R. graminis 
KGX 39 D(—)- and L(+)-mandelate dehydrogenases, L  curvatus D(—)-mandelate 
dehydrogenase and S. faecalis D(—)-2-hydroxyisocaproate dehydrogenase 
Crude extract (100 /il) was mixed with antiserum or rabbit normal serum (100 //I) and the 
mixture stood on ice for 1 h. Remaining enzymic activity in the supernatant was then 
assayed before and after centrifugation as in Methods 2.11.2. Two samples of antisera, 
raised in separate rabbits against the R. graminis KGX 39 D(—)-mandelate 
dehydrogenase, as well as a single sample of antiserum raised against the 
A. calcoaceticus C1123 D(—)-mandelate dehydrogenase were used. Assays were done 
in duplicate and the mean value is given. The results are shown as the percentage of the 
enzymic rates obtained after incubation of the extracts with rabbit normal serum.
(a) anti-/?, graminis D(—)-mandelate dehydrogenase
Before centrifugation After centrifugation
batch 253 batch 319 batch 253 batch 319
A  calcoaceticus D(—)-MDH 100 110 110 107
/?. graminis D(—)-MDH 11 36 6 14
R. graminis L(+)-MDH 103 ND ND ND
L  curvatus D(—)-MDH 121 130 116 108
S. faecalis D(—)-2-HIDH 134 107 121 118
(b) anti-A calcoaceticus D(—)-mandelate dehydrogenase
A  calcoaceticus D(—)-MDH 
R. graminis D(—)-MDH 
L  curvatus D(—)-MDH 
S. faecalis D(—)-2-HIDH
Before centrifugation 
52 
99 
113 
109
After centrifugation 
51 
107 
113 
138
ND, not determined
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Figure 6.1 Immuno-tltratlon of the D(—)-mandelate dehydrogenases of R  graminis 
KGX 39 and NCYC 980
Crude extracts were prepared as in Methods 2.9.1, except that high-speed centrifugation 
was omitted. The KGX 39 extract was diluted with 50 mM-Tris/HCI (pH 8.0) to give the 
same activity ml'1 as the NCYC 980 extract. Serial dilutions of antisera and rabbit normal 
serum [from undiluted serum to 1 : 8192 in 50 mM-Tris/HCI (pH 8 .0)], were prepared and 
crude extract (200 /j|) at the various dilutions and sera (200 fi\), were mixed and stood on 
ice for 1 h. The remaining phenylglyoxylate reductase activity in the mixture was then 
assayed as in Methods 2.4.2 (c). Assays were carried out in duplicate and the results are 
expressed as the mean value as a percentage of the original 100% value.
(a) f t  graminis KGX 39 D(—)-mandelate dehydrogenase, (b) R. graminis NCYC 980 
D(—)-mandelate dehydrogenase. Antiserum batch 253 ( £  ), antiserum batch 319 ( O )
and rabbit normal serum ( A ) -
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Figure 6.2 Immuno-titration of the D(—)-mandelate dehydrogenases of yeasts DB 2 
and DB 3
Crude extracts were prepared as in Methods 2.9.1, except that high-speed centrifugation 
was omitted. Both extracts were diluted with 50 mM-Tris/HCI (pH 8.0) to give the same 
activity ml"1 as the f t  graminis NCYC 980 extract (the lowest activity of the 4 extracts 
shown in Figure 6.1 and 6.2). Serial dilutions of antisera and rabbit normal serum 
[from undiluted serum to 1 : 8192 in 50 mM-Tris/HCI (pH 8.0)], were prepared and crude 
extract (200 jj \) at the various dilutions and sera (200 /jI), were mixed and stood on ice for 
1 h. The remaining phenylglyoxylate reductase activity in the mixture was then assayed 
as in Methods 2.4.2 (c). Assays were carried out in duplicate and the results are 
expressed as the mean value as a percentage of the original 100% value.
(a) Yeast DB 2 D(—)-mandelate dehydrogenase, (b) yeast DB 3 D(—)-mandelate 
dehydrogenase. Antiserum batch 253 ( %) ,  antiserum batch 319 ( O ) and rabbit normal 
serum ( A ) -
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6.4.2 Immuno-blottlng (Western blotting)
Immuno-blotting was used to determine whether any of the mandelate dehydrogenases 
would cross-react with the antisera, after being bound to nitrocellulose in the presence of 
SDS. Crude extracts of A  calcoaceticus C1219, f t  graminis KGX 39, L. curvatus and 
S. faecalis were run on SDS-polyacrylamide gels and, after the proteins had been 
transferred to nitrocellulose, they were probed with the antiserum raised against the 
A  calcoaceticus C1123 D(—)-mandelate dehydrogenase as well as with antisera raised 
against the f t  graminis KGX 39 D(—)-mandelate dehydrogenase (batches 253 and 319). 
Typical blots of the various extracts probed with the anti-A calcoaceticus C1123 
D(—)-mandelate dehydrogenase serum and anti-ft graminis KGX 39 D(—)-mandelate 
dehydrogenase serum are shown in Figures 6.3 and 6.4 respectively. 
The anti-A calcoaceticus C1123 D(—)-mandelate dehydrogenase serum cross-reacted 
with several proteins in the A  calcoaceticus C1219 extract, although it reacted primarily 
with the D(—)-mandelate dehydrogenase band. However, it did not cross-react with the 
purified D(—)-mande!ate dehydrogenase from R. graminis KGX 39 or with any other 
proteins in the various extracts tested (Figure 6.3). Likewise, the anti-ft graminis KGX 39 
D(—)-mandelate dehydrogenase sera cross-reacted with the homologous antigen, in 
crude extract and purified form, and no other significant cross-reactions were evident 
(Figure 6.4). The blot shown in Figure 6.4 was probed with antiserum batch 253 although 
the same result was obtained when identical samples were probed with batch 319.
The positive cross-reactions between the anti-/?, graminis KGX 39 
D(—)-mandelate dehydrogenase sera and the native D(—)-mandelate dehydrogenases of 
f t  graminis NCYC 980 and yeasts DB 2 and DB 3 were also analysed by immuno-blotting. 
In addition to extracts of mandelate-grown cells, equal loadings of extracts of 
glucose-grown cells were run as controls, as artifactual labelling of yeast proteins on 
nitrocellulose using polyclonal antisera has been reported to be a more common problem 
than with other organisms (Lillie & Brown, 1987). Therefore, by staining extracts of both 
induced and non-induced ceils, any non-specific cross-reactions with proteins in the 
extracts of mandelate-grown cells should also be observed in the extracts of 
glucose-grown cells, with the exception of those with any other mandelate and 
/3-ketoadipate pathway enzymes which are also induced during growth on mandelate 
(Durham et al., 1984). Both batches of antisera cross-reacted with the homologous 
antigen in the purified form and in crude extract (Figure 6.5), confirming the pattern shown 
in Figure 6.4, lanes A & B. Moreover, the D(—)-mandelate dehydrogenase band in the 
crude extract (which had been prepared in the presence of protease inhibitors) 
co-migrated with the purified enzyme, indicating that detectable proteolytic cleavage had 
not occurred during the purification procedure (Sections 3.3-3.7). Both batches of 
antisera also cross-reacted with a single band of protein in the extracts prepared from 
mandelate-grown cells of yeasts DB 2 and DB 3, as did batch 253 with the extract of 
mandelate-grown ft  graminis NCYC 980 (Figure 6.5). However, batch 319 cross-reacted 
with two bands of protein in the extract of mandelate-grown R. graminis NCYC 980
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(Figure 6.5 (b), lane H), although the upper band was also stained in the extract of 
glucose-grown cells (Figure 6.5 (b), lane I). Comparison of the two staining patterns 
therefore enabled the lower of the two bands to be assigned as the specific cross-reaction 
and, moreover, it ran with the same relative mobility as the single band identified when the 
same extract was probed with batch 253 (Figure 6.5 (a), lane H). The strongest 
cross-reaction, as indicated by the intensity of staining for an equal loading of enzymic 
activity, was for the homologous antigen. The three other bands were less intense, but 
approximately equal with each other, and this is consistent with the inhibition patterns of 
the enzymes in their native forms (Section 6.4.1). The three single bands stained in the 
extracts of mandelate-grown DB 2, DB 3 and R. graminis NCYC 980 co-migrated on 
SDS-polyacrylamide gels, indicating a similar subunit size, although all three were slightly 
larger than the R. graminis KGX 39 D(—)-mandelate dehydrogenase subunit (Figure 6.5).
Staining of extracts prepared from giucose-grown ceils also allowed identification 
of the mandelate dehydrogenases in the non-induced cultures. Direct observation of the 
blots showed faint bands in the R. graminis KGX 39, DB 2 and DB 3 extracts (but not in the 
R. graminis NCYC 980 extract), which migrated at the same position as the more heavily 
stained bands in the extracts of mandelate-grown cells. Unfortunately, they were of 
insufficient intensity to be visible on the photographs shown in Figure 6.5.
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Figure 6.3 Immuno-blot of purified R. graminis KGX 39 D(—)-mandelate 
dehydrogenase and crude extracts of R. graminis KGX 39, L. curvatus, S. faecalis 
and A. calcoaceticus C1219, probed with antiserum raised against the 
D(—)-mandelate dehydrogenase from A  calcoaceticus C1123
Samples were electrophoresed in 12.5% (w/v) SDS-polyacrylamide gels as described in 
Methods 2.10.1. Proteins were then electroblotted onto nitrocellulose 
[Methods 2.11.3 (a)], and the blots developed as described in Methods 2.11.3 (b).
Lanes : A, 0.5 pg of purified R. g ram in is KGX 39 D(—)-mandelate dehydrogenase;
B, 20 pg of R. g ram in is KGX 39 crude extract; C, 50 pg of L. curvatus crude extract; 
D, 50 pg of S. faeca lis  crude extract; E, 50 pg of A. ca lco ace tic u s  C1219 crude extract.
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Figure 6.4 Immuno-blot of purified R. graminis KGX 39 D(—)-mandelate  
dehydrogenase and crude extracts of R. graminis KGX 39, L. curvatus, S. faecalis 
and A. calcoaceticus C1219, probed with antiserum raised against the 
D(—)-mandelate dehydrogenase from R. graminis KGX 39 (batch 253)
Samples were electrophoresed in 12.5% (w/v) SDS-polyacrylamide gels as described in 
Methods 2.10.1. Proteins were then electroblotted onto nitrocellulose 
[Methods 2.11.3 (a)] and the blots developed as described in Methods 2.11.3 (b).
Lanes : A, 0.5 pg of purified R. gram in is KGX 39 D(—)-mandelate dehydrogenase; 
B, 20 pg of R. gram in is  KGX 39 crude extract; C, 50 pg of L. curvatus crude extract; 
D, 50 pg of S. faeca lis  crude extract; E, 50 pg of A. c a lco ace tic u s  C1219 crude extract.
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Figure 6.5 Immuno-blots of purified R. graminis KGX 39 D(-—)-mandelate 
dehydrogenase and crude extracts of R. graminis KGX 39, NCYC 980 and yeasts 
DB 2 and DB 3, probed with antisera raised against the D(—)-mandelate 
dehydrogenase from R. graminis KGX 39
Crude extracts of glucose and mandelate-grown cells were prepared as in Methods 2.9.1, 
except that the high speed centrifiugation was omitted. The extraction buffer also 
contained the following protease inhibitors; benzamidine (15.6 mg F1), leupeptin 
(0.5 mg I'1), pepstatin (0.68 mg I"1), and PMSF (35 mg I"1). Extracts of mandelate-grown 
cells with equal enzymic activities, (0.05 pmol min'1), plus an equivalent amount of protein 
from extracts of glucose-grown cells were electrophoresed in 12.5% (w/v) 
SDS-polyacrylamide gels as in Methods 2.10.1. Proteins were then electroblotted onto 
nitrocellulose [Methods 2.11.3 (a)] and the blots developed as described in 
Methods 2.11.3 (b).
Lanes : A, 0.5 pg of purified R. graminis KGX 39 D(—)-mande!ate dehydrogenase; 
B, 21 pg of mandelate-grown R. graminis KGX 39 crude extract; C, 21 pg of 
glucose-grown R. graminis KGX 39 crude extract; D, 41 pg of mandelate-grown DB 2 
crude extract; E, 41 pg of glucose-grown DB 2 crude extract; F, 50 pg of mandelate-grown 
DB 3 crude extract; G, 50 pg of glucose-grown DB 3 crude extract; H, 50 pg of 
mandelate-grown R. graminis NCYC 980 crude extract; I, 50 pg of glucose-grown 
f t  graminis NCYC 980 crude extract.
(a) Probed with batch 253, (b) probed with batch 319.
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6.5 Discussion
Selective enrichment was successful in isolating several yeasts capable of growth on 
D.L-mandelate as their sole source of carbon and energy and, moreover, it was a quick 
and simple method of isolating organisms with the desired phenotype. In contrast, the 
identification and subsequent isolation of the D(—)-2-hydroxyisocaproate dehydrogenase 
from S. faecal is, an enzyme with marked D(—)-mandelate dehydrogenase activity, was 
based on screening crude extracts of 96 strains of bacteria and 93 strains of yeast and 
other fungi (Yamazaki & Maeda, 1986); a process which although successful, was 
nevertheless profligate of time, cost and effort.
Although the yeasts tested for their ability to grow on D,L-mandelate represented 
a number of genera, the experiment was not designed to include as comprehensive a 
range as possible. However, it is still noteworthy that nearly all of the isolates showing 
growth on mandelate were species of Rhodotorula, and this may therefore represent a 
common, although not universal, trait within the genus. Although R. graminis KGX 39, 
NCYC 980 and NCYC 1401 grew on D.L-mandelate, strain NCYC 502 did not, indicating 
that as with bacteria such as A  calcoaceticus and P. putida, the ability to grow on 
mandelate is a strain specific rather than a species specific property (Stanier et a/., 1966; 
Baumann et a/., 1968; Fewson, 1988b). Furthermore, not all of the strains of Rhodotorula 
possessed both D(—)-enantiomer specific and L(+)-enantiomer specific mandelate 
dehydrogenases (e.g. R. glutinis NCYC 59 and R. grinbergsii IJFM 6000), and presumably 
the faster growth rates and higher growth yields on D.L-mandelate of strains such as 
R. graminis KGX 39, DB 2 and DB 3, is reflected by the presence of both enzymes. 
The inability to detect mandelate dehydrogenase activity in R. rubra NCYC 758, DB 10, 
DB 11 and DB 18, even though they could grow on D.L-mandelate was presumably 
because the specific activities of the enzyme(s) were too low to be detected using the 
assays employed. Indeed, not all fungal mandelate dehydrogenases are as easy to assay 
as the enzymes of ft  graminis KGX 39. The D(—)- and L(+)-mandelate dehydrogenases 
of Aspergillus niger strain UBC 814 have specific activities in crude extract of 0.81 munits 
(mg protein)'1 and 0.45 munits (mg protein)'1 respectively (Jamaluddin et ai., 1970), 
values which are 540 and 180 times less than the specific activities of the analogous 
enzymes in f t  graminis KGX 39 (Table 6.2). Alternatively, the inability to detect mandelate 
dehydrogenase activity in these yeasts might indicate that oxidation by the appropriate 
dehydrogenase does not form the first step in the catabolism of mandelate in these 
organisms.
Although immunological studies have been used to demonstrate homology 
amongst analogous enzymes from different organisms, e.g. the protocatechuate 
3,4-dioxygenases of Azotobacter vinelandii, Pseudomonas aeruginosa and 
A  calcoaceticus, and the benzaldehyde and benzyl alcohol dehydrogenases of 
A  calcoaceticus and P. putida (Durham et al., 1980; Durham & Ornston, 1980;
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Chalmers et al., 1990b), no homology between the mandelate dehydrogenases of 
R. gram inis  KGX 39, A. calcoaceticus  C1219, L. curvatus and the 
D(—)-2-hydroxyisocaproate dehydrogenase of S. faecalis was demonstrated.
In a systematic study of a number of avian lysozymes, Prager & Wilson (1971a) 
demonstrated a linear relationship between the sequence homology of the proteins and 
their immunological cross-reactivity. It was predicted that cross-reactivity would not be 
detectable above 40% sequence difference and subsequent analysis of a diverse range of 
other proteins generally confirmed this (Prager & Wilson, 1971b). Therefore, it is unlikely 
that any of the mandelate dehydrogenases listed above have more than 40% sequence 
identity with each other, and it is probable that values much less than this exist for 
pairwise comparisons between any of the soluble and membrane-bound enzymes, 
especially in view of the marked differences in properties and intracellular location. 
Moreover, if either of the antisera contained antibodies specific for epitope(s) at the 
mandelate binding site of the enzyme to which it was raised, the inability to inhibit the 
activity of the heterologous antigens in their native form suggests that although these sites 
have a common function i.e. the binding of mandelate, they do not share structural 
similarity. However, as pointed out by Arnheim et al. (1971) the “lack of cross-reactivity 
between two antigens using antisera directed against native structures does not 
necessarily indicate insignificant amino acid sequence similarity nor disparate 
three-dimensional structures*. For example, antisera raised against the catabolic ornithine 
carbamoyltransferases of Aeromonas formicans and P. aeruginosa, cross-react strongly 
with the E  coli anabolic ornithine carbamoyltransferase (argf product), but only weakly or 
not at all with the other E  coli anabolic ornithine carbamoyltransferase (argrl product), yet 
the two isoenzymes show an overall identity of 86% at the amino acid sequence level 
(Van Vliet et al., 1984; Tricot et al., 1989). Similarly, antisera raised against human 
leukaemia and hen egg-white lysozymes do not cross-react with their reciprocal, 
heterologous antigens even though the enzymes show 60% amino acid sequence identity 
and their three-dimensional structures are very similar (Arnheim et al., 1971; Blake & 
Swann, 1971).
A method commonly used to overcome such anomalous behaviour is to denature 
the antigen prior to immunisation, by reduction and carboxymethylation of cysteine side 
chains, thereby exposing normally buried residues to the immune system of the animal in 
which the antiserum is raised. Although this technique has been successful in 
demonstrating heterologous cross-reactions which are not observed between antigens 
and antisera raised against their native forms (Arnheim et al., 1971), it is unlikely that 
reduction and carboxymethylation of the single cysteine residue of the R. graminis KGX 39 
D(—)-mandelate dehydrogenase would produce significant unfolding of the polypeptide, 
especially if it was located on the protein surface and exposed to solvent, rather than 
being buried. Indeed, proteins are often very tolerant of structural modification e.g. 
substitution of a number of alanine residues into the structure of human growth hormone 
resulted in mutant proteins in which the folding of the polypeptide chain was
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Indistinguishable from that of the wild-type hormone (Cunningham & Wells, 1989). 
Even though the various mandelate dehydrogenases were not probed with antisera raised 
against the denatured A  calcoaceticus C1123 and R. graminis KGX 39 D(—)-mandelate 
dehydrogenases, it is likely that both antisera contained antibodies specific for native and 
denatured forms, since they could inhibit the activity of their homologous antigens in 
solution and bind to them after denaturation with SDS, a phenomenon also observed with 
A  calcoaceticus and P. putida benzaldehyde and benzyl alcohol dehydrogenases probed 
with antisera raised against the native antigens (Chalmers etal., 1990b).
In contrast, the NAD+-dependent D(—)-mande!ate dehydrogenases of the yeasts 
f t  graminis KGX 39, NCYC 980, DB 2 and DB 3 are certainly related to each other, as 
indicated by the marked cross-reactions between the antisera and the heterologous 
antigens in both native and denatured forms (Figure 6.1, 6.2 & 6.5). Therefore, they are 
likely to have in excess of 60% sequence identity (Prager & Wilson, 1971b), although it is 
presumably less than 100% as the heterologous cross-reactions were noticeably weaker 
than the homologous ones. However, the dye-linked L(+)-mandelate dehydrogenases of 
these yeasts do not seem to be related immunologically to the NAD+-dependent 
D(—)-mandelate dehydrogenases as cross-reactivity was not observed.
These experiments also highlighted a common problem associated with probing 
antigens with polyclonal antisera; that is the visualisation of non-specific cross-reactivity, 
which is particularly prevalent when testing crude extracts. For example, the extract of 
mandelate-grown R. graminis NCYC 980 probed with two independent batches of 
antisera, raised in different rabbits, resulted in the staining of two bands with one 
antiserum (batch 319) but only one with the other (batch 253). In this case, however, the 
inclusion of extracts of non-induced, glucose-grown cells as controls enabled the 
specific-cross reaction to be assigned, but it is clear that if only one antiserum had been 
used or if the non-induced culture had been omitted, incorrect conclusions may have 
been drawn. Indeed, variations amongst antisera from different rabbits and between 
different bleeds from the same rabbit are fairly common. For example, Lillie & Brown 
(1987) reported that a rabbit injected with a purified yeast protein p55 (Mf 55 000), 
produced immune-serum that stained a number of faint bands on a Western blot of yeast 
high-speed supernatant in addition to the expected one of Mr 55 000, whereas the 
pre-immune serum from this rabbit only stained the 55 000 band even though the rabbit 
had not been injected with the antigen.
Identification of trace amounts of D(—)-mandelate dehydrogenase in extracts of 
glucose-grown cells of R. graminis KGX 39, DB 2 and DB 3 by Western blotting, indicates 
that the enzymes are synthesized in the absence of the inducer and under conditions of 
catabolite repression. This is also supported by the observation that the specific activities 
of these enzymes in extracts of glucose-grown cells, as a percentage of the level in 
extracts of mandelate-grown cells, are 1.3%, 0.7%, and 0.7% respectively. Therefore, 
although the levels of these enzymes are regulated by mechanisms of induction and 
repression (Section 3.1; Durham, 1984), neither process is absolute and there is
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presumably a continual but limited turnover of D(—)-mandelate dehydrogenase in these 
yeasts. If the inducer of D(—)-mandelate dehydrogenase is phenylglyoxylate, as is the 
case for the mandelate dehydrogenases of A  calcoaceticus and P. putida (Hegeman, 
1966b,c; Livingstone & Fewson, 1972), the enzyme would presumably be able to convert 
any D(—)-mandelate entering the cell into phenylglyoxylate and so induce the expression 
of more enzyme. However, as the identity of the inducer of D(—)-mandelate 
dehydrogenase in these yeasts is as yet unknown it is unclear as to whether the presence 
of the enzymes under non-induced conditions has any physiological significance. 
The ability to detect D(—)-mandelate dehydrogenase activity in glucose-grown cells of 
R. graminis KGX 39 seems to contradict the results obtained by Durham (1984) and 
Middleton (1988), in which no activity was detected. However, in both these cases 
enzymic activity was assayed by following the oxidation of D(—)-mandelate, as compared 
to the above results where the reduction of phenylglyoxylate was measured. This would 
then account for the apparent discrepancy, as the forward/oxidation assay is notably less 
sensitive than the reverse/reduction assay (Section 4.3.1).
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CHAPTER 7 
CONCLUSIONS AND FUTURE WORK
7.1 Conclusions
The successful purification and preliminary characterization of D(—)-mandelate 
dehydrogenase from the yeast R. graminis strain KGX 39 has allowed a comparison of its 
properties with other mandelate dehydrogenases, which had previously been purified only 
from bacteria, and with various NAD+-dependent dehydrogenases.
The enzyme is analogous to both the D(—)-mandelate dehydrogenase of 
L. curvatus and the D(—)-2-hydroxyisocaproate dehydrogenase of S. faecalis (Yamazaki & 
Maeda, 1986; Hummel et al., 1988). All three enzymes are dimers of identical subunits 
and have similar properties with respect to Mr , quaternary structure, cofactor specificity, 
reversibility of the reaction catalysed, pH dependence of activity and common 2-hydroxy 
and 2-oxocarboxylic acids that they bind.
In contrast, comparison of the R. graminis D(—)-mandelate dehydrogenase with 
the D(—)- and L(+)-mandelate dehydrogenases of A  calcoaceticus shows them to be 
very different. Both of these bacterial enzymes are flavin-dependent, integral membrane 
proteins that catalyse the irreversible oxidation of mandelate. They differ from the 
R. graminis D(—)-mandelate dehydrogenase with respect to intracellular location, M{ , 
quaternary structure, pH optimum, cofactor used and sensitivity to thiol reagents 
(Allison et al., 1985a,b; Hoey et al., 1987). Furthermore, neither of the bacterial enzymes 
is related immunologically to the yeast enzyme. The L(+)-mandelate dehydrogenase of 
P. putida is similar to the A  calcoaceticus L(+)-mandelate dehydrogenase and, likewise, 
differs from the R. graminis D(—)-mandelate dehydrogenase with respect to intracellular 
location, , quaternary structure and cofactor used (Gunsalus et al., 1953; Stanier et al., 
1953; Tsou et al., 1990; C. A. Fewson, personal communication). The amino terminus of 
the P. putida L(+)-mandelate dehydrogenase also lacks homology with the R. graminis 
D(—)-mandelate dehydrogenase amino terminus and, even though there is some 
sequence similarity between TP 1 and the carboxy terminus of the P. putida enzyme, the 
two proteins are overall quite distinct. In addition to the bacterial NAD(P)+-independent 
mandelate dehydrogenase, the R. graminis L(+)-mandeIate dehydrogenase is also 
NAD(P)+-independent, catalyses the irreversible oxidation of mandelate, presumably 
contains flavin and is membrane "associated1' (Durham, 1984; M. Yasin, personal 
communication).
On the basis of these comparisons there seem to be two clearly definable groups 
of mandelate dehydrogenase in both prokaryotes and eukaryotes : integral membrane 
proteins requiring flavin as prosthetic group and soluble, NAD+-dependent proteins. This 
dichotomy is similar to that for other enzymes such as fructosebisphosphate aldolase, 
fumarase, quinate dehydrogenase and 3-dehydroquinase which are also found in more 
than one form, although the differences between the two groups of mandelate 
dehydrogenase reflects more closely the differences between the NAD+-dependent and 
NAD(P)+-independent lactate dehydrogenases found in bacteria (Garvie, 1980).
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However, classification of the various mandelate dehydrogenases into only two 
groups is perhaps rather superficial as regards their evolutionary origin, especially when 
one considers that marked differences occur between the enzymes within each group. 
For example, although all of the bacterial NAD(P)+-independent enzymes are monomeric, 
integral membrane proteins requiring flavin as prosthetic group, the D(—)-mandelate 
dehydrogenase of A  calcoaceticus has a Mf of 60 000 and uses FAD, whereas the 
L(+)-mandelate dehydrogenases of A  calcoaceticus and P. putida have Mx values of 
44 000 and use FMN. On the basis of these comparisons, the enzymes may be further 
divided into two sub-groups, one containing the A  calcoaceticus D(—)-mandelate 
dehydrogenase and the other containing the A  calcoaceticus and P. putida 
L(+)-mande!ate dehydrogenases, with the two groups presumably having independent 
evolutionary origin. Indeed, this delineation is supported by the observation that the 
D(—)-mandelate dehydrogenase of A  calcoaceticus is more similar to the D(—-)-lactate 
dehydrogenase of this bacterium, than it is to L(+)-mandelate dehydrogenase and, 
likewise, the L(+)-mandelate dehydrogenase is more similar to L(+)-lactate  
dehydrogenase than it is to D(—)-mandelate dehydrogenase (Table 7.1). Moreover, this 
has led to the suggestion that the pair of D(—)-enantiomer specific dehydrogenases had 
a common evolutionary origin, as did the pair of L(+)-enantiomer specific 
dehydrogenases but a common origin for all four enzymes is much less likely 
(Allison et al., 1985b; Hoey ef al., 1987).
Similarly, the enzymes of the NAD+-dependent group of mandelate 
dehydrogenases may be further divided into two sub-groups, one containing the 
R. graminis D(—)-mandelate dehydrogenase and the other containing the L. curvatus 
D(—)-mandelate dehydrogenase and S. faecalis D(—)-2-hydroxyisocaproate 
dehydrogenase. Although the three enzymes are similar in many respects (Table 7.2), 
there are significant differences between the R. graminis D(—)-mandelate dehydrogenase 
and the two bacterial enzymes. The yeast enzyme shows marked insensitivity to 
4-(chloromercuri)benzoate, is unable to oxidise a number of aliphatic 2-hydroxyacids 
which are substrates of the L  curvatus and S. faecalis enzymes and, in addition, it is not 
related immunologically to either of the bacterial enzymes. Furthermore, inclusion of all 
three enzymes in the same group ignores the fact that whilst the R. graminis 
D(—)-mandelate dehydrogenase is an inducible enzyme which forms part of a metabolic 
pathway for the catabolism of D(—-)-mandelate, the two bacterial enzymes are probably 
constitutively expressed and have a different physiological role. The two groups of 
NAD+-dependent mandelate dehydrogenases are likely to have had independent 
evolutionary origin, and their ability to oxidise D(—)-mandelate and reduce 
phenylglyoxylate has presumably arisen by coincidence rather than by a common 
functional requirement. This is perhaps not too surprising when one considers that 
R. graminis is a nutritionally versatile yeast whereas L. curvatus and S. faecalis are 
nutritionally fastidious bacteria, and presumably the selection pressures to which they are 
subject are quite dissimilar (Deibel & Seeley, 1974; Rogosa, 1974; Fell etaI., 1984).
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In conclusion, It seems highly unlikely that the R. graminis D(—)-mandelate 
dehydrogenase evolved from an NAD(P)+-independent enzyme as represented by the 
D(—)- and L(+)-mandelate dehydrogenases of A  calcoaceticus and P. putida. It is also 
unlikely to have evolved by means of duplication and subsequent mutation of the gene 
encoding L(+)-mandelate dehydrogenase in this yeast, as not only enantiomer specificity 
but also cofactor dependence and therefore reaction mechanism would have required 
major modification.
A much more likely candidate for the D(—)-mandelate dehydrogenase ancestor is 
another soluble, NAD+-dependent 2 -hydroxyacid dehydrogenase. Recruitment of such 
an enzyme by mutation or duplication of an existing gene might have provided an enzyme 
with an established NAD+-dependence and reaction mechanism capable of abstracting 
two hydrogens from a 2-hydroxyacid and, therefore, relatively few mutations at the 
substrate binding site might have been required to endow the resultant enzyme with 
D(—)-mandelate dehydrogenase activity. It is not too difficult to imagine such a process 
giving rise to D(—)-mandelate dehydrogenase activity, especially in view of the few 
mutations which were required at the active site of Bacillus stearothermophilus 
L(+)-lactate dehydrogenase in order to alter its substrate specificity away from oxidising 
lactate/reducing pyruvate towards oxidising malate/reducing oxaloacetate. In a rational 
re-design of the active site by site-directed mutagenesis, threonine-246 was mutated to a 
glycine thereby increasing the volume of the active site, glutamine-102 was mutated to an 
arginine to provide a counterion for the second carboxyl group of malate/oxaloacetate 
and aspartate-197 was mutated to an asparagine in order to avoid possible charge 
repulsion with the second carboxyl group. As a result, the triple-mutant enzyme catalysed 
the reduction of oxaloacetate (as determined by the ratio of kceA /  500 times more
effectively than the reduction of pyruvate, compared to the wild-type enzyme which 
catalysed the reduction of pyruvate 1000 times more effectively than the reduction of 
oxaloacetate and, furthermore, this change of substrate specificity was mirrored in the 
ability of the mutant enzyme to catalyse the oxidation of malate more effectively than the 
oxidation of L(+)-lactate (Clarke et al., 1987). If D(—)-mandelate dehydrogenase had 
evolved from another 2-hydroxyacid dehydrogenase, then it is plausible that incorporation 
of hydrophobic residues, which could solvate the aromatic ring of D(—)-mandelate, might 
have been the only substitutions required to alter the substrate specificity of the ancestral 
enzyme.
Recruitment of the enzyme to the mandelate pathway of R. graminis, even though 
it functions against the equilibrium of the reaction and has relatively poor D(—-)-mandelate 
dehydrogenase activity, presumably represented a strong selective advantage in enabling 
the yeast to grow on an additional carbon source. Indeed, recruitment of a reversible, 
NAD+-dependent lactate dehydrogenase in the bacterium Neisseria gonorrhoeae seems 
to be the mechanism by which mutants of this bacterium overcome deficiency of the 
membrane-bound, NAD(P)+-independent lactate dehydrogenase which normally 
catalyses the oxidation of lactate. The ability of the wild-type organism to grow on lactate,
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phenyllactate or 4-hydroxyphenyllactate as the sole source of carbon and energy is 
endowed, in part, by a broad-specificity membrane-bound, NAD(P)+-independent lactate 
dehydrogenase which irreversibly couples the oxidation of these 2-hydroxyacids to the 
reduction of c-type cytochromes (Bhatnagar et al., 1989). However, mutants which lack 
this enzyme can still grow on lactate (but not on phenyllactate or 4-hydroxyphenyllactate), 
since they retain a cytoplasmic, NAD+-dependent lactate dehydrogenase which 
presumably functions in the reverse-of-normal direction and, moreover, works against the 
equilibrium of the reaction in a similar manner to the R. graminis D(—)-mandelate 
dehydrogenase (Hendry etai., 1990).
Finally, if the L(+)-mandelate dehydrogenase was already established in this 
yeast, which is possible in view of the fact that no strains of Rhodotorula were found to 
have a D(—)-mandelate dehydrogenase in the absence of an L(+)-mandelate 
dehydrogenase, it would have enabled the organism to utilise both enantiomers and 
therefore compete more favourably against other microorganisms.
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Table 7.1 Comparison of the D(—)-mandelate and D(—)-lactate dehydrogenases and 
the L(+)-mandelate and L(+)-lactate dehydrogenases of A  calcoaceticus
Information is taken from Allison et al. (1985a,b), Allison & Fewson (1986) and Hoey et al. 
(1987). Reproduced from Hoey et al. (1987).
L-Mandelate L-Lactate D-Mandelate 
dehydrogenase dehydrogenase dehydrogenase
D -Lactate 
dehydrogenase
Inducer Phenylglyoxylate d -  or L-Lactate Phenylglyoxylate d - or L-Lactate
Location All are integral components of the cytoplasmic membrane
Solubilization by non-ionic 43-72 55-76 87-91 83-98
detergents (e.g. Triton-X-100 or
Lubrol) (% of activity released)
Solubilization by ionic detergents 4-42 13-32 78-91 63-87
(e.g. cholate or deoxycholate)
(%  of activity released)
M r (monomer) 44000 40000 60000 63000
pi value 4.2 <  4.0 5.5 5.8
pH optimum 7.5 7.5 8.0 7.7
Specific activity (units/mg of 16.1 27.6 322 338
protein)
Stereospecificity All are stereospecific for their substrate
Km value for substrate (j/m) 186 83 385 (in addition 308
D-lactate is a substrate
but Km — 4.8 mM)
Assay conditions 2,6-Dichloroindophenol reduction measured in the presence of Ar-methylphenazonium
methosulphate or V-methylphenazonium ethosulphate. All require bovine serum albumin
(or Triton X-100 in the case of D-mandelate dehydrogenase and D-lactate dehydrogenase)
in the reaction mixture for full activity
Inhibitors None is affected by a wide range of chelating agents. All are moderately susceptible to
several thiol-blocking reagents. All are inhibited by oxalate
Inhibition by p-chloro- Moderate ( > 3 0  « m )  Moderate Very severe (<  1 « m ) Severe (approx. 5 /iu)
mercuribenzoate (concn.
giving 50 % inhibition)
Cofactor (non-covalently bound) FM N  FM N  FAD FAD
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Table 7.2 Comparison of the D(—)-mandelate dehydrogenase of R. graminis, the 
D(—)-mandelate dehydrogenase of L  curvatus and the D(—)-2-hydroxyIsocaproate 
dehydrogenase of S. faecaiis
Information is taken from this thesis, Yamazaki & Maeda (1986) and Hummel etal. (1988).
R. graminis L  curvatus S. faecalis
Location all are soluble enzymes
Subunit M t 38 000 30 000 34 000
Quaternary structure all are dimeric enzymes
pi value 5.9 ND 4.9
Cofactor all use NAD(H) as a cofactor
Reversibility of reaction catalysed all catalyse reversible reactions
pH optimum for D(—)-mande!ate oxidation 9.5 8.5 9.2
pH optimum for phenylglyoxylate reduction 5.85 6.0 4.5
Apparent V value [units (mg protein)*1] :
D(—)-Mandelate oxidation 87 (pH 9.5) ND ND
Phenylglyoxylate reduction 572 (pH 5.85) 2122 (pH 6.0) 897 (pH 7.5)
K 'm for D(—)-mandelate (fjM) 3050 (pH 7.0) 500 (pH 8.5) ND
325 (pH 9.5)
K ' for phenylglyoxylate (pM) 52 (pH 5.85)
46 (pH 7.0) 220 (pH 7.0) 3200 (pH 7.5)
K 'm for NAD+ (pM) 309 (pH 7.0)
78 (pH 9.5) 210 (pH 8.5) ND
K 'm for NADH (pM) 38 (pH 5.85)
36 (pH 7.0) 36 (pH 7.0) 35 (pH 7.5)
Inhibition by None at 94% at 100% at
4-(chloromercuri) benzoate 5 mM 100 pM 500 pM
ND, Not determined
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The primary aim of this study was to purify and characterize D(—)-mandelate 
dehydrogenase from R. graminis KGX 39 in order to compare it with other mandelate 
dehydrogenases and NAD+-dependent dehydrogenases and, therefore, to allow 
speculation as to its evolutionary origin. However, the ability of the R. graminis 
D(—)-mandelate dehydrogenase to oxidise 4-hydroxy-3-methoxymandelate raises the 
possibility that this enzyme may be useful as a diagnostic test for determining the urinary 
concentration of this compound.
In mammals, including humans, D(—)-4-hydroxy-3-methoxymandelate 
(vanillymandelate) is a major breakdown product of the hormones adrenalin and 
noradrenalin, and is subsequently excreted from the body in the urine and faeces 
(Armstrong et al., 1957; Smith et al., 1959; Lun eta!., 1976). However, in pathological 
conditions such as neuroblastoma and certain hormonal diseases, the levels of urinary 
4-hydroxy-3-methoxymandelate may be greatly elevated over the levels normally found in 
healthy individuals (Tuchman et al., 1985). As a consequence, numerous methods for the 
quantitative determination of urinary 4-hydroxy-3-methoxymandelate have been 
developed, ranging from relatively simple techniques such as photometric analysis, paper 
chromatography, TLC and column chromatography, to more sophisticated ones such as 
gas chromatography, gas-liquid chromatography, HPLC and mass spectrometry 
(Pisano et al., 1962; Godicke & Brosowski, 1964; Annino ef al., 1965; Messiha etal., 1973; 
Lun etal., 1976; Muskiet etal., 1980; Tuchman etal., 1983; Hitoshi etal., 1989). However, 
several of these techniques are time consuming and lack specificity, and even those 
which are specific and quantitative are costly and often require complex laboratory 
equipment.
An alternative approach to these chemical techniques has been the use of 
specific enzymes. Although an early report claiming ability to measure urinary 
4-hydroxy-3-methoxymandelate using an enzyme preparation of P. fluorescens strain 
A.3.12 was later invalidated by the absence of a D(—)-mandelate dehydrogenase in this 
organism, and the inability of its mandelate racemase to interconvert the D(—)- and 
L(+)-enantiomers of 4-hydroxy-3-methoxymandelate (Rosano, 1964; Weil-Malherbe, 
1966), an enzymic method was subsequently developed using a strain of P. putida 
(Hegeman & Ellman, 1973). Despite this, enzymic methods do not seem to have been 
used in clinical practise.
However, with the discovery that purified D(—)-mandelate dehydrogenase from 
R. graminis KGX 39 and crude extracts of the yeasts DB 2 and DB 3 can oxidise 
4-hydroxy-3-methoxymandelate, the possibility arises that these enzymes could be used 
for a cheap and sensitive diagnostic test for determining the urinary concentration of this 
compound. The sensitivity is reliant upon the substantial rate of change in A^  observed 
during the assay of the enzymes with D,L-4-hydroxy-3-methoxymandelate as substrate 
(Section 4.3.6), which accounts for 7.1, 5.9 and 5.6 times the rate of change in Ag^ 
obtained with D(—)-mande!ate, using pure R. graminis KGX 39 D(—)-mandelate 
dehydrogenase and crude extracts of yeasts DB 2 and DB 3 respectively. Comparison of
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the absorption spectra of assay mixtures at equilibrium, with D(—)-mandelate or 
D,L-4-hydroxy-3-methoxymandelate as substrate, have shown that whilst phenylglyoxylate 
has negligible absorbance at 340 nm i.e. the monitoring wavelength (Section 4.3.6), 
4-hydroxy-3-methoxyphenylglyoxylate absorbs strongly at this wavelength and, moreover, 
produces a shift in the absorption maximum from 340 nm to 356 nm.
Before any of these enzymes could be used in such a diagnostic test, 
experiments would have to be carried out to determine the molar absorption coefficient of 
4-hydroxy-3-methoxyphenylglyoxylate in order to assess its contribution to the total rate of 
change in Ag^ produced during assay. This could possibly be achieved by de novo 
synthesis, or by enzymically converting D(—)-4-hydroxy-3-methoxymandelate to its 
corresponding substituted phenylglyoxylate. However, as 4-hydroxy-3-methoxymandelic 
acid is commercially available only as a racemic mixture, then the D(—)-enantiomer would 
require separation from the L(+)-enantiomer prior to enzymic oxidation. In the course of 
the present work, attempts were made to separate the two enantiomers by 
chromatography on a chiral column, and although some success was achieved in 
producing partial separation, the two enantiomers could not be fully separated. If pure 
4-hydroxy-3-methoxyphenylglyoxylic acid could be obtained, then the concentration of 
4-hydroxy-3-methoxymandelate in solution could be determined from a standard curve of 
the final A340 at equilibrium and the ratio of the molar absorption coefficients at 340 nm of 
NADH and 4-hydroxy-3-methoxyphenylglyoxylate.
if this procedure was found to be suitable as a potential diagnostic test, clinical 
trials could then be carried out to determ ine the concentrations of 
4-hydroxy-3-methoxymandelate in the urine of healthy individuals and patients with 
conditions producing abnormally high levels of this compound. Such a diagnostic test 
might involve spectrophotometric assay using the enzyme free in solution or, alternatively, 
the enzyme might be appropriate for use with a dip-stick if it could be coupled to a 
secondary enzyme e.g. an NADH-dependent reductase which could utilise the NADH 
produced by D(—)-mandelate dehydrogenase to reduce a suitable chromophore, and 
therefore indicate the concentration of 4-hydroxy-3-methoxymandelate by a colour 
change. It might also be necessary to over-express the enzyme in order to obtain large 
quantities, and the antisera raised against D(—)-mandelate dehydrogenase 
(Section 2 .11.1) would therefore be useful for screening an expression library 
(Young & Davis, 1983).
Finally, if such a diagnostic test was successful it would represent a cheaper 
means of screening a larger number of individuals, and even if it were not as accurate as 
some of the chromatographic techniques available it might nevertheless identify those 
individuals for which further analysis was appropriate.
Page 190
7.2 Future work
Although preliminary characterization of the R. graminis D(—)-mandelate dehydrogenase 
and comparison of its properties with other mandelate dehydrogenases and 
NAD+-dependent dehydrogenases has allowed speculation as to its evolutionary origin, 
a more detailed study is required to further elucidate any evolutionary relationships this 
enzyme may have with analogous and possibly homologous enzymes. To determine 
whether any such relationships exist and, in particular, to answer those questions raised 
in this thesis, a number of potentially useful future experiments are outlined in the 
following sections.
7.2.1 Cloning and sequencing of the D(—)-mandelate dehydrogenase gene
Although approximately one quarter of the D(—)-mandelate dehydrogenase amino acid 
sequence has so far been determined (Section 4.2.3 & 5.7), a more detailed comparison 
with other enzymes cannot be made until the full sequence of the yeast protein is known. 
Therefore, the gene encoding D(—)-mandelate dehydrogenase should be cloned and 
sequenced, and this would not only give the nucleotide sequence but also allow the 
amino acid sequence to be deduced.
Although the genes of S. cerevisiae contain very few introns, thereby allowing 
cloning of genomic DNA which corresponds exactly to the amino acid sequences of the 
respective proteins, the coding regions of other fungal genes have been found to be 
punctuated with introns e.g. those of Neurospora crassa, Schizosaccharomyces pombe 
and Trichoderma reesei (Shoemaker et al., 1983; Fink, 1987). Moreover, the 
phenylalanine ammonia lyase genes of Rhodotorula rubra and the related yeast 
Rhodosporidium toruloides contain 5 and 6 short introns respectively (Anson et al., 1987; 
Vaslet et al., 1988). Therefore, in order to avoid the possibility of cloning introns, the 
D(—)-mandelate dehydrogenase gene should be cloned from a cDNA library made from 
purified R. graminis mRNA. Then, after insertion into the appropriate vector(s) and 
transformation of E. coli or S. cerevisiae, positive clones should be identified using the 
oligonucleotide "probe" described in Section 4.5.1. The gene would then presumably be 
sequenced after cloning of restriction fragments into M13 sequencing vector(s).
Alternatively, in view of the fact that the subunit is only 350 or so residues in 
length, the sequence might more easily be determined by sequencing peptides produced 
from chemical and/or proteolytic cleavage. Indeed, cyanogen bromide cleavage as 
described by Kasper (1970) might be particularly useful in producing large peptides as 
the enzyme has relatively few methionine residues i.e. approximately 4 per subunit 
(Section 4.2.2).
Once the full gene and/or protein sequences are known, it would then enable a 
more thorough comparison with the archived sequences and structural motifs of other 
NAD+-dependent dehydrogenases as well as with the sequences of the P. putida 
mandelate racemase and L(+)-mandelate dehydrogenase, although comparison of the
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gene sequence would be more informative because of the degeneracy of the genetic 
code (Yokoyama et al., 1990). In addition, sequencing would enable the identity of the 
unknown residues of tryptic peptides 1 and 2  to be determined.
7.2.2 Further active site studies
Although various active site studies have already been carried out on the R. graminis 
D(—)-mandelate dehydrogenase, comparatively little is known about the active site of this 
enzyme as compared to the wealth of information available for other NAD+-dependent 
dehydrogenases. Therefore, a number of additional experiments are proposed which 
may be useful in identifying residues at the active site. Firstly, inhibition studies using 
diethylpyrocarbonate might indicate whether there is an active site histidine, which 
although it was suggested from the analysis of acid hydrolysates of enzyme inactivated 
with D(—)-2-(bromo[14C]acetyl)mandelate (Section 5.8), was nevertheless not proven. 
In addition, the reagent phenylglyoxal could also be tried as a potential inhibitor as it is 
structurally analogous to phenylglyoxylate and, as it is considered as an arginine specific 
reagent, might indicate the presence of an active site arginine residue which could 
potentially form a salt bridge with the carboxylate group of D(—)-mandelate and 
phenylglyoxylate.
It w ould  also be of im p o r ta n c e  to o b ta in  h o m o g e n e o u s  
D(—)-2-(bromoacety I)mandelic acid to repeat the inactivation studies and, in particular, 
the stoicheiometry of inactivation with affinity label free of contaminant. Furthermore, 
inactivation of D(—)-mandelate dehydrogenase at various values of pH should enable the 
pKa values of the groups which bind and react with the affinity label to be determined, and 
comparison with the pKa values obtained from the effect of pH on kcgX /Km , should 
indicate whether the same groups are involved in substrate binding and catalysis 
(Fersht, 1985).
7 .2 .3  Determ ination of the 3-dim ensional structure of D(—)-m andelate  
dehydrogenase by X-ray crystallography
Ultimately, the crystal structure of D(—)-mande!ate dehydrogenase should be determined 
in order to allow comparison with a number of other NAD+-dependent dehydrogenases 
for which crystal structures are available. In addition, comparisons could also be made 
with other mandelate pathway enzymes for which crystal structures are available or are 
presently being sought i.e. mandelate racemase and phenylglyoxylate decarboxylase 
from P. putida (Neidhart etal., 1988; G. A. Petsko, personal communication). The ability to 
purify tens of milligrams of homogeneous D(—)-mandelate dehydrogenase of sufficient 
purity for crystallographic study, without the prior need to over-express the protein should 
be of substantial benefit although, if the enzyme does crystallise, its sequence would have 
to be determined in order to fit the amino acid sequence to its electron density map.
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If the crystal structure of D(—)-mandelate dehydrogenase was determined it 
would allow some important questions regarding the structural evolution of this enzyme to 
be answered. For example, is the subunit composed of two distinct domains and, if so, 
does one of the domains bind the NAD+ and have the characteristic nucleotide-binding 
fold found in other NAD+-dependent dehydrogenases such as lactate, malate, alcohol 
and glyceraldehyde-3-phosphate dehydrogenases ? If so, it would support the notion 
that D(—)-mandelate dehydrogenase has evolved by recruitment of an NAD+-dependent 
dehydrogenase from another metabolic pathway.
Analysis of the crystal structure might also indicate which residues at the 
substrate binding site are responsible for the enzyme’s apparent specificity towards 
ring-containing substrates. In this respect, comparison with the crystal structures of 
mandelate racemase and phenylglyoxylate decarboxylase would be particularly 
interesting as D(—)-mandelate dehydrogenase binds the substrates of both these 
enzymes. Determination of the crystal structure, along with further active site studies and 
kinetic analysis should enable the role of specific active site residues in substrate binding 
and catalysis to be determined.
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